drug_1_CID,drug_1_name,drug_1_SMILES,relationship,drug_2_CID,drug_2_name,drug_2_SMILES
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,hypermagnesemia,CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,angiitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,angiitis,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,drug toxicity NOS,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,apoplexy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,drug toxicity NOS,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,erythema,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,Adenopathy,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,connective tissue disease,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,Adenopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,Adenopathy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,Clotting,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,loss of weight,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,cholecystitis,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,dysarthria,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,abnormal EEG,CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,icterus,CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,retinopathy of prematurity,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,insulin dependent diabetes mellitus,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,insulin dependent diabetes mellitus,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,gastric inflammation,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,insulin dependent diabetes mellitus,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,drug toxicity NOS,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,abnormal ECG,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,retinopathy of prematurity,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,insulin dependent diabetes mellitus,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,insulin dependent diabetes mellitus,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,Back Ache,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,insulin dependent diabetes mellitus,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,Adenopathy,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,ear infection,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002173,"6-{[Amino(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C,apoplexy,CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,angiitis,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,bursitis,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,chest pain,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,periodontitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Acne,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,myelodysplasia,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Back Ache,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,High blood pressure,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,contact dermatitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,hemiparesis,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,myelodysplasia,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,myelodysplasia,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug toxicity NOS,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,abnormal EEG,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,abnormal EEG,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,dysarthria,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,angiitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,icterus,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,thrombocytopenia,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,respiratory alkalosis,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,bursitis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Back Ache,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,heart rate increased,CID000003562,151-67-7,C(C(F)(F)F)(Cl)Br
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,deglutition disorder,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,excessive thirst,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,increased white blood cell count,CID000150610,ertapenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,myelodysplasia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Lyell,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,eruption,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug toxicity NOS,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,deglutition disorder,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,rhinorrhea,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,right heart failure,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,neumonia,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Pain,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Pain,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,bulging,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,angioedema,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Pain,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,heart rate increased,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,abnormal ECG,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,muscle disorder,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,als,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Dyspnea exertional,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,fracture nonunion,CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,thrombocytopenia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,thrombocytopenia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,muscle paresis,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,dysarthria,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,glossodynia,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,nervous tension,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,subarachnoid haemorrhage,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,allergic dermatitis,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,subarachnoid haemorrhage,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Pain,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Acne,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,angiitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Decreased Libido,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,allergic dermatitis,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug toxicity NOS,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,hypermagnesemia,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,right heart failure,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,glossodynia,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,abnormal EEG,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Diplopia,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,acute pancreatitis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,abnormal EEG,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,agitated,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,dysarthria,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Abnormal Gait,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,neumonia,CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,pulmonary hypertension,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Arrhythmia,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,eruption,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystectomies,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,thrombocytopenia,CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,dysarthria,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,bulging,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,constipated,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,enlarged liver,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,alkalosis,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Dyspnea exertional,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,weight gain,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug withdrawal,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,acute pancreatitis,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,peritonitis,CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,eruption,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,colitis ischemic,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,edema,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cellulitis,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,eruption,CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atrial ectopic beats,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Personality disorder,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug toxicity NOS,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,agitated,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,disseminated lupus erythematosus,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,thrombocytopenia,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Sinus headache,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug toxicity NOS,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,eruption,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Back Ache,CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Enuresis,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,periodontitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003345,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,aspiration pneumonia,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,atelectasis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,increased white blood cell count,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,abnormal ECG,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,drug toxicity NOS,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,abnormal ECG,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,nasopharyngitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,constipated,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000009433,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,nasopharyngitis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,eruption,CID000150610,ertapenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,insulin dependent diabetes mellitus,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,insulin dependent diabetes mellitus,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,carcinoma of the colon,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,thrombocytopenia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,loss of weight,CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,increased white blood cell count,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,heart rate increased,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,orchiectomy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,angiitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,myelodysplasia,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,edema,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,eruption,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,High blood pressure,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Pain,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,increased white blood cell count,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,angiitis,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Glucose intolerance,CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,weight gain,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,gastric inflammation,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,High blood pressure,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Pleural Effusion,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,hepatitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,thrombocytopenia,CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,allergic dermatitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,right heart failure,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Diplopia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,angiitis,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Bleeding,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,insulin dependent diabetes mellitus,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,right heart failure,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Sinusitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cellulitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,loss of weight,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,edema,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,insulin dependent diabetes mellitus,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,carcinoid syndrome,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cellulitis,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,right heart failure,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Adenopathy,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Bacteraemia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,angiitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,haemorrhage intracranial,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,hypochloraemia,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,loss of weight,CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,thrombocytopenia,CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,angiitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cellulitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,loss of weight,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,proctalgia,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,thrombocytopenia,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,thrombocytopenia,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,loss of weight,CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,gastric inflammation,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,confusion,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,metabolic encephalopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cellulitis,CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,weight gain,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,thrombocytopenia,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Dyspnea exertional,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,decubitus ulcer,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cellulitis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,erythema,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,aspiration pneumonia,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,metabolic encephalopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,apoplexy,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,High blood pressure,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,neumonia,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,deglutition disorder,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,agitated,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,confusion,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,loss of weight,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,myelodysplasia,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,gastric inflammation,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Excess potassium,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,muscle disorder,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,insulin dependent diabetes mellitus,CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,insulin dependent diabetes mellitus,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,myelodysplasia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cellulitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,myelodysplasia,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,heart rate increased,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,gastric inflammation,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,gastric inflammation,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,angiitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,thrombocytopenia,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,elevated erythrocyte sedimentation rate,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,ADVERSE DRUG EFFECT,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,weight gain,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,increased white blood cell count,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,confusion,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003929,rac-Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,colitis pseudomembranous,CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO
CID000150610,ertapenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O,convulsion,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Dyspnea exertional,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,drug toxicity NOS,CID000002800,911-45-5,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dacrocystitis,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,nasopharyngitis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,elevated erythrocyte sedimentation rate,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,weight gain,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,abnormal ECG,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Sinus headache,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastroenteritis viral,CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dysarthria,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,neumonia,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Acne,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,aspiration pneumonia,CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,anal pruritus,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,malabsorption,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,obesity,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Bleeding,CID000002215,Apomorphine,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Pain,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,nausea,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Bone Fracture Spontaneous,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Infection Upper Respiratory,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,deafness,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,inflammatory bowel disease,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Dyspnea exertional,CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dacrocystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Infection Upper Respiratory,CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Dyspnea exertional,CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Back Ache,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,empyema,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,angiitis,CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,mouth pain,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,increased white blood cell count,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Back Ache,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,angiitis,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,nasopharyngitis,CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,nasopharyngitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,ear ache,CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Acne,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,bursitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,myelodysplasia,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Dyspnea exertional,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Dyspnea exertional,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,thrombocytopenia,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,abnormal EEG,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Bleeding,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,drug withdrawal,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,thrombocytopenia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Sinus headache,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,deglutition disorder,CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dysarthria,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,bursitis,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,angiitis,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,angiitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,drug toxicity NOS,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,elevated cholesterol,CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,coughing blood,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Back Ache,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,arterial pressure NOS increased,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,panic attack,CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,elevated cholesterol,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,multifocal leukoencephalopathy,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dysarthria,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000024011,BLAH,S=[Se]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,atelectasis,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,insulin dependent diabetes mellitus,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,angiitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystectomies,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,weight gain,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,thrombocytopenia,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Back Ache,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Bone Fracture Spontaneous,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Dyspnea exertional,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,edema,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,drug withdrawal,CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Bone Fracture Spontaneous,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Dyspnea exertional,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Osteoarthritis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,abnormal ECG,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,abnormal EEG,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Acne,CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Dyspnea exertional,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Acne,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,abnormal ECG,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,confusion,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,increased white blood cell count,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dacrocystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,bipolar disorder,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,trigeminal neuralgia,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,right heart failure,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,hyperalimentation,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,abdominal pain upper,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,insulin dependent diabetes mellitus,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Back Ache,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,insulin dependent diabetes mellitus,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,disorder Renal,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,angina,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dacrocystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dysarthria,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Acne,CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastroenteritis viral,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,body temperature increased,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Back Ache,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Sinus headache,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dacrocystitis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Atherosclerosis,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,anal pruritus,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,angiitis,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dacrocystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,glaucoma,CID000002170,Amoxapine,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,confusion,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,icterus,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Atherosclerosis,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,rotator cuff syndrome,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,edema,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystectomies,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,aseptic necrosis bone,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,adenomyosis,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dacrocystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,apoplexy,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000002733,95-25-0,C1=CC2=C(C=C1Cl)NC(=O)O2
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Adenopathy,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,angiitis,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,erythema,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,angiitis,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,rotator cuff syndrome,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,hepatic neoplasia,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,loss of weight,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dysarthria,CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,periodontitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,back injury,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,dacrocystitis,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,cholecystitis,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,Decreased Libido,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,coughing blood,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,muscle inflammation,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000001302,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Back Ache,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,gout,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,ear ache,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,enlarged liver,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,allergic dermatitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,insulin dependent diabetes mellitus,CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,adenitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Adenopathy,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Neuromuscular Disorder,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Adenopathy,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,enlarged liver,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,gastric inflammation,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,erythema,CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,gout,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Adenopathy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,confusion,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,apoplexy,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Back Ache,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,thrombocytopenia,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,drug toxicity NOS,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,thrombocytopenia,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Adenopathy,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,subarachnoid haemorrhage,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,angiitis,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,dry skin,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,nausea,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,gastric inflammation,CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,drug toxicity NOS,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Back Ache,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,eruption,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Embolism pulmonary,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,ear ache,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,High blood pressure,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Adenopathy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,dizziness,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,thrombocytopenia,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,apoplexy,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,agitated,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,back injury,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,tetany,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Dyspnea exertional,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Adenopathy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,cholecystitis,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Difficulty breathing,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,loss of weight,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Adenopathy,CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
CID000005064,"1-Pentofuranosyl-1H-1,2,4-triazole-3-carboxamide",C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,thrombocytopenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,bleeding Vaginal,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,anaphylactic reaction,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,pulmonary hypertension,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,rhinorrhea,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,failure to thrive,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,eruption,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,respiratory failure,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,thrombocytopenia,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Fainting,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Spinal fracture,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,thrombocytopenia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,right heart failure,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,back injury,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Neutropenia,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,failure to thrive,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,methaemoglobinaemia,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,rotator cuff syndrome,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,right heart failure,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,deglutition disorder,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,pancreatic cancer,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,abnormal ECG,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Scleroderma,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,respiratory alkalosis,CID000005505,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,ear infection,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,erythema,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,edema,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,cholecystectomies,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,abnormal ECG,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Supraventricular tachycardia,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,nocturia,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,deglutition disorder,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Adenopathy,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,weight gain,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,hepatic neoplasia,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,myelodysplasia,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,High blood pressure,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,abnormal ECG,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,neumonia,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,metabolic encephalopathy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,edema,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Adenopathy,CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Adenopathy,CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,enlarged liver,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,failure to thrive,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,ADVERSE DRUG EFFECT,CID000024011,BLAH,S=[Se]
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,right heart failure,CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,erythema,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,eruption,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,diarrhea,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Bacteraemia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,allergic dermatitis,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,anaphylactic reaction,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,insulin dependent diabetes mellitus,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,dysarthria,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Adenopathy,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,neumonia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,nasopharyngitis,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,cellulitis,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Scleroderma,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,abnormal ECG,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,abnormal ECG,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gout,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Dyspnea exertional,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,drug toxicity NOS,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Adenopathy,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,fractured pelvis NOS,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,rectal polyp,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,weight gain,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,thrombocytopenia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Back Ache,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,right heart failure,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,thrombocytopenia,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,abnormal ECG,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,peritonitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,angiitis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,loss of weight,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Adenopathy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,thrombocytopenia,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000005267,"S-(10,13-Dimethyl-3,5′-dioxo-1,2,3,4′,5′,6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3′H-spiro[cyclopenta[a]phenanthrene-17,2′-furan]-7-yl) ethanethioate",CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,apoplexy,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,atelectasis,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,dysarthria,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,erythema,CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,erythema,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Infection Urinary Tract,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Adenopathy,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,gastric inflammation,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cholelithiasis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Adenopathy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,nasopharyngitis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Back Ache,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,disseminated lupus erythematosus,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,weight gain,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,bleeding Vaginal,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,galactorrhea,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,muscle disorder,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,back injury,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,gastric inflammation,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Back Ache,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cholecystitis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,abortion spontaneous,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,back injury,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Infection Upper Respiratory,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,migraine,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cholecystitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,eruption,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,hemiplegia,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,weight gain,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,lung edema,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,ear infection,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,apoplexy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cholecystectomies,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,gastric inflammation,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cholecystitis,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Back Ache,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,thrombocytopenia,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,dysarthria,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000010631,520-85-4,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,gastric inflammation,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Dyspnea exertional,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,bursitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,gastric inflammation,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,weight gain,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,neumonia,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,eruption,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,abnormal EEG,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,loss of weight,CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,apoplexy,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Adenopathy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,edema,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,eruption,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,abnormal ECG,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Adenopathy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,cholecystitis,CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,bursitis,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Alcoholic intoxication,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,erythema,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Adenopathy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Anxiety,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,erythema,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Back Ache,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,edema,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,dysarthria,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Adenopathy,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,nausea,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,pulmonary hypertension,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Back Ache,CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Back Ache,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,abnormal ECG,CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,edema,CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,loss of weight,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,elevated cholesterol,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Back Ache,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,apoplexy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,arteriosclerotic heart disease,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004601,Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,abnormal ECG,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Back Ache,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,weight gain,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Adenopathy,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,eruption,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,erythema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Arrhythmia,CID000005505,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Adenopathy,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,nasopharyngitis,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,myelodysplasia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gout,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Pain,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,weight gain,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Back Ache,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,erythema,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,tracheostomy,CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,bursitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Chronic Kidney Disease,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,nervous tension,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,increased white blood cell count,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,atelectasis,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Dyspnea exertional,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,ear infection,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gout,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,allergic dermatitis,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Adenopathy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,loss of weight,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Intertrigo,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Atherosclerosis,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,metabolic encephalopathy,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,loss of weight,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,erythema,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,adenomyosis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,erythema,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gout,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,loss of weight,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Dyspnea exertional,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gout,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Back Ache,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Dyspnea exertional,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Adenopathy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Sinus headache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,edema,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,loss of weight,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,angiitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,angiitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,atelectasis,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,erythema,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,esophageal spasm,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,ear ache,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Dyspnea exertional,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,aphasia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,ear ache,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Dyspnea exertional,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,weight gain,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Back Ache,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,angiitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,loss of weight,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,empyema,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Back Ache,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000005090,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,nasopharyngitis,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Adenopathy,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,icterus,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,dysarthria,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Dyspnea exertional,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,angiitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,cholecystitis,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,cholecystitis,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,right heart failure,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,elevated cholesterol,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,apoplexy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,cholelithiasis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Adenopathy,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Adenopathy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,eruption,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Bacteraemia,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Bleeding,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,apoplexy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Adenopathy,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,increased white blood cell count,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Adenopathy,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,cholecystitis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,nausea,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,neumonia,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,thrombocytopenia,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,angiitis,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,hypoxia,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,elevated cholesterol,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,gastric inflammation,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Dyspnea exertional,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,cellulitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,carcinoma of the cervix,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,apoplexy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Infection Upper Respiratory,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,thrombocytopenia,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,loss of weight,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,gastric inflammation,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005556,Triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,deglutition disorder,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,apoplexy,CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Adenopathy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,aortic regurgitation,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,weight gain,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,abnormal EEG,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,allergic dermatitis,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Back Ache,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Abnormal LFTs,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,insulin dependent diabetes mellitus,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,eruption,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,subarachnoid haemorrhage,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,High blood pressure,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,hyperglycaemia,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,hyperalimentation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,right heart failure,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,edema,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,respiratory failure,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,apoplexy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,kidney transplant,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Acne,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,apoplexy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,hyperglycaemia,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,neumonia,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,erythema,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,dizziness,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,elevated erythrocyte sedimentation rate,CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,failure to thrive,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,erythema,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,failure to thrive,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,bursitis,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,nausea,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cellulitis,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,weight gain,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,loss of weight,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,thrombocytopenia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,neumonia,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,hepatic neoplasia,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Spinal fracture,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,erythema,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,loss of weight,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Adenopathy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Adenopathy,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,apoplexy,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,drug toxicity NOS,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Bleeding,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,lung infiltration,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,insulin dependent diabetes mellitus,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,thrombocytopenia,CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Acne,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,polymyalgia rheumatica,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,bursitis,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholelithiasis,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,weight gain,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Bleeding,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,elevated cholesterol,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Adenopathy,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Excess potassium,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,ear infection,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,thrombocytopenia,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,thrombocytopenia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Fainting,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,erythema,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,enlarged liver,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,loss of weight,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,icterus,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastroenteritis viral,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,erythema,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,eye swelling,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,aortic regurgitation,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,ADVERSE DRUG EFFECT,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,back injury,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,bladder retention,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,loss of weight,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,Pain,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,erythema,CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,back injury,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,apoplexy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,weight gain,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,insulin dependent diabetes mellitus,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,abnormal EEG,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004946,b-Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Back Ache,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Light sensitivity,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,retinal degeneration,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,loss of weight,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,dry skin,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Back Ache,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,weight gain,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,cholecystitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,rotator cuff syndrome,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Abnormal LFTs,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Arrhythmia,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,heart rate increased,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,eruption,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,erythema,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Back Ache,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,apoplexy,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Adenopathy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,defaecation urgency,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,constipated,CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,eruption,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,weight gain,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,haematoma,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,hypermagnesemia,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,erythema,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,constipated,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Thrombophlebitis,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,erythema,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,nasopharyngitis,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,hypermagnesemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,abnormal ECG,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,deglutition disorder,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Aspartate Aminotransferase Increase,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,bursitis,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,edema,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Back Ache,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,constipated,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Adenopathy,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,abnormal ECG,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,atelectasis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,anaemia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,arteriosclerotic heart disease,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,apoplexy,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,dysarthria,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,eruption,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,esophageal stenosis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,agitated,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,myelodysplasia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,nasopharyngitis,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Acne,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,heart rate increased,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,right heart failure,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Adenopathy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gout,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Adenopathy,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,High blood pressure,CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,drug withdrawal,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,drug toxicity NOS,CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cellulitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Acidosis,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Acne,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Adenopathy,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,bursitis,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,dry skin,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,thrombocytopenia,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,excessive salivation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,herpes zoster,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,eruption,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,inflammatory bowel disease,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,abnormal ECG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,back injury,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,subarachnoid haemorrhage,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,atelectasis,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,drug toxicity NOS,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,constipated,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,sinus bradycardia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Adenopathy,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,constipated,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,elevated cholesterol,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,loss of weight,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,loss of weight,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,apoplexy,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,methaemoglobinaemia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Adenopathy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000005391,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,erythema,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,loss of weight,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,tremor,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,confusion,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,confusion,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,acute pancreatitis,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,constipated,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,agitated,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,eruption,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,Bleeding,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000005584,Trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal ECG,CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,cardiac disease,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,right heart failure,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,bladder retention,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal EEG,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal EEG,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,amenorrhea,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal EEG,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,myelodysplasia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,weight gain,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,atelectasis,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,apoplexy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,erythema,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal ECG,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,cholecystitis,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,deglutition disorder,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,pulmonary hypertension,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,cholecystitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal ECG,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal ECG,CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,arteriosclerotic heart disease,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,weight gain,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,thrombocytopenia,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,neuropathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Cardiomyopathy,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Bacteraemia,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,myelodysplasia,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,allergic dermatitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal ECG,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Pain,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,respiratory alkalosis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,High blood pressure,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,adenitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,weight gain,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,weight gain,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,respiratory alkalosis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,myelodysplasia,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal ECG,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Decreased hearing,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,bradycardia,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,weight gain,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Bacteraemia,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Bleeding,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,respiratory alkalosis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,weight gain,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,weight gain,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,night sweat,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,nasopharyngitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,confusion,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Ovarian cancer,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,atelectasis,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Arrhythmia,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal ECG,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Adenopathy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal ECG,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal EEG,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Cardiomyopathy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,cellulitis,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,Adenopathy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004212,65271-80-9,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,abnormal ECG,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,cervicalgia,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,Adenopathy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,muscle inflammation,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,drug toxicity NOS,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,bulging,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,allergic dermatitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,gastric inflammation,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,weight gain,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,rhinorrhea,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,loss of weight,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,atelectasis,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,neuropathy peripheral,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,apoplexy,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,drug toxicity NOS,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000060953,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,thrombocytopenia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,drug toxicity NOS,CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Adenopathy,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Pain,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,muscle paresis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,thrombocytopenia,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,abnormal ECG,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,weight gain,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,mast cell disease,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cholecystitis,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,respiratory alkalosis,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cellulitis,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,drug toxicity NOS,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,atelectasis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,dysarthria,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,thrombocytopenia,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,nausea,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cellulitis,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,lung neoplasm malignant,CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,elevated cholesterol,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,atelectasis,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,ear infection,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,herpes simplex,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Extrasystoles Ventricular,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,allergic dermatitis,CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,dysarthria,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,High blood pressure,CID000001117,14808-79-8,[O-]S(=O)(=O)[O-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,drug toxicity NOS,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,weight gain,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Bacteraemia,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cellulitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,rhinorrhea,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Adenopathy,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,enlarged liver,CID000001546,2-Chloro-9-(2-deoxypentofuranosyl)-9H-purin-6-amine,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,agitated,CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,apoplexy,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,hepatitis,CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Cardiomyopathy,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Pain,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,meningioma,CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,tetany,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,eruption,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,atelectasis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,thrombocytopenia,CID000002725,chlorphenamine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Back Ache,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,icterus,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Bacteraemia,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema multiforme,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,encephalitis viral,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,icterus,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Adenopathy,CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,neonatal respiratory distress syndrome,CID000003198,Econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,abnormal EEG,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,adenitis,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Infection Urinary Tract,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,drug toxicity NOS,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,atelectasis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,atelectasis,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,angiitis,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cellulitis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,constipated,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,atelectasis,CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cholecystitis,CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,scotoma,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,constipated,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,High blood pressure,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,angiitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Bacteraemia,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Extrasystoles Ventricular,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,abnormal ECG,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,right heart failure,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,weight gain,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,drug toxicity NOS,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,elevated cholesterol,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,glaucoma,CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,proctalgia,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,proctalgia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,neumonia,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,allergic dermatitis,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Diplopia,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,confusion,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,phlebothrombosis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,angiitis,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,allergic dermatitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,drug toxicity NOS,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,abnormal EEG,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,edema,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,drug toxicity NOS,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Bleeding,CID000002973,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,atelectasis,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,High blood pressure,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,angiitis,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Back Ache,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Arrhythmia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,angiitis,CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Bone Fracture Spontaneous,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cholecystitis,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,increased white blood cell count,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,apoplexy,CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cellulitis,CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,elevated cholesterol,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,nasopharyngitis,CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Bone Fracture Spontaneous,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,icterus,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,infection,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Adenopathy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,thrombocytopenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Bleeding,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Acute Respiratory Distress Syndrome,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,abnormal EEG,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,abnormal ECG,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,methaemoglobinaemia,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,abnormal EEG,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,abnormal EEG,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,dysarthria,CID000002019,50-76-0,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,ear infection,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,atelectasis,CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Back Ache,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,edema,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000000596,478511-21-6,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,loss of weight,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Bleeding,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],drug withdrawal,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],gastric inflammation,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Adenopathy,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],icterus,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],methaemoglobinaemia,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],right heart failure,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],neumonia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],trigeminal neuralgia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Adenopathy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],chest pain,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],cholelithiasis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],deglutition disorder,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],body temperature increased,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],bleeding Vaginal,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],gastric inflammation,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],eruption,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],loss of weight,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],dysarthria,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005726,"1-(3-Azido-2,3-dideoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Acidosis,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,body temperature increased,CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,eruption,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,elevated cholesterol,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,loss of weight,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,elevated cholesterol,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,elevated cholesterol,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,eruption,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,erythema,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,facial flushing,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,loss of weight,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,nasopharyngitis,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,insulin dependent diabetes mellitus,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,pleural pain,CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,insulin dependent diabetes mellitus,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,elevated cholesterol,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,allergic dermatitis,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,thrombocytopenia,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,nasopharyngitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,kidney pain,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,Dyspnea exertional,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,elevated cholesterol,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,cholelithiasis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,cholelithiasis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,erythema,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,contact dermatitis,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,herpes zoster,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,nasopharyngitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,thrombocytopenia,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,loss of weight,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,intraocular inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,nasopharyngitis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,erythema,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,insulin dependent diabetes mellitus,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,gastroenteritis viral,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,herpes zoster,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,elevated erythrocyte sedimentation rate,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,apoplexy,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,insulin dependent diabetes mellitus,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,insulin dependent diabetes mellitus,CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,bradycardia,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,erythema,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,erythema,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,Pain,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,Arrhythmia,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,loss of weight,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,eruption,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,glaucoma,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,Dyspnea exertional,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,Adenopathy,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002522,"26,27-Cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,elevated cholesterol,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Dyspnea exertional,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cholecystitis,CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cholecystitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Sinus headache,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,edema,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Back Ache,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,edema,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,abnormal ECG,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Decreased Libido,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,neuropathy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gout,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,polymyalgia rheumatica,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,allergic dermatitis,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Adenopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,abnormal ECG,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Stress incontinence,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cellulitis,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,bulging,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,kidney failure,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Adenopathy,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,atelectasis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Diplopia,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,insulin dependent diabetes mellitus,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Ovarian cancer,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,constipated,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,ild,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,abnormal ECG,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Back Ache,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,elevated cholesterol,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,erythema,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,dysarthria,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,back injury,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,erythema,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,rib fracture,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Back Ache,CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,polymyalgia rheumatica,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cholecystitis,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,arterial pressure NOS decreased,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,insulin dependent diabetes mellitus,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,abnormal EEG,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,pulmonary arrest,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cholecystitis,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,haemorrhage rectum,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,abnormal ECG,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,erythema,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,polymyalgia rheumatica,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,dysarthria,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Sinus headache,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,thrombocytopenia,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cholecystitis,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,weight gain,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,weight gain,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,insulin dependent diabetes mellitus,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Sinus headache,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,back injury,CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,drowsiness,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,weight gain,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Adenopathy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Adenopathy,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Back Ache,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,agitated,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,hepatitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,edema,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Supraventricular tachycardia,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,weight gain,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,neumonia,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Sinus headache,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,abnormal ECG,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Sinus headache,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,agitated,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cholecystitis,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,High blood pressure,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,abnormal ECG,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,loss of weight,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Ovarian cancer,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,elevated cholesterol,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Back Ache,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gout,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,polymyalgia rheumatica,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,haemorrhage intracranial,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,apoplexy,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,disseminated lupus erythematosus,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,dysarthria,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,angiitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003308,rac-Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,back injury,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,eruption,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,agitated,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,weight gain,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,agitated,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Back Ache,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Back Ache,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,dysarthria,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,respiratory failure,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystectomies,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,back injury,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,angiitis,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,dysarthria,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Pain,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,atelectasis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Back Ache,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,hepatic neoplasia,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,metabolic encephalopathy,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,rhinorrhea,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,failure to thrive,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Scleroderma,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Dyspnea exertional,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,insulin dependent diabetes mellitus,CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,weight gain,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,narcolepsy,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,dysarthria,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Erythema nodosum,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Colon Spastic,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,angiitis,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,failure to thrive,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,metabolic encephalopathy,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,loss of weight,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cellulitis,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,esophageal stenosis,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,back injury,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,agitated,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,myelodysplasia,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,rhinorrhea,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,weight gain,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,loss of weight,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,dysarthria,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Back Ache,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,agitated,CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Sinus headache,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,drug toxicity NOS,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,right heart failure,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,angiitis,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,peritonitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Bone Fracture Spontaneous,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,periodontitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,abnormal EEG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,weight gain,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,abnormal EEG,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,abnormal ECG,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,abnormal EEG,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Dyspnea exertional,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Back Ache,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,scotoma,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,increased white blood cell count,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Superficial thrombophlebitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Dyspnea exertional,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystectomies,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,abnormal ECG,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,agitated,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Dyspnea exertional,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,right heart failure,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Back Ache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,myelodysplasia,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,weight gain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,abnormal EEG,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,back injury,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Nail disorder,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,angiitis,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cataract,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Dyspnea exertional,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,dysarthria,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,drug toxicity NOS,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,myelodysplasia,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,ear ache,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,adenomyosis,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,loss of weight,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Back Ache,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,apoplexy,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Back Ache,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,myelodysplasia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,cholecystitis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,metabolic encephalopathy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Dyspnea exertional,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,dysarthria,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003446,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,erythema,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O,Pain,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O,abdominal pain upper,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID004183806,"Misoprostol, 1% in cellulose",CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O,Adenopathy,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,angiitis,CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,angiitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,deglutition disorder,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,allergic dermatitis,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,cholecystitis,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,elevated cholesterol,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,angiitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,erythema,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,erythema,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,bursitis,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,drug toxicity NOS,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,back injury,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,nasopharyngitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,enlarged liver,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,dysarthria,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,allergic dermatitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,back injury,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,hyperalimentation,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,weight gain,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Decreased Libido,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,constipated,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,weight gain,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,anaemia,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,back injury,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,eruption,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,hepatic necrosis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Back Ache,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,insulin dependent diabetes mellitus,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,thrombocytopenia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Dyspnea exertional,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,angiitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,bulging,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,loss of weight,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,contact dermatitis,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,atelectasis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,weight gain,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,High blood pressure,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,loss of weight,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,loss of weight,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,bursitis,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Pain,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Dyspnea exertional,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,agitated,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,weight gain,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,drug toxicity NOS,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,nausea,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,cholecystectomies,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,fracture nonunion,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,enlarged liver,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004107,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,weight gain,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Pain,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,confusion,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,angiitis,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,apoplexy,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,elevated cholesterol,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Infection Upper Respiratory,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,angiitis,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,eruption,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,drug toxicity NOS,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,narcolepsy,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,erythema,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,dysarthria,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,edema,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,drug toxicity NOS,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,insulin dependent diabetes mellitus,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,thrombocytopenia,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,bursitis,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,hepatitis,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,erythema,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,deglutition disorder,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,apoplexy,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,weight gain,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,erythema,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Dyspnea exertional,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Bacteraemia,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,dysarthria,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,peritonitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,elevated cholesterol,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Pain,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,erythema,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,insulin dependent diabetes mellitus,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,drug toxicity NOS,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,herpes zoster,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Acne,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,bulging,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Back Ache,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,elevated cholesterol,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Hypoventilation,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Pain,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Dyspnea exertional,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,edema,CID000024011,BLAH,S=[Se]
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,insulin dependent diabetes mellitus,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,High blood pressure,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,erythema,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,loss of weight,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Arrhythmia,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004917,58-38-8,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,gastric inflammation,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cellulitis,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,loss of weight,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,angiitis,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,thrombocytopenia,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Atherosclerosis,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,fibrosing alveolitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Bacteraemia,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,psoriasis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,amentia,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,drug toxicity NOS,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,agitated,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,myelodysplasia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,constipated,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,thrombocytopenia,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,dizziness,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,dry skin,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,deglutition disorder,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,erythema,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,loss of weight,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,bradycardia,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,back injury,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cellulitis,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Bacteraemia,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Infection Upper Respiratory,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,acute pancreatitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Sinus headache,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,myelodysplasia,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,erythema,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,erythema,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,allergic dermatitis,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,increased white blood cell count,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,subarachnoid haemorrhage,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,dysarthria,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,edema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Bacteraemia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,psychoses,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Acne,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,aortic aneurysm,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,edema,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,edema,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,loss of weight,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,High blood pressure,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Back Ache,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,agitated,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,thrombocytopenia,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,bulging,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,back injury,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,coughing blood,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,difficulty in walking,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,erythema,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,allergic dermatitis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,dysarthria,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Back Ache,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,deglutition disorder,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,atelectasis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,loss of weight,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,atelectasis,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,weight gain,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,myelodysplasia,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,abdominal pain upper,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Back Ache,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Anorexia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,heart attack,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Sinus headache,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,diarrhea,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,ear infection,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,loss of weight,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,atelectasis,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,constipated,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Bilirubinaemia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gout,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,elevated cholesterol,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,weight gain,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gout,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,excessive thirst,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,back injury,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,allergic dermatitis,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,rectal prolapse,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Clotting,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,increased white blood cell count,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,increased white blood cell count,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,insulin dependent diabetes mellitus,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,bradycardia,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,loss of weight,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,contact dermatitis,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,rotator cuff syndrome,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,gastric inflammation,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Pain,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,insulin dependent diabetes mellitus,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,erythema,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Back Ache,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,bursitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Adenopathy,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,alopecia,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,Bleeding,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,weight gain,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,cholecystitis,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,ear infection,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003161,"2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione",CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,apoplexy,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,deglutition disorder,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,insomnia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,loss of weight,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,loss of weight,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,elevated cholesterol,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,phlebothrombosis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,loss of weight,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,loss of weight,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,drug toxicity NOS,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Extrasystoles Ventricular,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,dysarthria,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,ear ache,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,back injury,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,agitated,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,alopecia,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,back injury,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,adenomyosis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,right heart failure,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,atelectasis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Back Ache,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,hyperglycaemia,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,ADVERSE DRUG EFFECT,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,back injury,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cerebellar ataxia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gout,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,back injury,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,thrombocytopenia,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,chest pain,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Hypoventilation,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,folate deficiency,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,dysarthria,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystectomies,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,constipated,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,right heart failure,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Back Ache,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,myelodysplasia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,atelectasis,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,confusion,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,hematoma subdural,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,weight gain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,thrombocytopenia,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,back injury,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal EEG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,eruption,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cataract,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,thrombocytopenia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000054454,79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,back injury,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Chest infection,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,cholecystitis,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gout,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,right heart failure,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,respiratory failure,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,angioedema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Adenopathy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,nasopharyngitis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,ADVERSE DRUG EFFECT,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,cholecystitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,right heart failure,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal ECG,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,apoplexy,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal EEG,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Dyspnea exertional,CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Adenopathy,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,peritonitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Back Ache,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,bleeding Vaginal,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,right heart failure,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal EEG,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,right heart failure,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Hepatic failure,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,failure to thrive,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,apoplexy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Adenopathy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal ECG,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal ECG,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,increased white blood cell count,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,peritonitis,CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,weight gain,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,colitis ischemic,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,neumonia,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal ECG,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Infection Upper Respiratory,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,defaecation urgency,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal ECG,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,atelectasis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,ADVERSE DRUG EFFECT,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Sinus headache,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,failure to thrive,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal ECG,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,apoplexy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,apoplexy,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,malnourished,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Excess potassium,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,myelodysplasia,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal EEG,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal ECG,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,acanthosis nigricans,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,allergic dermatitis,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,increased white blood cell count,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Cardiomyopathy,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema multiforme,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,hematoma subdural,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,defaecation urgency,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,right heart failure,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,allergic dermatitis,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Sinus headache,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,insulin dependent diabetes mellitus,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,trigeminal neuralgia,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal ECG,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,dysarthria,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,respiratory alkalosis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,pulmonary arrest,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,scotoma,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Extrasystoles Ventricular,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,obesity,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,rectal polyp,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,subarachnoid haemorrhage,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Back Ache,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,narcolepsy,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Infection Upper Respiratory,CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,stridor,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gout,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,right heart failure,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,panic disorder,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,apoplexy,CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,peritonitis,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,failure to thrive,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,cholecystitis,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,erythema,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,acanthosis nigricans,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,drug toxicity NOS,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal ECG,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Aspartate Aminotransferase Increase,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Dyspnea exertional,CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Adenopathy,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,still birth,CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Atrioventricular block first degree,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,abnormal EEG,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,apoplexy,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,apoplexy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,apoplexy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,Infection Upper Respiratory,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,loss of weight,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,gastric inflammation,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,subarachnoid haemorrhage,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,haematoma,CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
CID000002156,"2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}-N,N-diethylethanaminium",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCC[NH+](CC)CC)I,atelectasis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cellulitis,CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Bone Fracture Spontaneous,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angina,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,methaemoglobinaemia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Bone Fracture Spontaneous,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,weight gain,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,thrombocytopenia,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Dyspnea exertional,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Bacteraemia,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,deglutition disorder,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,drug toxicity NOS,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,haemorrhage intracranial,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,xerosis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,thrombocytopenia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Acute Respiratory Distress Syndrome,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Hoarseness,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,thrombocytopenia,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,muscle inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Cardiomyopathy,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000002973,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,High blood pressure,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,neumonia,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Bone Fracture Spontaneous,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,erythema,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,insulin dependent diabetes mellitus,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,erythema,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,erythema,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,disseminated lupus erythematosus,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Arrhythmia,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,elevated cholesterol,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Bone Fracture Spontaneous,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,CMV infection,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,High blood pressure,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Paraesthesia,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,nausea,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,proctalgia,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,dysarthria,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cellulitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,proctalgia,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,failure to thrive,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,acute pancreatitis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,atelectasis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,methaemoglobinaemia,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Back Ache,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Bilirubinaemia,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,methaemoglobinaemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,respiratory failure,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,bulging,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,thrombocytopenia,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,atelectasis,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Dyspnea exertional,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,abnormal ECG,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,dysarthria,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,ear infection,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,abnormal EEG,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,thrombocytopenia,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gingivitis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Scleroderma,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,abnormal ECG,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,insulin dependent diabetes mellitus,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,allergic dermatitis,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,heart rate increased,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,abnormal ECG,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,muscle paresis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Dyspnea exertional,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,carcinoma of the colon,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,bradycardia,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,methaemoglobinaemia,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,bulging,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,deglutition disorder,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,abnormal ECG,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,increased white blood cell count,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,dacrocystitis,CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,thrombocytopenia,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cellulitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,convulsion,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Pleural Effusion,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,neumonia,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,abnormal ECG,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,disseminated lupus erythematosus,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002907,Ciclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Pain,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,Back Ache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,nervous tension,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,constipated,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,cholecystectomies,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,ear ache,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,apoplexy,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,angiitis,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,cholecystitis,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,Bleeding,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,cholecystitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,dacrocystitis,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,Back Ache,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,edema,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,erythema,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,haematoma,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,apoplexy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,cholecystitis,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,gastric inflammation,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,myelodysplasia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,Adenopathy,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,enlarged spleen,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,loss of weight,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,Adenopathy,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,thrombocytopenia,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,myelodysplasia,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,loss of weight,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,erythema,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,Back Ache,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,bursitis,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,subarachnoid haemorrhage,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,elevated cholesterol,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000083786,"1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one",C1=NNC2=C1NC=NC2=O,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Sinus headache,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,back injury,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,haemorrhage intracranial,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,back injury,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Sinus headache,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,weight gain,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,weight gain,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Drug hypersensitivity,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,angiitis,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,asthma,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,constipated,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Back Ache,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Enuresis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,angiitis,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,atelectasis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,thrombocytopenia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Dyspnea exertional,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,thrombocytopenia,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,increased white blood cell count,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystectomies,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,weight gain,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Dyspnea exertional,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,bleeding Vaginal,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,allergic dermatitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,enlarged liver,CID000024011,BLAH,S=[Se]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,weight gain,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Sinus headache,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,food allergy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,drug toxicity NOS,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Back Ache,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,icterus,CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Extrasystoles Ventricular,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Dyspnea exertional,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,drug toxicity NOS,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,angiitis,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,rotator cuff syndrome,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,myelodysplasia,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,hyperparathyroidism,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,allergic dermatitis,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,abortion spontaneous,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,angiitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Scleroderma,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Glucose intolerance,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,abnormal ECG,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystectomies,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,angiitis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Acne,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,angiitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,thrombocytopenia,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,elevated cholesterol,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,dysarthria,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,eruption,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Back Ache,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,thrombocytopenia,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gout,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,hypochloraemia,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,thyroid cancer,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Back Ache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,insulin dependent diabetes mellitus,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,periodontitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,allergic dermatitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,edema,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,drug toxicity NOS,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,elevated cholesterol,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,back injury,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,constipated,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,thrombocytopenia,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,ear infection,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cataract,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Sinus headache,CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,allergic dermatitis,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,back injury,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,insulin dependent diabetes mellitus,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,hypochloraemia,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,weight gain,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Bone Fracture Spontaneous,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Acne,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,deglutition disorder,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,back injury,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystitis,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,cholecystectomies,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,apoplexy,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,Adenopathy,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,erythema,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,gastric inflammation,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003348,83799-24-0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,loss of weight,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],eruption,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],hepatitis,CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],dysarthria,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],subarachnoid haemorrhage,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],loss of weight,CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],allergic dermatitis,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],allergic dermatitis,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],gastric inflammation,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],confusion,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],myelodysplasia,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],thrombocytopenia,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],dysarthria,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],abnormal EEG,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],High blood pressure,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],cholecystitis,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],apoplexy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Excess potassium,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Bacteraemia,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],drug toxicity NOS,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],dizziness,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Alcoholic intoxication,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],increased white blood cell count,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],deglutition disorder,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],constipated,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],abnormal ECG,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],dysarthria,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],High blood pressure,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],thrombocytopenia,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],apoplexy,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],rectal prolapse,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],loss of weight,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],High blood pressure,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],abnormal EEG,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],heart rate increased,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],loss of weight,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],loss of weight,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],blood in urine,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],dysarthria,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],rhinorrhea,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],increased white blood cell count,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],emesis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Alcoholic intoxication,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],thrombocytopenia,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],respiratory alkalosis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],loss of weight,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],drug toxicity NOS,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],deglutition disorder,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],drug toxicity NOS,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],sick sinus syndrome,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],gastric inflammation,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Chronic Kidney Disease,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],edema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],drug toxicity NOS,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],loss of weight,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Dyspnea exertional,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],heart rate increased,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],bursitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],increased white blood cell count,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Pain,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],atelectasis,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],dysarthria,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],aortic regurgitation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],deglutition disorder,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],drug toxicity NOS,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Bacteraemia,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],gastric inflammation,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],allergic dermatitis,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],atelectasis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],thrombocytopenia,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],thrombocytopenia,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],cholecystitis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],hemiparesis,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],increased white blood cell count,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],dysarthria,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Candida Infection,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Bacteraemia,CID000002637,3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],neumonia,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],bradycardia,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],apoplexy,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],haemorrhage intracranial,CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],lung infiltration,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Dyspnea exertional,CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],thrombocytopenia,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],aseptic necrosis bone,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],cellulitis,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],arterial pressure NOS increased,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],bradycardia,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],loss of weight,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],bradycardia,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],loss of weight,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],eruption,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Bacteraemia,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],apoplexy,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],loss of weight,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],abnormal EEG,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],eruption,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],increased white blood cell count,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],panic disorder,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],thrombocytopenia,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],deglutition disorder,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],weight gain,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],thrombocytopenia,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],ear ache,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],angiitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],drug toxicity NOS,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],Adenopathy,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002617,"3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-],erythema,CID000004873,Potassium chloride,[Cl-].[K+]
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,kidney failure,CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,weight gain,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,neumonia,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,arteriosclerotic heart disease,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Ovarian cancer,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Acidosis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Back Ache,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,drug toxicity NOS,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Aspartate Aminotransferase Increase,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,neumonia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,allergic dermatitis,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,drug toxicity NOS,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,thrombocytopenia,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,loss of weight,CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,haematoma,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,abdominal pain upper,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,rhinorrhea,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,glaucoma,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,glaucoma,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,loss of weight,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,confusion,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,increased white blood cell count,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,drug toxicity NOS,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,deglutition disorder,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,thrombocytopenia,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Hypoventilation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,glaucoma,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,eruption,CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,drug toxicity NOS,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,erythema,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Back Ache,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,muscle disorder,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Bacteraemia,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,nausea,CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,loss of weight,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,hiccough,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,confusion,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,glaucoma,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,allergic dermatitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Dyspnea exertional,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,erythema,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,hematoma subdural,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Pain,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Back Ache,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Back Ache,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,drug toxicity NOS,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000004873,Potassium chloride,[Cl-].[K+]
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Back Ache,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,arteriosclerotic heart disease,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,arteriosclerotic heart disease,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Aspartate Aminotransferase Increase,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,drug toxicity NOS,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,eruption,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Pain,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Aspartate Aminotransferase Increase,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Pain,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,weight gain,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,exophthalmos,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,eruption,CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,weight gain,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,anaphylactic reaction,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,thrombocytopenia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,difficulty in walking,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,angiitis,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,myelodysplasia,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,angiitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,cholecystitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Adenopathy,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,keratoacanthomas,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,thrombocytopenia,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Adenopathy,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,myelodysplasia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,adenomyosis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Acute Respiratory Distress Syndrome,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,weight gain,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,cholecystitis,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,esophageal stenosis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,elevated cholesterol,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,cholecystectomies,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Adenopathy,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,abnormal ECG,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Adenopathy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,loss of weight,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,abnormal ECG,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,respiratory alkalosis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Back Ache,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,nasopharyngitis,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,back injury,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,hepatitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,apoplexy,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,cholecystitis,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gout,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,thrombocytopenia,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,muscle inflammation,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,apoplexy,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,enlarged spleen,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,heart rate increased,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,right heart failure,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,disseminated lupus erythematosus,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,right heart failure,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,abnormal ECG,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,loss of weight,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Acute Respiratory Distress Syndrome,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,thrombocytopenia,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,deglutition disorder,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,lipoma,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,nasopharyngitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,myelodysplasia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,loss of weight,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,abnormal EEG,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,apoplexy,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Adenopathy,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,right heart failure,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,edema,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,agitated,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,abnormal EEG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,cholecystectomies,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,loss of weight,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,haemorrhage rectum,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,erythema multiforme,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Adenopathy,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Adenopathy,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,flashing lights,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000024011,BLAH,S=[Se]
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,dysarthria,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,peritonitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,aching muscles,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,eruption,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,Adenopathy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000006691,2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-one,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,gastric inflammation,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,loss of weight,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,Adenopathy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,loss of weight,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,allergic dermatitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,loss of weight,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,eruption,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,increased white blood cell count,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,Dyspnea exertional,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,elevated cholesterol,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,Embolism pulmonary,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,weight gain,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,Hepatic failure,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,drug toxicity NOS,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,thrombocytopenia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,deglutition disorder,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,Dyspnea exertional,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,apoplexy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,Chest infection,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,eruption,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,hyperglycaemia,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,apoplexy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,angiitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,eruption,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,dry skin,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,abnormal EEG,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,deglutition disorder,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,eruption,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,arterial pressure NOS increased,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,thrombocytopenia,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,eruption,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,cellulitis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,eruption,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,abnormal EEG,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,thrombocytopenia,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Superficial thrombophlebitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,methaemoglobinaemia,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,myelodysplasia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Back Ache,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,dysarthria,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,back injury,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,ecchymoses,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,elevated cholesterol,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,allergic dermatitis,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,aspiration pneumonia,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,nasopharyngitis,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystectomies,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,alopecia,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,weight gain,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,allergic dermatitis,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,back injury,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,subarachnoid haemorrhage,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,myelodysplasia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Acne,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,allergic dermatitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,atelectasis,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,right heart failure,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,defaecation urgency,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,proctalgia,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Superficial thrombophlebitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Extrasystoles Ventricular,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Acute Respiratory Distress Syndrome,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,eruption,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,drug toxicity NOS,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,elevated erythrocyte sedimentation rate,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,fracture nonunion,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Diplopia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,abnormal ECG,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,drug toxicity NOS,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,atelectasis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,dysarthria,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000024011,BLAH,S=[Se]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,abnormal ECG,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,body temperature increased,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Superficial thrombophlebitis,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Back Ache,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,metabolic encephalopathy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,aching muscles,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,fracture nonunion,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Back Ache,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,thrombocytopenia,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,movement disorder,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,haemorrhage rectum,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,metabolic encephalopathy,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Acne,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,myelodysplasia,CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,excessive thirst,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Hepatic failure,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,nasopharyngitis,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,pain in throat,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,eczema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,bulging,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,atelectasis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,angiitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,abnormal ECG,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Extrasystoles Ventricular,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,metabolic encephalopathy,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Pain,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,belching,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,weight gain,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Bone Fracture Spontaneous,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystectomies,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,bladder cancer,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,deglutition disorder,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,atelectasis,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,agitated,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,back injury,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Pain,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,aspiration pneumonia,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,constipated,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,heart rate increased,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,arteriosclerotic heart disease,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,failure to thrive,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,High blood pressure,CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Back Ache,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,methaemoglobinaemia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,deglutition disorder,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Acne,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,abnormal EEG,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,methaemoglobinaemia,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Pain,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,abnormal ECG,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,dysarthria,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,sleep disorder,CID000004211,53-19-0,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Acne,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,methaemoglobinaemia,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Diplopia,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,insulin dependent diabetes mellitus,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,eruption,CID000005505,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gout,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,abnormal ECG,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,eruption,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,angiitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Bacteraemia,CID000004913,procainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,drug toxicity NOS,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,methaemoglobinaemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,angiitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,confusion,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Dyspnea exertional,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,adenomyosis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,methaemoglobinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,back injury,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003937,N~2~-(1-Carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Dyspnea exertional,CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Back Ache,CID000004723,pemoline,C1=CC=C(C=C1)C2C(=O)N=C(O2)N
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Adenopathy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Adenopathy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Adenopathy,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,erythema,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,deglutition disorder,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Back Ache,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,rhinorrhea,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,allergic dermatitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,agitated,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,weight gain,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,dysarthria,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,back injury,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,deglutition disorder,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Back Ache,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,dysarthria,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cellulitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,neumonia,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Bacteraemia,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,thrombocytopenia,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,angina,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,dysarthria,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cholecystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,confusion,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,agitated,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,dysarthria,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,nasopharyngitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Multiple Myeloma,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,erythema,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,deglutition disorder,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,abnormal ECG,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,edema extremities,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,defaecation urgency,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,drug toxicity NOS,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,drug toxicity NOS,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,angiitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,abnormal EEG,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,eruption,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,thrombocytopenia,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Acne,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,heart rate increased,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,bulging,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Pain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,agitated,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cellulitis,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,bradycardia,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,weight gain,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Back Ache,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,abnormal EEG,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Back Ache,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,erythema,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cellulitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ear infection,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Adenopathy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,erythema,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,difficulty in walking,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,subarachnoid haemorrhage,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,back injury,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000004158,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,apoplexy,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,abnormal ECG,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,apoplexy,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,glossodynia,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,dysarthria,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Dyspnea exertional,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Arthritis bacterial,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,abnormal ECG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Adenopathy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,apoplexy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,atelectasis,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,increased white blood cell count,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,adenomyosis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cholecystitis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,eruption,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,dizziness,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Scleroderma,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cellulitis,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cholecystitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,back injury,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,chondrocalcinosis pyrophosphate,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Adenopathy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,abnormal ECG,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,bulging,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,emesis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,weight gain,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,enlarged liver,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,allergic dermatitis,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,loss of weight,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,angiitis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Back Ache,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gout,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,adenomyosis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,enlarged liver,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,back injury,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,dizziness,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,erythema,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,erythema,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Adenopathy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,neumonia,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,migraine,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,erythema,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,loss of weight,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Diplopia,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,thrombocytopenia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005523,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,loss of weight,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Scleroderma,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystectomies,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,respiratory failure,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,back injury,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,kidney failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,weight gain,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Dyspnea exertional,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,eruption,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,edema,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,metabolic encephalopathy,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystectomies,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,abnormal EEG,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,hepatitis,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,hepatic neoplasia,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Acne,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,ear infection,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,bursitis,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,myelodysplasia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Acne,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystectomies,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,icterus,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,dysarthria,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,weight gain,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,thrombocytopenia,CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,nausea,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,weight gain,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Scleroderma,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,insulin dependent diabetes mellitus,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,myelodysplasia,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,abnormal EEG,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Dyspnea exertional,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,deglutition disorder,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,constipated,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,thrombocytopenia,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,tremor,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,dysarthria,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Infection Upper Respiratory,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Diplopia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,elevated erythrocyte sedimentation rate,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,myelodysplasia,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Back Ache,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,lung infiltration,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,edema,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,dysarthria,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,drug toxicity NOS,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,muscle paresis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,constipated,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angina,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,right heart failure,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,malnourished,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,methaemoglobinaemia,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,eruption,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,abnormal EEG,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,respiratory alkalosis,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,glaucoma,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,epilepsy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Infection Urinary Tract,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,allergic dermatitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,dysarthria,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,dysarthria,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,aortic regurgitation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,eruption,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,body temperature increased,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,aspiration pneumonia,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,odynophagia,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,ADH inappropriate,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,myelodysplasia,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,myelodysplasia,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,haemorrhage rectum,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,hiccough,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,malnourished,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Back Ache,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,eruption,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,narcolepsy,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004112,DL-Amethopterin,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,bradycardia,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,elevated cholesterol,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,abnormal ECG,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,cholecystitis,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,allergic dermatitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,elevated cholesterol,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,haematoma,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,dermatitis exfoliative,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,abnormal EEG,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,arterial pressure NOS decreased,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,peritonitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,Near Syncope,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,abnormal ECG,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,erythema,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,neuropathy peripheral,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,Bleeding,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,erythema,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,Dyspnea exertional,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,hepatitis,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,loss of weight,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,bradycardia,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,haemorrhage intracranial,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,weight gain,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,loss of weight,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,muscle inflammation,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,increased white blood cell count,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000004473,HMS1361F11,CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,thrombocytopenia,CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000002733,95-25-0,C1=CC2=C(C=C1Cl)NC(=O)O2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Back Ache,CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear infection,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,edema,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acidosis,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,insulin dependent diabetes mellitus,CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thrombocytopenia,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,weight gain,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,back injury,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,insulin dependent diabetes mellitus,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000001117,14808-79-8,[O-]S(=O)(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,aortic aneurysm,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,back injury,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,respiratory alkalosis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angioedema,CID000003372,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,back injury,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,still birth,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,High blood pressure,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,panic attack,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,back injury,CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,High blood pressure,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000002141,Amifostine,C(CN)CNCCSP(=O)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,edema,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Rheumatic fever,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Back Ache,CID000002551,Carbachol,C[N+](C)(C)CCOC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Bacteraemia,CID000002370,Bethanechol,CC(C[N+](C)(C)C)OC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,subarachnoid haemorrhage,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear infection,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,back injury,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,weight gain,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholelithiasis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,fracture nonunion,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,edema,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,dysarthria,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystectomies,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Hypoventilation,CID000002800,911-45-5,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Nail disorder,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thrombocytopenia,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,meningitides,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,food allergy,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,pain in throat,CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,respiratory alkalosis,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,right heart failure,CID000002719,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear infection,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angiitis,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,phlebothrombosis,CID000002725,chlorphenamine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cellulitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bundle branch block right,CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,malnourished,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Dyspnea exertional,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,dysarthria,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000002973,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,acute pancreatitis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bursitis,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,back injury,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,still birth,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,rhinorrhea,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,excessive thirst,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004723,pemoline,C1=CC=C(C=C1)C2C(=O)N=C(O2)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,trigeminal neuralgia,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastroenteritis viral,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,hepatic neoplasia,CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,increased white blood cell count,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystectomies,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000002266,Azelaic acid,C(CCCC(=O)O)CCCC(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,dysarthria,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angiitis,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,haemorrhage intracranial,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Sinus headache,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,right heart failure,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,epilepsy,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thrombocytopenia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,acute pancreatitis,CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000002099,122852-42-0,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear infection,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,right heart failure,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Dyspnea exertional,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,blood sodium decreased,CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Bone Fracture Spontaneous,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000003381,"4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gout,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cellulitis,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,weight gain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,back injury,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angiitis,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug withdrawal,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bursitis,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug withdrawal,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thrombocytopenia,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Back Ache,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystectomies,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Pain,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bulging,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Sinus headache,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,disorder Renal,CID000005505,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug toxicity NOS,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,contact dermatitis,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,allergic dermatitis,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,dysarthria,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,atelectasis,CID000024011,BLAH,S=[Se]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bursitis,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,eruption,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000003278,58-54-8,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,allergic dermatitis,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bacterial endocarditis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,elevated erythrocyte sedimentation rate,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,dysarthria,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug toxicity NOS,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystectomies,CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000002708,Chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Dyspnea exertional,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Porphyria,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear ache,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Sinus headache,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,eruption,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,hepatic neoplasia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,malnourished,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,weight gain,CID000002182,Anagrelide,C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,agitated,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Arrhythmia,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,alopecia,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,still birth,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,nasopharyngitis,CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastroenteritis viral,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,periodontitis,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,neumonia,CID000444033,"2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate",CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bleeding Vaginal,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug withdrawal,CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,nasopharyngitis,CID000003008,Racemethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Sinus headache,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug toxicity NOS,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angiitis,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angiitis,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,phlebothrombosis,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,flashing lights,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,weight gain,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,right heart failure,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug toxicity NOS,CID000001206,(±)-Metamfetamine,CC(CC1=CC=CC=C1)NC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thrombocytopenia,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000001046,pyrazinamide,C1=CN=C(C=N1)C(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,respiratory failure,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear ache,CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,High blood pressure,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,eruption,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,weight gain,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angiitis,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,right heart failure,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Bone Fracture Spontaneous,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug toxicity NOS,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,elevated cholesterol,CID000004211,53-19-0,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystectomies,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,confusion,CID000003198,Econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,hydronephrosis,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,malabsorption,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thyroid cancer,CID000040976,"(17R)-13-Ethyl-17-ethynyl-17-hydroxy-11-methylene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one",CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,colitis ischemic,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bleeding Vaginal,CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Caesarean Section,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,right heart failure,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,food allergy,CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,eruption,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bulging,CID000002215,Apomorphine,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID005311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,conjunctivitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,insulin dependent diabetes mellitus,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,nasopharyngitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,allergic dermatitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,thrombocytopenia,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,thrombocytopenia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,pleural pain,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,loss of weight,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,loss of weight,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,loss of weight,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,loss of weight,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,back injury,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,dry skin,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,hemiparesis,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,abnormal ECG,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000032797,"(8ξ,10ξ,13ξ,14ξ)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,ecchymoses,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,thrombocytopenia,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,gastric inflammation,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,cholecystitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,gastric inflammation,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,enlarged liver,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,weight gain,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,erythema,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,drug toxicity NOS,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,gingival pain,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,cholecystectomies,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,itch,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,haemorrhage intracranial,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,thrombocytopenia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,apoplexy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,cellulitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,loss of weight,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,dysarthria,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,apoplexy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,disseminated lupus erythematosus,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,movement disorder,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,glossodynia,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,dizziness,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,dysarthria,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,abnormal EEG,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,drug toxicity NOS,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,loss of weight,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,angiitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,abnormal EEG,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,apoplexy,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,apoplexy,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,dysarthria,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,drug toxicity NOS,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,apoplexy,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000059708,Etiracetam,CCC(C(=O)N)N1CCCC1=O,apoplexy,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,adenomyosis,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Arrhythmia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,erythema,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,loss of weight,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Adenopathy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,thrombocytopenia,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,nasopharyngitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,apoplexy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,insulin dependent diabetes mellitus,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,nausea,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,agitated,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Adenopathy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,shoulder pain,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,confusion,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,apoplexy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Back Ache,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,nasopharyngitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,neumonia,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,allergic dermatitis,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,eruption,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,drug toxicity NOS,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,loss of weight,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,atelectasis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Diplopia,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Sinus headache,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystectomies,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,back injury,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,eruption,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,angina,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,eruption,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,hepatitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,loss of weight,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,adenomyosis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,deglutition disorder,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Extrasystoles Ventricular,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,back injury,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,confusion,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,heart rate increased,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Diplopia,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,dizziness,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,neumonia,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,back injury,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,loss of weight,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,neumonia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystectomies,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Gastric Cancer,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gastroenteritis viral,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,eruption,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gout,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,dysarthria,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,confusion,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Sinus headache,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,apoplexy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gout,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,loss of weight,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,nocturia,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,weight gain,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,atelectasis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,rhinorrhea,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,nausea,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,elevated cholesterol,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,erythema,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gout,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,back injury,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,heart attack,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,apoplexy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,apoplexy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Adenopathy,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Adenopathy,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,dysarthria,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003826,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,drug toxicity NOS,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,abdominal pain upper,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cholecystectomies,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,aspiration pneumonia,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,dizziness,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,myelodysplasia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,atelectasis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,bulging,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,atelectasis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cellulitis,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cellulitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,muscle inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,deglutition disorder,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,drug toxicity NOS,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cellulitis,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Infection Upper Respiratory,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Cardiomyopathy,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,neumonia,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,deglutition disorder,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,belching,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,periodontitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,empyema,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Infection Upper Respiratory,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Infection Upper Respiratory,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Arrhythmia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,weight gain,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Porphyria,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,eruption,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,proctalgia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cholecystitis,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,periodontitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,confusion,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,eruption,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,edema,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,narcolepsy,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,apoplexy,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,atelectasis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Dyspnea exertional,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,colitis ischemic,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,abnormal ECG,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Dyspnea exertional,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,apoplexy,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Neutropenia,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cholecystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Back Ache,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Neutropenia,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,failure to thrive,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Back Ache,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,scotoma,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,abnormal ECG,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,mouth pain,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Bone Fracture Spontaneous,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gingivitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,abnormal ECG,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,eating disorder,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,weight gain,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,allergic dermatitis,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,apoplexy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,deglutition disorder,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cholecystitis,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Dyspnea exertional,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Ovarian cancer,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,atelectasis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,atelectasis,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,increased white blood cell count,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Infection Urinary Tract,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,thrombocytopenia,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,weight gain,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,thrombocytopenia,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,erythema,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Dyspnea exertional,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,erythema,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,myelodysplasia,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,apoplexy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,erythema,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Lyell,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,thrombocytopenia,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Pain,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Bone marrow fibrosis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,apoplexy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,angina,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,apoplexy,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,failure to thrive,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Acute Respiratory Distress Syndrome,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Adenopathy,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,erythema,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,Bacteraemia,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,deglutition disorder,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,angioedema,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,erythema,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,gingivitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003143,"4-Acetoxy-1,7,10-trihydroxy-13-{[2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,erythema,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,apoplexy,CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,apoplexy,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,apoplexy,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,apoplexy,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,apoplexy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,deglutition disorder,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,loss of weight,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004736,"1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,loss of weight,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Adenopathy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,nervous tension,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,haemorrhoids,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Adenopathy,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,acute pancreatitis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,abnormal ECG,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,insulin dependent diabetes mellitus,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,increased white blood cell count,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,narcolepsy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,increased white blood cell count,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Irritation Skin,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,allergic dermatitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,disorder Renal,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Dyspnea exertional,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,hepatic neoplasia,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,dysarthria,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,erythema,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Adenopathy,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Infection Upper Respiratory,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,erythema multiforme,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Abnormal LFTs,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,dysarthria,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,abnormal ECG,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,thrombocytopenia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,neuropathy,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,myelodysplasia,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,abnormal EEG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,herpes zoster,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Back Ache,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,odynophagia,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,thrombocytopenia,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,acute pancreatitis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Infection Upper Respiratory,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,back injury,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,dysarthria,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,drug toxicity NOS,CID000005505,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,metabolic encephalopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,edema,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,deglutition disorder,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Dyspnea exertional,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,myelodysplasia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,thrombocytopenia,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,thrombocytopenia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,ear infection,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,muscle disorder,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Back Ache,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cellulitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Dyspnea exertional,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,subarachnoid haemorrhage,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,back injury,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,neumonia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,hepatic necrosis,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystectomies,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,eruption,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cellulitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,weight gain,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Back Ache,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,thrombocytopenia,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,metabolic encephalopathy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Sinus headache,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,haemorrhage rectum,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,apoplexy,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,abnormal ECG,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,atelectasis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,elevated cholesterol,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,back injury,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,loss of weight,CID000024011,BLAH,S=[Se]
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,drug toxicity NOS,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,increased white blood cell count,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Bleeding,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Adenopathy,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,methaemoglobinaemia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,gastric inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005038,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Cardiomyopathy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Adenopathy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,angiitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,adenomyosis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Adenopathy,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Adenopathy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,insulin dependent diabetes mellitus,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,insulin dependent diabetes mellitus,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Infection Upper Respiratory,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,deglutition disorder,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,confusion,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,deglutition disorder,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Diplopia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,agitated,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,eruption,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,drug toxicity NOS,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,heart rate increased,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,myelodysplasia,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Hepatic failure,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,erythema,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,eating disorder,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,erythema,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,eruption,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,dry skin,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,bulging,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,loss of weight,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,right heart failure,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,abnormal ECG,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,deglutition disorder,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Dyspnea exertional,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,thrombocytopenia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,erythema,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,arterial pressure NOS decreased,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,abnormal EEG,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,constipated,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,loss of weight,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,ear ache,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,enlarged liver,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,weight gain,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,nasopharyngitis,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,angiitis,CID003086258,CHEMBL270363,CCC1=C2C=C3C(=C(C(=CC4=NC(=CC5=NC(=CC(=C1C)N2)C(=C5CCC(=O)O)C)C(=C4C)CCC(=O)O)N3)C(C)O)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,narcolepsy,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,acute pancreatitis,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Adenopathy,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Infection Upper Respiratory,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,rhinorrhea,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,loss of weight,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,erythema,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Back Ache,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Acne,CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-]
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,erythema,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Acne,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,erythema,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,eruption,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,thrombocytopenia,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,abnormal ECG,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,bulging,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,abnormal EEG,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Dyspnea exertional,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,atelectasis,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,abscess,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,abortion spontaneous,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,thrombocytopenia,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,erythema,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,loss of weight,CID000024011,BLAH,S=[Se]
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,angiitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,Bleeding,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cholecystitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,bursitis,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,thrombocytopenia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,gastric inflammation,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,insulin dependent diabetes mellitus,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000005039,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,eruption,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],Adenopathy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],Back Ache,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],respiratory failure,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],back injury,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],loss of weight,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],gastroenteritis viral,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],nasopharyngitis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],nausea,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],nasopharyngitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],agitated,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],failure to thrive,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],drug toxicity NOS,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],drug toxicity NOS,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],weight gain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],Adenopathy,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],flashing lights,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],cellulitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],insulin dependent diabetes mellitus,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],weight gain,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],arterial pressure NOS increased,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],hydronephrosis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],erythema,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],drug toxicity NOS,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],status epilepticus,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000028112,Lithium Aluminium Hydride,[Li+].[AlH4-],deglutition disorder,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,High blood pressure,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,abnormal EEG,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Pain,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,metabolic encephalopathy,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Adenopathy,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Adenopathy,CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,failure to thrive,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,edema,CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,arteriosclerotic heart disease,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,periodontitis,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,myelodysplasia,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,acute brain syndrome,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,nasopharyngitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,eruption,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,angiitis,CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Dyspnea exertional,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Atrioventricular block first degree,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,palsies,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,myelodysplasia,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,bursitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,back injury,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,myelodysplasia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,metabolic encephalopathy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,increased white blood cell count,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,neumonia,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,subarachnoid haemorrhage,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,weight gain,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,haemorrhage rectum,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,abnormal ECG,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,increased white blood cell count,CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,abnormal EEG,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,acute pancreatitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,belching,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Adenopathy,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,angiitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Dyspnea exertional,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,bleeding Vaginal,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,atelectasis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,myelodysplasia,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,belching,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,alopecia,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,peritonitis,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,right heart failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,eruption,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,right heart failure,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Adenopathy,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,increased white blood cell count,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,nasopharyngitis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Pain,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,nasopharyngitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,abnormal ECG,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,xerosis,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,nasopharyngitis,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,back injury,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,malnourished,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,defaecation urgency,CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,increased white blood cell count,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystectomies,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Back Ache,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,nasopharyngitis,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,defaecation urgency,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,right heart failure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Infection Upper Respiratory,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Cor pulmonale,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,myelodysplasia,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,defaecation urgency,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,myelodysplasia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Back Ache,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,abdominal pain upper,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,abnormal EEG,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastroenteritis viral,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,aptyalism,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,weight gain,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,adenomyosis,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gout,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,constipated,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,respiratory alkalosis,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,angiitis,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gout,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Dyspnea exertional,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,angiitis,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Back Ache,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastroenteritis viral,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,angiitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Back Ache,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,arterial pressure NOS decreased,CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,abnormal ECG,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,back injury,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,colitis ischemic,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,right heart failure,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,acute pancreatitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,angiitis,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Back Ache,CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,angiitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,back injury,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Cardiomyopathy,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,nocturia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,colitis ischemic,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,myelodysplasia,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Adenopathy,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,peritonitis,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,haemorrhage rectum,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Bilirubinaemia,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Adenopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,dysarthria,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Adenopathy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,abnormal EEG,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,back injury,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,High blood pressure,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,gastric inflammation,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,loss of weight,CID000024011,BLAH,S=[Se]
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,drug toxicity NOS,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,erythema,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,abnormal ECG,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,apoplexy,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002162,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Bone Fracture Spontaneous,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,apoplexy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,aspiration pneumonia,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,bipolar disorder,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cholecystitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,dysaesthesia,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,periodontitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,loss of weight,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,increased white blood cell count,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cholecystitis,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,allergic dermatitis,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,bradycardia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,erythema,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,Pain,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,dysarthria,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,subarachnoid haemorrhage,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,elevated cholesterol,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,loss of weight,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,loss of weight,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,apoplexy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,abnormal ECG,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,dysarthria,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,abnormal ECG,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,eruption,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,Pain,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,Arrhythmia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,apoplexy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,ecchymoses,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,deglutition disorder,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,ear infection,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,periodontitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,agitated,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,loss of weight,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,erythema,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,rotator cuff syndrome,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,eruption,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,aseptic necrosis bone,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,High blood pressure,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,Dyspnea exertional,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,myelodysplasia,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,apoplexy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,Paraesthesia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,hematoma subdural,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,myelodysplasia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,atelectasis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,loss of weight,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cholecystitis,CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,edema,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,deglutition disorder,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,erythema,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,Hypoventilation,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,proctalgia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,deglutition disorder,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,hematoma subdural,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,Pain,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,atelectasis,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,allergic dermatitis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,abnormal ECG,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,eruption,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,Extrasystoles Ventricular,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,apoplexy,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,Adenopathy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,coughing blood,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,allergic dermatitis,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004259,354812-41-2,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,apoplexy,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,insulin dependent diabetes mellitus,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,Small intestinal obstruction,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,weight gain,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,eruption,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,Extrasystoles Ventricular,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,back injury,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000119607,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,Arrhythmia,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,thrombocytopenia,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,myelodysplasia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,dysarthria,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,apoplexy,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,atelectasis,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,ADVERSE DRUG EFFECT,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,Bleeding,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,neumonia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,narcolepsy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,insulin dependent diabetes mellitus,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,hepatic neoplasia,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,loss of weight,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,Pain,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,angina,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,Aspartate Aminotransferase Increase,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,Adenopathy,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,bulging,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,gout,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,dizziness,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000087177,MALTULOSE,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,dysarthria,CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,weight gain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Adenopathy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,angiitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,ild,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,weight gain,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,anaemia,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,ecchymoses,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,right heart failure,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,dysarthria,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,ear infection,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,subarachnoid haemorrhage,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,angiitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,periodontitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Adenopathy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,rhinorrhea,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,weight gain,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Back Ache,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Acne,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Dyspnea exertional,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,brain neoplasm,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,heart rate increased,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Adenopathy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,constipated,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Bacteraemia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Infection Upper Respiratory,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,anaphylactic reaction,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,angiitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,allergic dermatitis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystectomies,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,right heart failure,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,weight gain,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,femur fracture,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,malnourished,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Sinus headache,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gout,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,neumonia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,elevated cholesterol,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,allergic dermatitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Paraesthesia,CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Sinus headache,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Acne,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000024011,BLAH,S=[Se]
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,right heart failure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,aortic regurgitation,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,malnourished,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Adenopathy,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,aspiration pneumonia,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Back Ache,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,abnormal EEG,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,elevated cholesterol,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,angiitis,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,thrombocytopenia,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,insulin dependent diabetes mellitus,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,confusion,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,abnormal ECG,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Bleeding,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Back Ache,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,adenomyosis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,angiitis,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,weight gain,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,weight gain,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,cholecystitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003957,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,drug toxicity NOS,CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,acute pancreatitis,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,loss of weight,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,confusion,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,bursitis,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,apoplexy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,myelodysplasia,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,respiratory failure,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,haemorrhage intracranial,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,malnourished,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,eruption,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,deglutition disorder,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Back Ache,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,muscle inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Back Ache,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Back Ache,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,loss of weight,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,erythema,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,synovial cyst,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,apoplexy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,atelectasis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,nausea,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,nausea,CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,drug toxicity NOS,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,methaemoglobinaemia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,proctalgia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,bursitis,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,loss of weight,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,methaemoglobinaemia,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,loss of weight,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,erythema,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,allergic dermatitis,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,atelectasis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Infection Upper Respiratory,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,pulmonary arrest,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,erythema multiforme,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,weight gain,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,insulin dependent diabetes mellitus,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,bulimia,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,haemorrhage rectum,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,methaemoglobinaemia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,angiitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,methaemoglobinaemia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,hepatic neoplasia,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,ecchymoses,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,metabolic encephalopathy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,contracture,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,aortic regurgitation,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Blood calcium decreased,CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,drug toxicity NOS,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,hypermagnesemia,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,heart rate increased,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,methaemoglobinaemia,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,angiitis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,abnormal ECG,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Atherosclerosis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Bilirubinaemia,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,erythema,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,thrombocytopenia,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,hypermagnesemia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,weight gain,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,angiitis,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,abnormal EEG,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,diarrhea infectious,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,right heart failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,loss of weight,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cellulitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,High blood pressure,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,erythema,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,apoplexy,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,angiitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,drug withdrawal,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,methaemoglobinaemia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,motor retardation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,thrombocytopenia,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,methaemoglobinaemia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,eruption,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cellulitis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,drug toxicity NOS,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Bone Fracture Spontaneous,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,apoplexy,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,drug toxicity NOS,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cellulitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Back Ache,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Adenopathy,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,hematoma subdural,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,abnormal EEG,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,eruption,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Back Ache,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,dysarthria,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004595,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,methaemoglobinaemia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,right heart failure,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,Adenopathy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,nasopharyngitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,confusion,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,Scleroderma,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,hepatic neoplasia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,abnormal ECG,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,neuropathy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,myelodysplasia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,pulmonary hypertension,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,drug withdrawal,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,nephrotic syndrome,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,weight gain,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,thrombocytopenia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,weight gain,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,weight gain,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cellulitis,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,weight gain,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cellulitis,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000004645,"2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydro-1,3,12(2H,4H,5H)-tetracenetrione",CC1(C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cellulitis,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gout,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,angiitis,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,right heart failure,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,back injury,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Anorexia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Infection Urinary Tract,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cardiac enlargement,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,periodontitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,herpes zoster,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Acne,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,rotator cuff syndrome,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,methaemoglobinaemia,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,rotator cuff syndrome,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,defaecation urgency,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,heart rate increased,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,bursitis,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,drug toxicity NOS,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,angiitis,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Bone Fracture Spontaneous,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,angiitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,colitis,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,narcolepsy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Back Ache,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Infection Urinary Tract,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,nasopharyngitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,proctalgia,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,eruption,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,increased white blood cell count,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Pain,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholelithiasis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,deglutition disorder,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystectomies,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,insulin dependent diabetes mellitus,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Hepatitis A,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,elevated cholesterol,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,panic attack,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,angiitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,odynophagia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,back injury,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastroenteritis viral,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,abnormal ECG,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,failure to thrive,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Pain,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000002733,95-25-0,C1=CC2=C(C=C1Cl)NC(=O)O2
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,angiitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,nasopharyngitis,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,back injury,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Atherosclerosis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,methaemoglobinaemia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,abnormal ECG,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,atelectasis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystectomies,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,haemorrhage rectum,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,edema,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Back Ache,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,weight gain,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,methaemoglobinaemia,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,failure to thrive,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,rhinorrhea,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,back injury,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Dyspnea exertional,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gout,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,loss of weight,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,weight gain,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,thrombocytopenia,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Acne,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Acne,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,cholecystitis,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,angiitis,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,ear infection,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,thrombocytopenia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,dysarthria,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,drug toxicity NOS,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Adenopathy,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,agitated,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,apoplexy,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,angiitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002666,7-[(Aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,back injury,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,weight gain,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,heart rate increased,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,apoplexy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,weight gain,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,constipated,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,insulin dependent diabetes mellitus,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,cellulitis,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,Cardiomyopathy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,Infection Upper Respiratory,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,loss of weight,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,apoplexy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,abnormal EEG,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,drug withdrawal,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,insulin dependent diabetes mellitus,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,apoplexy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,loss of weight,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,insulin dependent diabetes mellitus,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,insulin dependent diabetes mellitus,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,dry skin,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,weight gain,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,loss of weight,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,Excoriation,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,drug toxicity NOS,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,agitated,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,weight gain,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,loss of weight,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,loss of weight,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003007,Amphetamine,CC(CC1=CC=CC=C1)N,Dyspnea exertional,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,drug toxicity NOS,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,deglutition disorder,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,edema extremities,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,deglutition disorder,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,Back Ache,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,apoplexy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,Bleeding,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,dysarthria,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,loss of weight,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,cellulitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,icterus,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,weight gain,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,increased white blood cell count,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,alcohol consumption,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,loss of weight,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,elevated erythrocyte sedimentation rate,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,High blood pressure,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,drug toxicity NOS,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,dysarthria,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,angioedema,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,dysarthria,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,cardiac murmur,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,myelodysplasia,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,weight gain,CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,gastric inflammation,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,Atherosclerosis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,aseptic necrosis bone,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,constipated,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,erythema,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,elevated cholesterol,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,obesity,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,drug toxicity NOS,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004506,"7-Nitro-5-phenyl-3H-1,4-benzodiazepin-2-ol",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,nasopharyngitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,erythema multiforme,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,apoplexy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,allergic dermatitis,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,atelectasis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,agitated,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,apoplexy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,cholecystectomies,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Small intestinal obstruction,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,apoplexy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,apoplexy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,abnormal EEG,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Back Ache,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,constipated,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,loss of weight,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Small intestinal obstruction,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,loss of weight,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,obesity,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,peritonitis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Adenopathy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Back Ache,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,agitated,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,bladder retention,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,dysarthria,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Extrasystoles Ventricular,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,apoplexy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Bilirubinaemia,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,erythema,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,loss of weight,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,acute pancreatitis,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,cholecystectomies,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,loss of weight,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,ADVERSE DRUG EFFECT,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,cholecystectomies,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,loss of weight,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,increased white blood cell count,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,erythema,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,eruption,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,apoplexy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,dysarthria,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003559,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Bilirubinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,nasopharyngitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,abnormal ECG,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,Hypercapnia,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,hepatitis,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,Adenopathy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,Adenopathy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,Adenopathy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,hypoxia,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,High blood pressure,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,High blood pressure,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,alopecia,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,drug toxicity NOS,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,rhinorrhea,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,erythema,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,thrombocytopenia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,deglutition disorder,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,deglutition disorder,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,loss of weight,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,elevated erythrocyte sedimentation rate,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,abnormal ECG,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,hepatitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,Pain,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,weight gain,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,right heart failure,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,eruption,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,Nail disorder,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,cellulitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,deglutition disorder,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,dysarthria,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,dysarthria,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,dysarthria,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,apoplexy,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,Adenopathy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,Adenopathy,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,coughing blood,CID000444033,"2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate",CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,asystole,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000060831,"7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,Adenopathy,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Hypoventilation,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,eruption,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,back injury,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,fracture nonunion,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,heart rate increased,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,diarrhea,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,increased white blood cell count,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,rectal prolapse,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,eruption,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,deglutition disorder,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,defaecation urgency,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,weight gain,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,myelodysplasia,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,CMV infection,CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,failure to thrive,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,pulmonary hypertension,CID000003008,Racemethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,abnormal ECG,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,nausea,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,bradycardia,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,elevated cholesterol,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,defaecation urgency,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,dysarthria,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,abnormal ECG,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Arrhythmia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,abnormal ECG,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Extrasystoles Ventricular,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,edema,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,haemorrhage intracranial,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,lung infiltration,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,abnormal ECG,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,High blood pressure,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,right heart failure,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Infection Upper Respiratory,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,bursitis,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,obesity,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,atelectasis,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,autonomic instability,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,dysphemia,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,angioedema,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Dyspnea exertional,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,eruption,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,neumonia,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Acne,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Arrhythmia,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,hyperparathyroidism,CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,ADVERSE DRUG EFFECT,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,coughing blood,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,eruption,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,bulging,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,constipated,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,back injury,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,thrombocytopenia,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,leucocytosis,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Back Ache,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Superficial thrombophlebitis,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,narcolepsy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,abnormal ECG,CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,thrombocytopenia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,neumonia,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,allergic dermatitis,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,icterus,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,asthenia,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,nasopharyngitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,abnormal ECG,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,atelectasis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,abnormal ECG,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,heart rate increased,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,elevated cholesterol,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,ADVERSE DRUG EFFECT,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Back Ache,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,drug toxicity NOS,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,myelodysplasia,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,atelectasis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,contracture,CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,dysarthria,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,brain neoplasm,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,weight gain,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,constipated,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,hyperalimentation,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Disorder Retinal,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Adenopathy,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,drug toxicity NOS,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Bleeding,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Arrhythmia,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,bursitis,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,panic attack,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,esophageal stenosis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,apoplexy,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,Dyspnea exertional,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002520,52-53-9,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,erythema,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,mouth ulcer,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,Sinusitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,glaucoma,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,eosinophilic pneumonia,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,Sinus headache,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,Pain,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,heart rate increased,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,angiitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,bulging,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,angiitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,abnormal ECG,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,inflammatory bowel disease,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,glossodynia,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000060852,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,angiitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,panic attack,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,Arrhythmia,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,heart rate increased,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,weight gain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,apoplexy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,loss of weight,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,elevated cholesterol,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,elevated cholesterol,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,weight gain,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,abnormal EEG,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,insulin dependent diabetes mellitus,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,confusion,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,glaucoma,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,ecchymoses,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,erythema,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,erythema,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,insulin dependent diabetes mellitus,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,rotator cuff syndrome,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,atrial ectopic beats,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,arterial pressure NOS decreased,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,insulin dependent diabetes mellitus,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Infection Upper Respiratory,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,abnormal ECG,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,coughing blood,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,deglutition disorder,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,right heart failure,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,elevated cholesterol,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,increased white blood cell count,CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,ear ache,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Back Ache,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Salivary Gland Calculus,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,thrombocytopenia,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,abnormal ECG,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,myelodysplasia,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,angiitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,allergic dermatitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,elevated cholesterol,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,abdominal pain upper,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID005353980,"(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cellulitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Decreased Libido,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,erythema,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gangrene,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,back injury,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,phlebothrombosis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,trigeminal neuralgia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,right heart failure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,weight gain,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,muscle disorder,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,defaecation urgency,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,erythema,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,belching,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,thrombocytopenia,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,edema,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,abnormal EEG,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,erythema,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cellulitis,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,drug withdrawal,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Bleeding,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,edema,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,atelectasis,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,neumonia,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,allergic dermatitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystectomies,CID000024011,BLAH,S=[Se]
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,abnormal ECG,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,thrombocytopenia,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,haematoma,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,atelectasis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,phlebothrombosis,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,weight gain,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Back Ache,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,drug toxicity NOS,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,erythema,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Adenopathy,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,bundle branch block right,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Pain,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,dry skin,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,hypernatraemia,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004889,"3,5-dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cellulitis,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005505,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,Neutropenia,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005505,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,muscle disorder,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],drug toxicity NOS,CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],thrombocytopenia,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],erythema,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],increased white blood cell count,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],Difficulty breathing,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],cholecystitis,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],failure to thrive,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],eruption,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],erythema,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],loss of weight,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],ADVERSE DRUG EFFECT,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],erythema,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],Adenopathy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],loss of weight,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],drug toxicity NOS,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],eruption,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],eruption,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],Ovarian cancer,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],gastric inflammation,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],erythema,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],confusion,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],gingivitis,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],deglutition disorder,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],bulging,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],aseptic necrosis bone,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000038904,NSC 241240,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],Small intestinal obstruction,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID005281007,"4-(3,3-Dimethyltriazanylidene)-4H-imidazole-5-carboxamide",CN(C)NN=C1C(=NC=N1)C(=O)N,pleural pain,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,gastric inflammation,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,loss of weight,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Chronic Kidney Disease,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Acidosis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,erythema,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,loss of weight,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,neumonia,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Bacteraemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,eruption,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,thrombocytopenia,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Scleroderma,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,erythema,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,thyroid cancer,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,thrombocytopenia,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Bacteraemia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,arterial pressure NOS decreased,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,elevated erythrocyte sedimentation rate,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,confusion,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,abnormal ECG,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,dysarthria,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,erythema,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,fibroadenoma of breast,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,hepatitis,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,atelectasis,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,cholecystitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Infection Upper Respiratory,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,dysarthria,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,icterus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,High blood pressure,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,thrombocytopenia,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Sinus headache,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Arrhythmia,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,back injury,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,right heart failure,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Pain,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,deglutition disorder,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,back injury,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,bleeding Vaginal,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,heart attack,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,edema,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,right heart failure,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Back Ache,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Amnesia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,drug toxicity NOS,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Adenopathy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,eruption,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,dizziness,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Dyspnea exertional,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,abnormal ECG,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,angiitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,rhinorrhea,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,nasopharyngitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,nasopharyngitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,leucocytosis,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,methaemoglobinaemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Adenopathy,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,hypermagnesemia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,abnormal EEG,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Adenopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,erythema,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Sinus headache,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,allergic dermatitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,edema,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,weight gain,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Sinus headache,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,muscle inflammation,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,thrombocytopenia,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,hepatitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,gastroenteritis viral,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Sinus headache,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Dyspnea exertional,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,bleeding Vaginal,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,methaemoglobinaemia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,cholelithiasis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,gout,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,glaucoma,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,back injury,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,increased white blood cell count,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,apoplexy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,atelectasis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Clotting,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,hypermagnesemia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,deglutition disorder,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,metabolic encephalopathy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,angiitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004485,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,dry skin,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,Incontinence,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,folate deficiency,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,erythema,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,mouth bleeding,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,apoplexy,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,folate deficiency,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,Bacteraemia,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,neumonia,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,allergic dermatitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,dysarthria,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,allergic dermatitis,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,thrombocytopenia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,confusion,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,acute pancreatitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,elevated cholesterol,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,agitated,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,hyperglycaemia,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,allergic dermatitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,hepatic encephalopathy,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,drug toxicity NOS,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,confusion,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,eruption,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,proctalgia,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,apoplexy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,mouth bleeding,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,Bilirubinaemia,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,confusion,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,deglutition disorder,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,causalgia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,abnormal ECG,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,thrombocytopenia,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,hepatitis,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004539,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,hepatitis,CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,ear ache,CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,deglutition disorder,CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,thrombocytopenia,CID000024011,BLAH,S=[Se]
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,ear infection,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,anaphylactic reaction,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,hyperalimentation,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,neumonia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,right heart failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,increased white blood cell count,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,angiitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,apoplexy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,gastric inflammation,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,angiitis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,abnormal ECG,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,conjunctivitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,nasopharyngitis,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,back injury,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,insulin dependent diabetes mellitus,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,thrombocytopenia,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,thrombocytopenia,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,back injury,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,elevated cholesterol,CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,weight gain,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,apoplexy,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,heart rate increased,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Sinus headache,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Back Ache,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,abnormal ECG,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,angiitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,trigeminal neuralgia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,angina,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Pain,CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,elevated erythrocyte sedimentation rate,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,rhinorrhea,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,cholecystitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Decreased hearing,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,herpes zoster,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,neumonia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,elevated cholesterol,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,erythema multiforme,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,icterus,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,erythema,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,alopecia,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,erythema,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,cholecystitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,erythema,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,failure to thrive,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,nausea,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,cellulitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,thrombocytopenia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,deglutition disorder,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,gastric inflammation,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,bursitis,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,gastric inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,angiitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,Adenopathy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,thrombocytopenia,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,cholecystitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000176870,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,abnormal ECG,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,hematoma subdural,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,abnormal ECG,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,insulin dependent diabetes mellitus,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Adenopathy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,drug toxicity NOS,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Back Ache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Back Ache,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,coughing blood,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,increased white blood cell count,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,nasopharyngitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Multiple Myeloma,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,loss of weight,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,weight gain,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000041774,"4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucopyranose",CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Gastric Cancer,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,adenitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,loss of weight,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,Difficulty breathing,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,thrombocytopenia,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,phlebothrombosis,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,eruption,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,abnormal ECG,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,dysarthria,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,migraine,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,High blood pressure,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,nausea,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,periodontitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Sinus headache,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,dysarthria,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,dysarthria,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,narcolepsy,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,drowsiness,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,muscle inflammation,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,thrombocytopenia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,erythema,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,High blood pressure,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,bradycardia,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,neumonia,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,haemorrhage intracranial,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Sinus headache,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,increased white blood cell count,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,adenomyosis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,weight gain,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,Adenopathy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,apoplexy,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,back injury,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,disseminated lupus erythematosus,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,dysarthria,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,thrombocytopenia,CID000040976,"(17R)-13-Ethyl-17-ethynyl-17-hydroxy-11-methylene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one",CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,gastric inflammation,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,loss of weight,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,apoplexy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,rhinorrhea,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,aching muscles,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,back injury,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cholecystitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,back injury,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,thrombocytopenia,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,Pain,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,apoplexy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cholecystitis,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,eruption,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,loss of weight,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,back injury,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,failure to thrive,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,apoplexy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,erythema,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,gangrene,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,eruption,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,erythema,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,loss of weight,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,Infection Urinary Tract,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,gastric inflammation,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,back injury,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,erythema,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,erythema,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,Acne,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,erythema,CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,Sinus headache,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,confusion,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,aching muscles,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,loss of weight,CID000024011,BLAH,S=[Se]
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,gastric inflammation,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,apoplexy,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,abdominal pain upper,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,nasopharyngitis,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,edema,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,dysarthria,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,loss of weight,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cholecystitis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,abdominal pain upper,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,body temperature increased,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,allergic dermatitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,cellulitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005656,93413-69-5,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,loss of weight,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholecystitis,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,High blood pressure,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,Bacteraemia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,thrombocytopenia,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,failure to thrive,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,eruption,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,thrombocytopenia,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,atelectasis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,apoplexy,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholecystitis,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholelithiasis,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,Cardiomyopathy,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,abnormal ECG,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,edema,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,subarachnoid haemorrhage,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,eruption,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cellulitis,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,thrombocytopenia,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,myelodysplasia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,gastric inflammation,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,atelectasis,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,peritonitis,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,drug withdrawal,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,apoplexy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,methaemoglobinaemia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,apoplexy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,neumonia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,apoplexy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,disseminated lupus erythematosus,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,abnormal ECG,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,thrombocytopenia,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,deglutition disorder,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,right heart failure,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,erythema,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,peritonitis,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,angiitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,eruption,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,atelectasis,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholecystitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,atelectasis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,methaemoglobinaemia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,icterus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,thrombocytopenia,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,Bleeding,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,Pain,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005651,1404-90-6,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,dysarthria,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,Pain,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,apoplexy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,loss of weight,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,cholecystitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,drug toxicity NOS,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,erythema,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,weight gain,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,asthma,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,gastric inflammation,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005717,Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],erythema,CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],erythema,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],abnormal EEG,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],neumonia,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],loss of weight,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],erythema,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Adenopathy,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Fainting,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],gastric inflammation,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Bleeding,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],erythema,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Pain,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],migraine,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Bilirubinaemia,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],dysarthria,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Bilirubinaemia,CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cellulitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],neumonia,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],alopecia,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],abnormal EEG,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],metabolic acidosis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],neumonia,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],alopecia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],thrombocytopenia,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],gastric inflammation,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],deglutition disorder,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Bilirubinaemia,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],dysarthria,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Adenopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],loss of weight,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],angiitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],loss of weight,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],eruption,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],peritonitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Adenopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],gastric inflammation,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],dysarthria,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],dysarthria,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],agitated,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],heart rate increased,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],neumonia,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],nephrotic syndrome,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],gastric inflammation,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],angiitis,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],pneumothorax,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],dysarthria,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],right heart failure,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],angiitis,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],erythema,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],neuropathy,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],thrombocytopenia,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],failure to thrive,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],loss of weight,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Adenopathy,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],erythema,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cardiovascular collapse,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],bulging,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Arrhythmia,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],sepsis,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],abnormal EEG,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],neumonia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Bacteraemia,CID000002725,chlorphenamine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Bleeding,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],abnormal EEG,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],eruption,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],heart rate increased,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002650,"7-{[(2-Amino-1,3-thiazol-4-yl){[(2-carboxy-2-propanyl)oxy]imino}acetyl]amino}-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],Amnesia,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,weight gain,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,thrombocytopenia,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,thrombocytopenia,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,bulimia,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,confusion,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,multifocal leukoencephalopathy,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,aspiration pneumonia,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,methaemoglobinaemia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Arrhythmia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Sinus headache,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,neumonia,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Back Ache,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,dysarthria,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Dyspnea exertional,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,brain neoplasm,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Dyspnea exertional,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,insulin dependent diabetes mellitus,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Back Ache,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,dysarthria,CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema multiforme,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,difficulty in walking,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,insulin dependent diabetes mellitus,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,increased white blood cell count,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,myelodysplasia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,constipated,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,neumonia,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Dyspnea exertional,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,dysarthria,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,increased white blood cell count,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,arterial pressure NOS decreased,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Pain,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cerebral haemorrhage,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,methaemoglobinaemia,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,dysarthria,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystectomies,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,dizziness,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,enlarged liver,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,eruption,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,myelodysplasia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cellulitis,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,icterus,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,drug toxicity NOS,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,colitis ischemic,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,angiitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,animal bite,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,angiitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,insulin dependent diabetes mellitus,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,abnormal EEG,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cerebral vascular disorder,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cataract,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,hepatitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Back Ache,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,drug toxicity NOS,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,disseminated lupus erythematosus,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,pulmonary arrest,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,bradycardia,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,ADH inappropriate,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,dysarthria,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,weight gain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,abnormal ECG,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,back injury,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Pain,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,weight gain,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,methaemoglobinaemia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,methaemoglobinaemia,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,elevated cholesterol,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,abnormal ECG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Pleural Effusion,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,constipated,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema multiforme,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystectomies,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,weight gain,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,pregnancy induced hypertension,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,hypermagnesemia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,bursitis,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,back injury,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,methaemoglobinaemia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,thrombocytopenia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,thrombocytopenia,CID000004211,53-19-0,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Extrasystoles Ventricular,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,acute pancreatitis,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,rhinorrhea,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,methaemoglobinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Aspartate Aminotransferase Increase,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Dyspnea exertional,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,angiitis,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,defaecation urgency,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,disseminated lupus erythematosus,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,erythema,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,myelodysplasia,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,heart attack,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,rhinorrhea,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gastric inflammation,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,drug toxicity NOS,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,acute pancreatitis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cholecystitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003222,N-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanylproline,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,gingivitis,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,bradycardia,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,cholecystitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,thrombocytopenia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,edema,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,apoplexy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,neumonia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Light sensitivity,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,thrombocytopenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,failure to thrive,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,increased white blood cell count,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,deafness,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,drug toxicity NOS,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Chronic Kidney Disease,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,erythema,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,insulin dependent diabetes mellitus,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Pleural Effusion,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,apoplexy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,thrombocytopenia,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Dyspnea exertional,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,angioedema,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,apoplexy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,loss of weight,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Osteoarthritis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Feeling unwell,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,folliculitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,gastroenteritis viral,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,insulin dependent diabetes mellitus,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004201,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,apoplexy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,abnormal EEG,CID005481350,201341-05-1,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,abnormal EEG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cerebral vascular disorder,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,drug toxicity NOS,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,bundle branch block right,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema multiforme,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cellulitis,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,myelodysplasia,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Dyspnea exertional,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,right heart failure,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,metabolic encephalopathy,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Excess potassium,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Extrasystoles Ventricular,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,failure to thrive,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,retinopathy of prematurity,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,increased white blood cell count,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,pulmonary arrest,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,weight gain,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,amyloidosis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,right heart failure,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,peritonitis,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,bursitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,allergic vasculitis,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000024011,BLAH,S=[Se]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,angiitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,drug withdrawal,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,weight gain,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,respiratory alkalosis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,angiitis,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,drug toxicity NOS,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,edema,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Back Ache,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,right heart failure,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Bone Fracture Spontaneous,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,dysarthria,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,edema,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,back injury,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,right heart failure,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,belching,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,myelodysplasia,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,edema,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,neumonia,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cerebral vascular disorder,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,abnormal EEG,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,food allergy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,angiitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,folate deficiency,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gout,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,dysarthria,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cellulitis,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,angiitis,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,excessive thirst,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Back Ache,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,fracture nonunion,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,right heart failure,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,High blood pressure,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Extrasystoles Ventricular,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,atelectasis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,bursitis,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,failure to thrive,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,weight gain,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,subarachnoid haemorrhage,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,fracture nonunion,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystectomies,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,respiratory alkalosis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,abnormal ECG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Back Ache,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,right heart failure,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,dysarthria,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Scleroderma,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Back Ache,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Dyspnea exertional,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,abnormal ECG,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,esophageal stenosis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,drug toxicity NOS,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,High blood pressure,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,back injury,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Dyspnea exertional,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Dyspnea exertional,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,neumonia,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,insulin dependent diabetes mellitus,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Osteogenesis Imperfecta,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,insulin dependent diabetes mellitus,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,haemorrhage rectum,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Back Ache,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,respiratory alkalosis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,insulin dependent diabetes mellitus,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,right heart failure,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,bladder retention,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,drug toxicity NOS,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,atelectasis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Bone marrow fibrosis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Aspartate Aminotransferase Increase,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,abnormal ECG,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,atelectasis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Bilirubinaemia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cardiovascular collapse,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,ear infection,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,metabolic encephalopathy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gout,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,drug toxicity NOS,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,abnormal ECG,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003440,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,birth defect,CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Adenopathy,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystectomies,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,nausea,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,thrombocytopenia,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,thrombocytopenia,CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystectomies,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Adenopathy,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,bladder retention,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,scotoma,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,apoplexy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,peritonitis,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,abnormal EEG,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,dysarthria,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,pain in throat,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,abnormal EEG,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,thrombocytopenia,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,weight gain,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,nervous tension,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,glaucoma,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,High blood pressure,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Adenopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,methaemoglobinaemia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,fibroadenoma of breast,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,coughing blood,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,drug toxicity NOS,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,abnormal ECG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Dyspnea exertional,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,nasopharyngitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,methaemoglobinaemia,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,dysarthria,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gastric inflammation,CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholelithiasis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,aseptic necrosis bone,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,lung infiltration,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,drug toxicity NOS,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,abnormal ECG,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,eruption,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,insulin dependent diabetes mellitus,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,deglutition disorder,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Alcoholic intoxication,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,glossodynia,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,weight gain,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,eruption,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,eruption,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,bursitis,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Adenopathy,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,thrombocytopenia,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,apoplexy,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gout,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,weight gain,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Hepatic failure,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Infection Urinary Tract,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,methaemoglobinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Back Ache,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cellulitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Scleroderma,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,abnormal EEG,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,abnormal EEG,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Back Ache,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,azotaemia,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystectomies,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,aptyalism,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Adenopathy,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gastric inflammation,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cellulitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gastric inflammation,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,apoplexy,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,insulin dependent diabetes mellitus,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,methaemoglobinaemia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Neuralgia,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Dyspnea exertional,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,dysarthria,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,abnormal ECG,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,dry skin,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cellulitis,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Adenopathy,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,subarachnoid haemorrhage,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,ecchymoses,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,drug toxicity NOS,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,eye pain,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Acute Respiratory Distress Syndrome,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Pain,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,eruption,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,edema,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cellulitis,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,agitated,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,aortic stenosis,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,convulsion,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema multiforme,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,methaemoglobinaemia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,defaecation urgency,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,ecchymoses,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Adenopathy,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,increased white blood cell count,CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystectomies,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,myelodysplasia,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,rhinorrhea,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,gout,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,angiitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,constipated,CID000002973,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,erythema,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,myelodysplasia,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,weight gain,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cholecystitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,increased white blood cell count,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,hypermagnesemia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,enteritis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,encephalitis viral,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Pain,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,loss of weight,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002909,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,bursitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,diabetic acidosis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000057469,99011-02-6,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,erythema,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,Porphyria,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,food allergy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,edema,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,loss of consciousness,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,angiitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,elevated cholesterol,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,cellulitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,hiccough,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,cholecystitis,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,apoplexy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,drug toxicity NOS,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,chest pain,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,trigeminal neuralgia,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,icterus,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,atelectasis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,Abnormal Gait,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,cellulitis,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,ear ache,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,angiitis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,drug toxicity NOS,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,Chronic Kidney Disease,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,defaecation urgency,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,thrombocytopenia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,hepatic neoplasia,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,Extrasystoles Ventricular,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000027661,Isosorbide 5-nitrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O,right heart failure,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Adenopathy,CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,lung infiltration,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Adenopathy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,heart rate increased,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,adenitis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,weight gain,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,gastric inflammation,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,weight gain,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,myelodysplasia,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,thrombocytopenia,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,eruption,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,elevated cholesterol,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,apoplexy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,agitated,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,trigeminal neuralgia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Adenopathy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,allergic dermatitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,loss of weight,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,abnormal ECG,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Hypoventilation,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,eruption,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Adenopathy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,apoplexy,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,heart rate increased,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,erythema,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,herpes zoster,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,dysarthria,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Adenopathy,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,enlarged liver,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,apoplexy,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,deglutition disorder,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,rhinorrhea,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005647,2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,Adenopathy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,edema,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,belching,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,bulging,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,Chronic Kidney Disease,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,abdominal pain upper,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,gastric inflammation,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,Adenopathy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,Dyspnea exertional,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,heart rate increased,CID000444033,"2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate",CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,back injury,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,neumonia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000123620,"(8ξ,11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,neumonia,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000000271,Calcium(II) ion,[Ca+2],apoplexy,CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000000271,Calcium(II) ion,[Ca+2],lung infiltration,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000000271,Calcium(II) ion,[Ca+2],Adenopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000000271,Calcium(II) ion,[Ca+2],weight gain,CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
CID000000271,Calcium(II) ion,[Ca+2],insulin dependent diabetes mellitus,CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-]
CID000000271,Calcium(II) ion,[Ca+2],insulin dependent diabetes mellitus,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000000271,Calcium(II) ion,[Ca+2],myelodysplasia,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000271,Calcium(II) ion,[Ca+2],angiitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000000271,Calcium(II) ion,[Ca+2],eruption,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000271,Calcium(II) ion,[Ca+2],right heart failure,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000000271,Calcium(II) ion,[Ca+2],Adenopathy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000000271,Calcium(II) ion,[Ca+2],gastric inflammation,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000000271,Calcium(II) ion,[Ca+2],Adenopathy,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000271,Calcium(II) ion,[Ca+2],allergic dermatitis,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000000271,Calcium(II) ion,[Ca+2],apoplexy,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000000271,Calcium(II) ion,[Ca+2],eruption,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000000271,Calcium(II) ion,[Ca+2],apoplexy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000000271,Calcium(II) ion,[Ca+2],aseptic necrosis bone,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000000271,Calcium(II) ion,[Ca+2],angiitis,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000000271,Calcium(II) ion,[Ca+2],hypermagnesemia,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000271,Calcium(II) ion,[Ca+2],dry skin,CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],apoplexy,CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000271,Calcium(II) ion,[Ca+2],abnormal ECG,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000000271,Calcium(II) ion,[Ca+2],cholecystitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000000271,Calcium(II) ion,[Ca+2],glaucoma,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000000271,Calcium(II) ion,[Ca+2],apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000271,Calcium(II) ion,[Ca+2],myelodysplasia,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000000271,Calcium(II) ion,[Ca+2],cholecystitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000000271,Calcium(II) ion,[Ca+2],apoplexy,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000000271,Calcium(II) ion,[Ca+2],angiitis,CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],apoplexy,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000000271,Calcium(II) ion,[Ca+2],Bacteraemia,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000000271,Calcium(II) ion,[Ca+2],enlarged liver,CID000001117,14808-79-8,[O-]S(=O)(=O)[O-]
CID000000271,Calcium(II) ion,[Ca+2],hypermagnesemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000271,Calcium(II) ion,[Ca+2],apoplexy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000000271,Calcium(II) ion,[Ca+2],angiitis,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000271,Calcium(II) ion,[Ca+2],enlarged spleen,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],weight gain,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000271,Calcium(II) ion,[Ca+2],dry skin,CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000000271,Calcium(II) ion,[Ca+2],gout,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000000271,Calcium(II) ion,[Ca+2],right heart failure,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000271,Calcium(II) ion,[Ca+2],contracture,CID000002019,50-76-0,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
CID000000271,Calcium(II) ion,[Ca+2],pyelonephritis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000000271,Calcium(II) ion,[Ca+2],cholecystitis,CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000000271,Calcium(II) ion,[Ca+2],ear infection,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000271,Calcium(II) ion,[Ca+2],cholecystitis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000000271,Calcium(II) ion,[Ca+2],weight gain,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000000271,Calcium(II) ion,[Ca+2],Chronic Kidney Disease,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000000271,Calcium(II) ion,[Ca+2],Anxiety,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000000271,Calcium(II) ion,[Ca+2],hypermagnesemia,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],deglutition disorder,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000000271,Calcium(II) ion,[Ca+2],Ekbom Syndrome,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000000271,Calcium(II) ion,[Ca+2],insulin dependent diabetes mellitus,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000000271,Calcium(II) ion,[Ca+2],contracture,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000000271,Calcium(II) ion,[Ca+2],Adenopathy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000000271,Calcium(II) ion,[Ca+2],gangrene,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],gout,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000000271,Calcium(II) ion,[Ca+2],bone fracture,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000000271,Calcium(II) ion,[Ca+2],cholecystitis,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000000271,Calcium(II) ion,[Ca+2],deglutition disorder,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000000271,Calcium(II) ion,[Ca+2],angiitis,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],meningioma,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000000271,Calcium(II) ion,[Ca+2],failure to thrive,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],cholecystitis,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000000271,Calcium(II) ion,[Ca+2],contracture,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000000271,Calcium(II) ion,[Ca+2],myelodysplasia,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000000271,Calcium(II) ion,[Ca+2],myelodysplasia,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000000271,Calcium(II) ion,[Ca+2],apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
CID000000271,Calcium(II) ion,[Ca+2],neumonia,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000271,Calcium(II) ion,[Ca+2],angioedema,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000000271,Calcium(II) ion,[Ca+2],defaecation urgency,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000000271,Calcium(II) ion,[Ca+2],right heart failure,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000000271,Calcium(II) ion,[Ca+2],mouth bleeding,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000000271,Calcium(II) ion,[Ca+2],dry skin,CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O
CID000000271,Calcium(II) ion,[Ca+2],eruption,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000271,Calcium(II) ion,[Ca+2],hypermagnesemia,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000000271,Calcium(II) ion,[Ca+2],haematoma,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000271,Calcium(II) ion,[Ca+2],Adenopathy,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000271,Calcium(II) ion,[Ca+2],Pain,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000271,Calcium(II) ion,[Ca+2],pyelonephritis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000000271,Calcium(II) ion,[Ca+2],dermatitis exfoliative,CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S
CID000000271,Calcium(II) ion,[Ca+2],abdominal pain upper,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000000271,Calcium(II) ion,[Ca+2],mouth bleeding,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000000271,Calcium(II) ion,[Ca+2],gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000271,Calcium(II) ion,[Ca+2],dry skin,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000000271,Calcium(II) ion,[Ca+2],angiitis,CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
CID000000271,Calcium(II) ion,[Ca+2],Dyspnea exertional,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000271,Calcium(II) ion,[Ca+2],angiitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000000271,Calcium(II) ion,[Ca+2],Chronic Kidney Disease,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000000271,Calcium(II) ion,[Ca+2],Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000271,Calcium(II) ion,[Ca+2],allergic dermatitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000271,Calcium(II) ion,[Ca+2],cellulitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000000271,Calcium(II) ion,[Ca+2],bradycardia,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000000271,Calcium(II) ion,[Ca+2],angiitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000000271,Calcium(II) ion,[Ca+2],erythema,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000000271,Calcium(II) ion,[Ca+2],constipated,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000271,Calcium(II) ion,[Ca+2],gout,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000000271,Calcium(II) ion,[Ca+2],loss of weight,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000271,Calcium(II) ion,[Ca+2],neuropathy,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000000271,Calcium(II) ion,[Ca+2],hypermagnesemia,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000271,Calcium(II) ion,[Ca+2],arterial pressure NOS increased,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,elevated erythrocyte sedimentation rate,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Infection Upper Respiratory,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,gastric inflammation,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,eruption,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,nasopharyngitis,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Back Ache,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,cholecystitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Dyspnea exertional,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,myelodysplasia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,abnormal ECG,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,colitis ischemic,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,nasopharyngitis,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,cholecystitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,aortic stenosis,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,neumonia,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Acidosis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,pain in throat,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,erythema,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,abnormal EEG,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Dyspnea exertional,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,insulin dependent diabetes mellitus,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Bilirubinaemia,CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,deafness,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Paraesthesia,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,abnormal ECG,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,allergic dermatitis,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,dysarthria,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,colitis ischemic,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,apoplexy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,gout,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,dysarthria,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,apoplexy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,dysarthria,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,apoplexy,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,weight gain,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,body temperature increased,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,abnormal ECG,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,myelodysplasia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,abnormal ECG,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,abnormal ECG,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,apoplexy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Infection Upper Respiratory,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,right heart failure,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000002405,66722-44-9,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,Adenopathy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,angiitis,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,right heart failure,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,neuropathy,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Enuresis,CID000003372,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Back Ache,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,rhinorrhea,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cellulitis,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,aphasia,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,insulin dependent diabetes mellitus,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastroenteritis viral,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,constipated,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,erythema,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,abnormal EEG,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,atelectasis,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,glaucoma,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,drug toxicity NOS,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,constipated,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,abnormal ECG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Back Ache,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,neumonia,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,abnormal EEG,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,malnourished,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,methaemoglobinaemia,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Back Ache,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,bulging,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Adenopathy,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,insulin dependent diabetes mellitus,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,abnormal ECG,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,abdominal pain upper,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,erythema,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,icterus,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,agitated,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Hepatic failure,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,angiitis,CID000003198,Econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cellulitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Cystitis Interstitial,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,eruption,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Acne,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Adenopathy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,proctalgia,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,abnormal ECG,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,thrombocytopenia,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Pain,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,als,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Acute Respiratory Distress Syndrome,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,pneumothorax,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of consciousness,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Adenopathy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,excessive thirst,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,bursitis,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,increased white blood cell count,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Bleeding,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,erythema,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,muscle disorder,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastroenteritis viral,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000003278,58-54-8,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,abnormal EEG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,nasopharyngitis,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,bulging,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,insulin dependent diabetes mellitus,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,subarachnoid haemorrhage,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,bulging,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Enuresis,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,drug toxicity NOS,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,nausea,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,myelodysplasia,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystectomies,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,metabolic encephalopathy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Adenopathy,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,allergic dermatitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,weight gain,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,weight gain,CID000004645,"2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydro-1,3,12(2H,4H,5H)-tetracenetrione",CC1(C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,angiitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,allergic dermatitis,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,angiitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,erythema,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,erythema,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,dysarthria,CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,myelodysplasia,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,coughing blood,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,angiitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,drug toxicity NOS,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,drug toxicity NOS,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Sinus headache,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,erythema,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Diplopia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,icterus,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,erythema,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,weight gain,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Pain,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,erythema,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,abnormal ECG,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Adenopathy,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,insulin dependent diabetes mellitus,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gout,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,right heart failure,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Sinus headache,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,facial flushing,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,abnormal ECG,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,nasopharyngitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,myelodysplasia,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,dysarthria,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Pain,CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,drug toxicity NOS,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Back Ache,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,hepatic necrosis,CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cellulitis,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,angiitis,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Hepatic failure,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Diplopia,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,drug toxicity NOS,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,apoplexy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,eruption,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,myelodysplasia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,cholecystitis,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Extrasystoles Ventricular,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,myelodysplasia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,body temperature increased,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,drug toxicity NOS,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,back injury,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,dysarthria,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,micturition urgency,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Porphyria,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,gastric inflammation,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003016,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,loss of weight,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,Back Ache,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,drug toxicity NOS,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,loss of weight,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,weight gain,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,myelodysplasia,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,apoplexy,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,eruption,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,fecal occult blood,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,thrombocytopenia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,Pain,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,thrombocytopenia,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,loss of weight,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,thrombocytopenia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,loss of weight,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,cellulitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,drug toxicity NOS,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,apoplexy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,apoplexy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,Amnesia,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,High blood pressure,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,malabsorption,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,eruption,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004189,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,loss of weight,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,abdominal pain upper,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,loss of weight,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,neumonia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,gastric inflammation,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,deep vein thromboses,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,hepatic neoplasia,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Infection Urinary Tract,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Small intestinal obstruction,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,glossodynia,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,loss of weight,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,eruption,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,gastric inflammation,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,respiratory failure,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Back Ache,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,malnourished,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,thrombocytopenia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Bone Fracture Spontaneous,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,erythema,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,peritonitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,insulin dependent diabetes mellitus,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,cellulitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,neumonia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,thrombocytopenia,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,abnormal EEG,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Neutropenia,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,eruption,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Excess potassium,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,drug toxicity NOS,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,edema,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,insulin dependent diabetes mellitus,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,eruption,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,increased white blood cell count,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,edema,CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,emesis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,dry skin,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,right heart failure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,haemorrhoids,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,lung infiltration,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,atelectasis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,failure to thrive,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,loss of weight,CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,failure to thrive,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Small intestinal obstruction,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,drug toxicity NOS,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,apoplexy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,loss of weight,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,loss of weight,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Adenopathy,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Adenopathy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,right heart failure,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Dyspnea exertional,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,thrombocytopenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,dysarthria,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,thrombocytopenia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,erythema,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,failure to thrive,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,apoplexy,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,eruption,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,neumonia,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,gastric inflammation,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,thrombocytopenia,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,dysarthria,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,thrombocytopenia,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Adenopathy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,hypoxia,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Difficulty breathing,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Neutropenia,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,hypermagnesemia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,loss of weight,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,thrombocytopenia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,eruption,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,eruption,CID000024011,BLAH,S=[Se]
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,hypogonadism,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Pain,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Pain,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,loss of weight,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,bulging,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,deglutition disorder,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Drug hypersensitivity,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,erythema,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Adenopathy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,hepatic neoplasia,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,thrombocytopenia,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Ovarian cancer,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Dyspnea exertional,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,angiitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Back Ache,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,nasopharyngitis,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,thrombocytopenia,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,gastric inflammation,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,cellulitis,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Scleroderma,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,constipated,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,increased white blood cell count,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,gastric inflammation,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,High blood pressure,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,aspiration pneumonia,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Adenopathy,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Pain,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,eruption,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,allergic dermatitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,urethritis,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,anaphylactic reaction,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],thrombocytopenia,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],erythema,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Back Ache,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],drug toxicity NOS,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],hypochloraemia,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],periodontitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Adenopathy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],neumonia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],trigeminal neuralgia,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],heart rate increased,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystectomies,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],nephrotic syndrome,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],apoplexy,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],rhinorrhea,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],insulin dependent diabetes mellitus,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],defaecation urgency,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],weight gain,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],dysarthria,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Clotting,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],myelodysplasia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Rheumatic fever,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],angiitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],hepatitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Back Ache,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],narcolepsy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Adenopathy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Acne,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cellulitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cellulitis,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],loss of weight,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],nausea,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],acute pancreatitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],confusion,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],abnormal EEG,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],High blood pressure,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],loss of weight,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Acute Respiratory Distress Syndrome,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],periodontitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],herpes zoster,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],agitated,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],bursitis,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],insulin dependent diabetes mellitus,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],metabolic encephalopathy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],myocarditis,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],eruption,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],apoplexy,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],fracture nonunion,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],periodontitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],nephrotic syndrome,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],metabolic encephalopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cellulitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],erythema,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],excessive thirst,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],apoplexy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],agitated,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],increased white blood cell count,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],neumonia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],hepatitis,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gout,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],atelectasis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],lower GI bleeding,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],deglutition disorder,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],angiitis,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Back Ache,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004173,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cellulitis,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,loss of weight,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,myelodysplasia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,deglutition disorder,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gastric inflammation,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,deglutition disorder,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,angiitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,anaphylactic reaction,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gout,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,neumonia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Pain,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Dyspnea exertional,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,eruption,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,loss of weight,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,myelodysplasia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,loss of weight,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,angiitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,deglutition disorder,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,erythema,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,eruption,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Diplopia,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,bruxism,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Bacteraemia,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,hematoma subdural,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Pleural Effusion,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,weight gain,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,anaemia,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,abnormal EEG,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,angiitis,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,heart attack,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Back Ache,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,weight gain,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,muscle disorder,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,thrombocytopenia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,kidney transplant,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Scleroderma,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,peritonitis,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,weight gain,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,subarachnoid haemorrhage,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Adenopathy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Bacteraemia,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Irritation Skin,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Adenopathy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,eruption,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,hepatic neoplasia,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Cystitis Interstitial,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,aspiration pneumonia,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,trigeminal neuralgia,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Adenopathy,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Back Ache,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,ear infection,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,respiratory alkalosis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,High blood pressure,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,angina,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,sepsis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gastric inflammation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,abnormal EEG,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Adenopathy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Ovarian cancer,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,eruption,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004159,"11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,apoplexy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O,atelectasis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID005311297,2-{2-[(3R)-3-{3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}-3-sulfanylpropyl]phenyl}-2-propanol,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O,weight gain,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,dysarthria,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,eruption,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,abnormal ECG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Endometrial cancer,CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Bleeding,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Hepatic failure,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,back injury,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,abnormal EEG,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,allergic dermatitis,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Embolism pulmonary,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,allergic dermatitis,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gout,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,eruption,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Adenopathy,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,drug toxicity NOS,CID000001117,14808-79-8,[O-]S(=O)(=O)[O-]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,High blood pressure,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,eruption,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,erythema,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,failure to thrive,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Adenopathy,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,eruption,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Back Ache,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Back Ache,CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,erythema,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystectomies,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,allergic dermatitis,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,trigeminal neuralgia,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Adenopathy,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cellulitis,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,allergic dermatitis,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,thrombocytopenia,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,abnormal ECG,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,dysarthria,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,angiitis,CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,elevated erythrocyte sedimentation rate,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,erythema,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,allergic dermatitis,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Back Ache,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,trigeminal neuralgia,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,elevated cholesterol,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,High blood pressure,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,respiratory alkalosis,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Clotting,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,back injury,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,thrombocytopenia,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,dizziness,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,dysarthria,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,back injury,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cellulitis,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Adenopathy,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Dyspnea exertional,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,aspiration pneumonia,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,allergic dermatitis,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Dyspnea exertional,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gout,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,angiitis,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,eruption,CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,abnormal ECG,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,aptyalism,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,abnormal ECG,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,erythema,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,abnormal ECG,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,asthenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,trigeminal neuralgia,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Infection Upper Respiratory,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,respiratory alkalosis,CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,eruption,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Scleroderma,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,elevated cholesterol,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,insulin dependent diabetes mellitus,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,respiratory failure,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,bursitis,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,insulin dependent diabetes mellitus,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000001065,6′-Methoxycinchonan-9-ol,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastroenteritis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,hepatic neoplasia,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,back injury,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gout,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,adenomyosis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,angiitis,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,erythema,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,right heart failure,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Adenopathy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Anxiety,CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,angiitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,back injury,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,agitated,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,angiitis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Back Ache,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,right heart failure,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,eruption,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,myelodysplasia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,deglutition disorder,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Back Ache,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,pleural pain,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,drug withdrawal,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,methaemoglobinaemia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Arrhythmia,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Dyspnea exertional,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,erythema,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,drug withdrawal,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,dysarthria,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cellulitis,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,nausea,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Infection Upper Respiratory,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,rotator cuff syndrome,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,myocarditis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,right heart failure,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,eruption,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,facial flushing,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Back Ache,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Bone Fracture Spontaneous,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastroenteritis viral,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Arrhythmia,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,insulin dependent diabetes mellitus,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Adenopathy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,nasopharyngitis,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Adenopathy,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,abnormal ECG,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,dysarthria,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,dysarthria,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,abnormal EEG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,agitated,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,abnormal EEG,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,subarachnoid haemorrhage,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of weight,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,loss of consciousness,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,colitis ischemic,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,confusion,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,erythema,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,deglutition disorder,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,methaemoglobinaemia,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,insulin dependent diabetes mellitus,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,heart rate increased,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,gastric inflammation,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002576,78-44-4,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,Breakthrough bleeding,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Dyspnea exertional,CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,arterial pressure NOS increased,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,excessive thirst,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,subarachnoid haemorrhage,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Acne,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,thrombocytopenia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholelithiasis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,nasopharyngitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cataract,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cellulitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,angiitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Bleeding,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,dry skin,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Adenopathy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,thrombocytopenia,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Bladder inflammation,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,drug toxicity NOS,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,belching,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abdominal pain upper,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Acne,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,weight gain,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,myelodysplasia,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,weight gain,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,phlebothrombosis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,erythema,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,contact dermatitis,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,allergic dermatitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,erythema,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,arterial pressure NOS increased,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Adenopathy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,angiitis,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Bleeding,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,elevated cholesterol,CID000002708,Chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,bursitis,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,global amnesia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Back Ache,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal ECG,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,thrombocytopenia,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,edema,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,thrombocytopenia,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Chronic Kidney Disease,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,erythema multiforme,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,respiratory alkalosis,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal ECG,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,pancreatitis,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,sinus tachycardia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,elevated erythrocyte sedimentation rate,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,bladder retention,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,erythema,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cellulitis,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,dysarthria,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,weight gain,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,colitis,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Sinus headache,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,elevated cholesterol,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,back injury,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,narcolepsy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Back Ache,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,angiitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Scleroderma,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,atelectasis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,atelectasis,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,right heart failure,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Bleeding,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal EEG,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Bleeding,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,myelodysplasia,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Arrhythmia,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,constipated,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,angiitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,elevated cholesterol,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Dyspnea exertional,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,angiitis,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,hyperlipaemia,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Acute Respiratory Distress Syndrome,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,thrombocytopenia,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,myelodysplasia,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal ECG,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,bradycardia,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,bulging,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Cardiomyopathy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,weight gain,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,erythema,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal ECG,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,edema,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Adenopathy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,thrombocytopenia,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Arrhythmia,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Adenopathy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,eruption,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,hyperhidrosis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal ECG,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,aseptic necrosis bone,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,increased white blood cell count,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,lung neoplasm malignant,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal ECG,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,angiitis,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,erythema,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,elevated cholesterol,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Back Ache,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Infection Upper Respiratory,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,thrombocytopenia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gingivitis,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,erythema,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002541,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,High blood pressure,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,methaemoglobinaemia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Arrhythmia,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,High blood pressure,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Chronic Kidney Disease,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cardiac failure,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,eruption,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,eruption,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,enlarged liver,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,deglutition disorder,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,parotitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,fracture nonunion,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema multiforme,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cellulitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Back Ache,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema multiforme,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,nephrotic syndrome,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,atelectasis,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,High blood pressure,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,thrombocytopenia,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,weight gain,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,myelodysplasia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,drug toxicity NOS,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,hepatitis,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Chronic Kidney Disease,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,edema,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,High blood pressure,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,dysarthria,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,insulin dependent diabetes mellitus,CID000002973,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,atelectasis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,angiitis,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Dyspnea exertional,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,eruption,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,rotator cuff syndrome,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,methaemoglobinaemia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Bleeding,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,dysarthria,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cellulitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,rotator cuff syndrome,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,trigeminal neuralgia,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,eruption,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystectomies,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Dyspnea exertional,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,rhinorrhea,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Back Ache,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,atelectasis,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,thrombocytopenia,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Infection Urinary Tract,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Drug hypersensitivity,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Back Ache,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,eruption,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,iron deficiency anaemia,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,thrombocytopenia,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,methaemoglobinaemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Ataxia,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Arrhythmia,CID000024011,BLAH,S=[Se]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,methaemoglobinaemia,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cardiac enlargement,CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,angiitis,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema multiforme,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,nasopharyngitis,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Back Ache,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Extrasystoles Ventricular,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,back injury,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,abnormal ECG,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,myelodysplasia,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,allergic dermatitis,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,methaemoglobinaemia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,convulsion,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,High blood pressure,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,myelodysplasia,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,abnormal EEG,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,thrombocytopenia,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,weight gain,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,allergic dermatitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cellulitis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,belching,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,leucocytosis,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,fracture nonunion,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gout,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,subarachnoid haemorrhage,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,loss of weight,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,atelectasis,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,ventricular fibrillation,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,methaemoglobinaemia,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,confusion,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,eruption,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,abnormal ECG,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Cardiomyopathy,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,malabsorption,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,upper gastrointestinal bleeding,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,weight gain,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,insulin dependent diabetes mellitus,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,rotator cuff syndrome,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,aphasia,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,insulin dependent diabetes mellitus,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,methaemoglobinaemia,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,erythema,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,thrombocytopenia,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Adenopathy,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,coughing blood,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,aortic regurgitation,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,myelodysplasia,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,angiitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,rhinorrhea,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,aortic regurgitation,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Infection Upper Respiratory,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,endocrine disorder,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cholecystitis,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,methaemoglobinaemia,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,methaemoglobinaemia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,gastric inflammation,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,weight gain,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,pain in throat,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,metabolic encephalopathy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002585,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Dyspnea exertional,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,gastric inflammation,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,neumonia,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,bursitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,Adenopathy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,abnormal ECG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,rotator cuff syndrome,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,rotator cuff syndrome,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,insulin dependent diabetes mellitus,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,Adenopathy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,back injury,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,apoplexy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,rotator cuff syndrome,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,back injury,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,apoplexy,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,dysarthria,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,bursitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,gout,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,loss of weight,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,allergic dermatitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,back injury,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,gastric inflammation,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,Acne,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,loss of weight,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,back injury,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,Sinusitis,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004599,1-(3-Hexyl-4-oxo-2-oxetanyl)-2-tridecanyl N-formylleucinate,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,rotator cuff syndrome,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,respiratory alkalosis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,drug toxicity NOS,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,hemiparesis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,loss of weight,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,erythema,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,thrombocytopenia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,nausea,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,intestinal perforation,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,glaucoma,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cholecystitis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,loss of weight,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Adenopathy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,weight gain,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Dyspnea exertional,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,loss of weight,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000019090,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,ADVERSE DRUG EFFECT,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,apoplexy,CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,apoplexy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,erythema,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,gastric inflammation,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Bone Fracture Spontaneous,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,weight gain,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,loss of weight,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,haemorrhage intracranial,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,erythema,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystectomies,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,respiratory alkalosis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,elevated cholesterol,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystectomies,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,abnormal EEG,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,thrombocytopenia,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cellulitis,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,erythema,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,apoplexy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cellulitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,weight gain,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Pain,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,confusion,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,allergic dermatitis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,hypochloraemia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,ear infection,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,neumonia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Pain,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystectomies,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,angiitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,thrombocytopenia,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,apoplexy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,elevated cholesterol,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,drug toxicity NOS,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,right heart failure,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,apoplexy,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Abnormal LFTs,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,drug toxicity NOS,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,peritonitis,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,bruxism,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,myelodysplasia,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cardiovascular collapse,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,abnormal EEG,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,thrombocytopenia,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,deglutition disorder,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,allergic dermatitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,dysarthria,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,nasopharyngitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,methaemoglobinaemia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,weight gain,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,weight gain,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,myelodysplasia,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,back injury,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Adenopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Bleeding,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,myelodysplasia,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,hepatitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,methaemoglobinaemia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,heart rate increased,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,High blood pressure,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,rhinorrhea,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,constipated,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,confusion,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,weight gain,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,elevated cholesterol,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,right heart failure,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,loss of weight,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,acute pancreatitis,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Osteoarthritis,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,gastric inflammation,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,gastric inflammation,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Adenopathy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,angiitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,loss of weight,CID000004211,53-19-0,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Adenopathy,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,drug toxicity NOS,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Pleural Effusion,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,edema,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Alcoholic intoxication,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,dysarthria,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,right heart failure,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,loss of weight,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,abnormal ECG,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Dyspnea exertional,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,apoplexy,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,erythema,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,loss of weight,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Pain,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,respiratory alkalosis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,apoplexy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cholecystitis,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003640,"11,17,21-Trihydroxypregn-4-ene-3,20-dione",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,bulging,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,nausea,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,rhinorrhea,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,deglutition disorder,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,myelodysplasia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,abnormal ECG,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,Back Ache,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,dizziness,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,gastric inflammation,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,bulging,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,eruption,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,icterus,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,bulging,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,gastric inflammation,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,Adenopathy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,rhinorrhea,CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,thrombocytopenia,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,metabolic encephalopathy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,dysarthria,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,gastric inflammation,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,hyperglycaemia,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,erythema,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,elevated cholesterol,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005512,2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,confusion,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,elevated cholesterol,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,deglutition disorder,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,asthenia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,eruption,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,brain neoplasm,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,weight gain,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,angiitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,abnormal ECG,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,myelodysplasia,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,hepatic neoplasia,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,trigeminal neuralgia,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,loss of weight,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,gastric inflammation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,abnormal ECG,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,dysarthria,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,sepsis,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,Infection Upper Respiratory,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,loss of weight,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,Dyspnea exertional,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,weight gain,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,apoplexy,CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005533,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,elevated cholesterol,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,peritonitis,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,muscle inflammation,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Acne,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,angiitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,arteriosclerotic heart disease,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,apoplexy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,excessive thirst,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,acute kidney failure,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,deglutition disorder,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Infection Urinary Tract,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,hay fever,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,erythema,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,eruption,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,dysarthria,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,failure to thrive,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,proctalgia,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,High blood pressure,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000077999,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,apoplexy,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,confusion,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,eruption,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,atelectasis,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,blood in urine,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,synovial cyst,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,abdominal pain upper,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,neumonia,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,right heart failure,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,allergic dermatitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,myelodysplasia,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,disseminated lupus erythematosus,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,thrombocytopenia,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Sinus headache,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,hypermagnesemia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Bacteraemia,CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,eruption,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,High blood pressure,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,adenocarcinoma,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,methaemoglobinaemia,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,herpes simplex,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Back Ache,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,drug toxicity NOS,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Bone marrow fibrosis,CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,neumonia,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,dry skin,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,acute pancreatitis,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Back Ache,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Abnormal LFTs,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,nervous tension,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,drowsiness,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,thrombocytopenia,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,hyperglycaemia,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Acne,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,myelodysplasia,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,acute kidney failure,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,failure to thrive,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,abnormal ECG,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,angiitis,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,drug toxicity NOS,CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,elevated cholesterol,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,aptyalism,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,back injury,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,atelectasis,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,hypermagnesemia,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Extrasystoles Ventricular,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000002141,Amifostine,C(CN)CNCCSP(=O)(O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,back injury,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Bacteraemia,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,edema,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,periodontitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,drug toxicity NOS,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,methaemoglobinaemia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,thrombocytopenia,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,nasopharyngitis,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,agitated,CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,atelectasis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,bladder retention,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,ADH inappropriate,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,failure to thrive,CID000003198,Econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cellulitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,kidney failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,drug toxicity NOS,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,weight gain,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,asthenia,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,metabolic encephalopathy,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,eruption,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Back Ache,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,insulin dependent diabetes mellitus,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,angiitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,abnormal ECG,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,insulin dependent diabetes mellitus,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,thrombocytopenia,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,myelodysplasia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cellulitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,abnormal EEG,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,failure to thrive,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,right heart failure,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Alcoholic intoxication,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Back Ache,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Pain,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,periodontitis,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,weight gain,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,vitiligo,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Back Ache,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Pain,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,angiitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,elevated cholesterol,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Alcoholic intoxication,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,back injury,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,metabolic encephalopathy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Arrhythmia,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cellulitis,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Extrasystoles Ventricular,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,angiitis,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Back Ache,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,hepatic neoplasia,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,methaemoglobinaemia,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,elevated cholesterol,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Acute Respiratory Distress Syndrome,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Back Ache,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002022,Aciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Cardiomyopathy,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,thrombocytopenia,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,weight gain,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,gastroenteritis viral,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,apoplexy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,brain neoplasm,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,Retinal artery occlusion,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,deglutition disorder,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,apoplexy,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,weight gain,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,apoplexy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,weight gain,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,apoplexy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,weight gain,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,cholelithiasis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,abnormal ECG,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,haematoma,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,dizziness,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,Decreased Libido,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,Back Ache,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,enlarged spleen,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,dizziness,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,prostatitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,Arrhythmia,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,brain neoplasm,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,arteriosclerotic heart disease,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,weight gain,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,dizziness,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,apoplexy,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,weight gain,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,High blood pressure,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,constipated,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,eruption,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,erythema,CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,edema,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,apoplexy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,prostatism,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,dysarthria,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,hyperglycaemia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,apoplexy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,dysarthria,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,confusion,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,aching muscles,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,Decreased Libido,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,neumonia,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,heart rate increased,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,Bleeding,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,loss of weight,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000002092,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,Cough,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,gastric inflammation,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,neumonia,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Infection Upper Respiratory,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Adenopathy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,atelectasis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,malnourished,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,edema,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Adenopathy,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,gastric inflammation,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,neumonia,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,abnormal EEG,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,neumonia,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,acute pancreatitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Adenopathy,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,neumonia,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,subarachnoid haemorrhage,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Arrhythmia,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,rectal prolapse,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,loss of weight,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,eating disorder,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,drug toxicity NOS,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,dysarthria,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,loss of weight,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,deglutition disorder,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,haemorrhage intracranial,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,right heart failure,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,erythema,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,myelodysplasia,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,neumonia,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,allergic dermatitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,loss of weight,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,bradycardia,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Adenopathy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,haemorrhage intracranial,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,gastric inflammation,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Supraventricular tachycardia,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,atelectasis,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,loss of weight,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,allergic dermatitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,mouth ulcer,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,drug toxicity NOS,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,subarachnoid haemorrhage,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,myelodysplasia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,drug toxicity NOS,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,myelodysplasia,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,loss of weight,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,loss of weight,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,hepatitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,bradycardia,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,methaemoglobinaemia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,weight gain,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Acne,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,myelodysplasia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,drug toxicity NOS,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,eruption,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,edema,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,atelectasis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,thrombocytopenia,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,eruption,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003793,"2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Adenopathy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,haemorrhage intracranial,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,eruption,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,gastric inflammation,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,toxic shock,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000036339,rac-Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,erythema,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,eruption,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,abdominal pain upper,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,erythema,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,glaucoma,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Back Ache,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Back Ache,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,allergic dermatitis,CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Retinal artery occlusion,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cerebellar ataxia,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,thrombocytopenia,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000002733,95-25-0,C1=CC2=C(C=C1Cl)NC(=O)O2
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,muscle paresis,CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Back Ache,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,bursitis,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000002099,122852-42-0,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,enlarged liver,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,High blood pressure,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,myelodysplasia,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,narcolepsy,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,muscle inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,myelodysplasia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,bursitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,erythema,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,rhinorrhea,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,aseptic necrosis bone,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,rotator cuff syndrome,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,hydronephrosis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,heart rate increased,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Back Ache,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,bursitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,adenomyosis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,adenomyosis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,ADH inappropriate,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,rotator cuff syndrome,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,insomnia,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,abnormal ECG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,itch,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,abnormal ECG,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,abnormal ECG,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Fainting,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,erythema,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Bacteraemia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Back Ache,CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,bulging,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,insulin dependent diabetes mellitus,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Rheumatic fever,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,eruption,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,adenomyosis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,right heart failure,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,elevated cholesterol,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,elevated cholesterol,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,angiitis,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,dysarthria,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,weight gain,CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,weight gain,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,angiitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,bleeding Vaginal,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystectomies,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Acne,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,insulin dependent diabetes mellitus,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,movement disorder,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,abnormal ECG,CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Dyspnea exertional,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Back Ache,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,drug toxicity NOS,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Dyspnea exertional,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,chest pain,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Cystitis Interstitial,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,still birth,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Adenopathy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000001117,14808-79-8,[O-]S(=O)(=O)[O-]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystectomies,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,adenomyosis,CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Bone Fracture Spontaneous,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,breast neoplasm,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Bone Fracture Spontaneous,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,abnormal mammogram,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,erythema,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,failure to thrive,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,adenomyosis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,adenomyosis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Acne,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,bleeding Vaginal,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,abnormal ECG,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,adenomyosis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,emesis,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,abnormal ECG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Dyspnea exertional,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,back injury,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,adenomyosis,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,angiitis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,periodontitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,erythema,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cellulitis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,apoplexy,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000000450,"13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,weight gain,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,elevated cholesterol,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Sinus headache,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Acne,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,bleeding Vaginal,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,lung infiltration,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Sinus headache,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,enlarged liver,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,failure to thrive,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,herpes zoster,CID000444033,"2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate",CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Thrombophlebitis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,bulging,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,ear infection,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystectomies,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Bleeding,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Arrhythmia,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,back injury,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,atelectasis,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,allergic dermatitis,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,back injury,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,angiitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,rhinorrhea,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,bleeding Vaginal,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000024011,BLAH,S=[Se]
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,weight gain,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,ecchymoses,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,allergic dermatitis,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,hepatitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,increased white blood cell count,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,abnormal EEG,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,abnormal ECG,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Back Ache,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,rotator cuff syndrome,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Erythema nodosum,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,dysarthria,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,weight gain,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,elevated erythrocyte sedimentation rate,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,High blood pressure,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Dyspnea exertional,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,edema,CID000003657,Hydroxyurea,C(=O)(N)NO
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,thrombocytopenia,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,bleeding Vaginal,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,dysarthria,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,back injury,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,thrombocytopenia,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,atelectasis,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,angiitis,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,abnormal EEG,CID000002725,chlorphenamine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Bleeding,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Dyspnea exertional,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Acne,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,increased white blood cell count,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,bleeding Vaginal,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,deglutition disorder,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,insulin dependent diabetes mellitus,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000003381,"4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,insulin dependent diabetes mellitus,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Sinus headache,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,High blood pressure,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Back Ache,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,High blood pressure,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Acne,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,rhinorrhea,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Bleeding,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,myelodysplasia,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Pain,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Hypoventilation,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Acne,CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Back Ache,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Atherosclerosis,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,malnourished,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Dyspnea exertional,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,back injury,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,abnormal ECG,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,glossodynia,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,bursitis,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,elevated cholesterol,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,abnormal ECG,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,loss of weight,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,eruption,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,angioedema,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,myelodysplasia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Hepatic failure,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,angiitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,edema,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
CID000002678,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastroenteritis viral,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,weight gain,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,hypermagnesemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,aptyalism,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,edema,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Dyspnea exertional,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,thrombocytopenia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,bulging,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,insulin dependent diabetes mellitus,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,haemorrhage rectum,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,loss of weight,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,loss of weight,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,right heart failure,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,dysarthria,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,allergic dermatitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,dysarthria,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Aspartate Aminotransferase Increase,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,hepatitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Acne,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Bacteraemia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,deglutition disorder,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,erythema,CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Adenopathy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,hypermagnesemia,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,neumonia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,convulsion,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Bacteraemia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,right heart failure,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,dry skin,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Difficulty breathing,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,dry skin,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,apoplexy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Dyspnea exertional,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,abnormal ECG,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Sinus headache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,methaemoglobinaemia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,insulin dependent diabetes mellitus,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,diarrhea infectious,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,deglutition disorder,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,constipated,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,drug withdrawal,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,erythema,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,erythema,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,abnormal ECG,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Paraesthesia,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004927,(±)-Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,angiitis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,apoplexy,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,Dyspnea exertional,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,loss of weight,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,rotator cuff syndrome,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,rotator cuff syndrome,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,back injury,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,loss of weight,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,pleural pain,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,angiitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,Dyspnea exertional,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,abnormal ECG,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,ventricular fibrillation,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,angiitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,Ovarian cancer,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,drug toxicity NOS,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,abnormal ECG,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,abnormal ECG,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,hepatitis,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,drug toxicity NOS,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,bursitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,dizziness,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,cellulitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,allergic dermatitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,apoplexy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,apoplexy,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,bursitis,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,thrombocytopenia,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,back injury,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,thrombocytopenia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,allergic dermatitis,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,cholecystitis,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,loss of weight,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,abnormal ECG,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,confusion,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,thrombocytopenia,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,apoplexy,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,rotator cuff syndrome,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,thrombocytopenia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,apoplexy,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,eruption,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,muscle inflammation,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,confusion,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,drug toxicity NOS,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,dysarthria,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,cholecystitis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,bursitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,bursitis,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema multiforme,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,bursitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,rotator cuff syndrome,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,drug toxicity NOS,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,erythema,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,Neutropenia,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,bursitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,gastric inflammation,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,constipated,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002756,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,allergic dermatitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,Neutropenia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,thrombocytopenia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,thrombocytopenia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,thrombocytopenia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,icterus,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,erythema,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,angiitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,dysarthria,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,enlarged liver,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,weight gain,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,loss of weight,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,erythema,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,erythema,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,erythema,CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,gastric inflammation,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,enlarged liver,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005672,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,erythema,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,weight gain,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,dysarthria,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,loss of weight,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,myelodysplasia,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,confusion,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,weight gain,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,acute kidney failure,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Pain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,dental caries,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,loss of weight,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,thrombocytopenia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,eruption,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Adenopathy,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,deglutition disorder,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Erythema nodosum,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Hepatic failure,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Adenopathy,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,decubitus ulcer,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,gastric inflammation,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,loss of weight,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,arterial pressure NOS increased,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,nausea,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,convulsion,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,allergic dermatitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,narcolepsy,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,dysarthria,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000060835,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003657,Hydroxyurea,C(=O)(N)NO,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003657,Hydroxyurea,C(=O)(N)NO,Abnormal LFTs,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003657,Hydroxyurea,C(=O)(N)NO,Excess potassium,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003657,Hydroxyurea,C(=O)(N)NO,Pain,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003657,Hydroxyurea,C(=O)(N)NO,angiitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003657,Hydroxyurea,C(=O)(N)NO,jaundice neonatal,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003657,Hydroxyurea,C(=O)(N)NO,thrombocytopenia,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003657,Hydroxyurea,C(=O)(N)NO,allergic dermatitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003657,Hydroxyurea,C(=O)(N)NO,apoplexy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003657,Hydroxyurea,C(=O)(N)NO,Diplopia,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003657,Hydroxyurea,C(=O)(N)NO,confusion,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003657,Hydroxyurea,C(=O)(N)NO,thrombocytopenia,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003657,Hydroxyurea,C(=O)(N)NO,eruption,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003657,Hydroxyurea,C(=O)(N)NO,subarachnoid haemorrhage,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003657,Hydroxyurea,C(=O)(N)NO,drug toxicity NOS,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003657,Hydroxyurea,C(=O)(N)NO,loss of weight,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003657,Hydroxyurea,C(=O)(N)NO,Infection Upper Respiratory,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003657,Hydroxyurea,C(=O)(N)NO,angiitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003657,Hydroxyurea,C(=O)(N)NO,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003657,Hydroxyurea,C(=O)(N)NO,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003657,Hydroxyurea,C(=O)(N)NO,eruption,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003657,Hydroxyurea,C(=O)(N)NO,erythema,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003657,Hydroxyurea,C(=O)(N)NO,portal vein thrombosis,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003657,Hydroxyurea,C(=O)(N)NO,lung edema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003657,Hydroxyurea,C(=O)(N)NO,weight gain,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003657,Hydroxyurea,C(=O)(N)NO,deglutition disorder,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003657,Hydroxyurea,C(=O)(N)NO,thrombocytopenia,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003657,Hydroxyurea,C(=O)(N)NO,hepatitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003657,Hydroxyurea,C(=O)(N)NO,Bone marrow fibrosis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003657,Hydroxyurea,C(=O)(N)NO,angiitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003657,Hydroxyurea,C(=O)(N)NO,portal vein thrombosis,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003657,Hydroxyurea,C(=O)(N)NO,eruption,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003657,Hydroxyurea,C(=O)(N)NO,adenitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003657,Hydroxyurea,C(=O)(N)NO,nausea,CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
CID000003657,Hydroxyurea,C(=O)(N)NO,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003657,Hydroxyurea,C(=O)(N)NO,apoplexy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003657,Hydroxyurea,C(=O)(N)NO,dizziness,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003657,Hydroxyurea,C(=O)(N)NO,dysarthria,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003657,Hydroxyurea,C(=O)(N)NO,apoplexy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003657,Hydroxyurea,C(=O)(N)NO,abnormal ECG,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003657,Hydroxyurea,C(=O)(N)NO,nausea,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,bulging,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,Anxiety,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,insulin dependent diabetes mellitus,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID004475485,1024064-70-7,CC(C)C1=NC(=NC(=C1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,edema,CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,drug toxicity NOS,CID000002719,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,weight gain,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,increased white blood cell count,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,dysarthria,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,drug toxicity NOS,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,High blood pressure,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,carcinoid syndrome,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,metabolic encephalopathy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,nausea,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,coughing blood,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Back Ache,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,back injury,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,bulging,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,increased white blood cell count,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,back injury,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Scleroderma,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,phlebothrombosis,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,back injury,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,right heart failure,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,drug toxicity NOS,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gingivitis,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholelithiasis,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,angiitis,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,nervous tension,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,adenomyosis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Pain,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,coughing blood,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Back Ache,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,failure to thrive,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystectomies,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Dyspnea exertional,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Back Ache,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Chest infection,CID000002673,CHEMBL1161461,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,difficulty in walking,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,respiratory alkalosis,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,acanthosis nigricans,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,muscle inflammation,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,abnormal ECG,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,drug toxicity NOS,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Bone Fracture Spontaneous,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,angiitis,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gout,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,dysarthria,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,haemorrhage rectum,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,back injury,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,confusion,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,abnormal ECG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,dysarthria,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,deglutition disorder,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Bone Fracture Spontaneous,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Bilirubinaemia,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,dysarthria,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,abnormal EEG,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,adenomyosis,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,myelodysplasia,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,angiitis,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,eruption,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,neurogenic bladder,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Chronic Kidney Disease,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,nasopharyngitis,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000003381,"4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Hypotension Orthostatic,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Anorexia,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,angiitis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,drug withdrawal,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,pharyngeal inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,bursitis,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Sinus headache,CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,trigeminal neuralgia,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,road traffic accident,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Dyspnea exertional,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,periodontitis,CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Abnormal Laboratory Findings,CID000002725,chlorphenamine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,malabsorption,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,dizziness,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,thrombocytopenia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,dysarthria,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,neuropathy,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000002182,Anagrelide,C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,thrombocytopenia,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,nasopharyngitis,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,abnormal ECG,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000002099,122852-42-0,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,abnormal ECG,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,haemorrhage rectum,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,nasopharyngitis,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,thrombocytopenia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,fractured pelvis NOS,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gout,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,angiitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,abdominal pain upper,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,ild,CID000002973,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000024011,BLAH,S=[Se]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,ADVERSE DRUG EFFECT,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystectomies,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,High blood pressure,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cellulitis,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Anxiety,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystectomies,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,atelectasis,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,ear ache,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,adenomyosis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,thrombocytopenia,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,adenomyosis,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,dysphonia,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,heart rate increased,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002088,alendronic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Arrhythmia,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,erythema,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000156419,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,dry skin,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],myelodysplasia,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Anorexia,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],proctalgia,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Adenopathy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],dysarthria,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],High blood pressure,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Back Ache,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],dysarthria,CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],eruption,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],abdominal pain upper,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],glaucoma,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],back injury,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Adenopathy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],cholecystitis,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Back Ache,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],dysarthria,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],encephalitis viral,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],atelectasis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Back Ache,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Adenopathy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],angioedema,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],atrioventricular block,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],myelodysplasia,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],thrombocytopenia,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],abnormal ECG,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],weight gain,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Dyspnea exertional,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Drug hypersensitivity,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Bacteraemia,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],allergic dermatitis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],thrombocytopenia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],nasopharyngitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],angiitis,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Bleeding,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],muscle disorder,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],thrombocytopenia,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],erythema,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Dyspnea exertional,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],cholecystitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Adenopathy,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],elevated cholesterol,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bleeding Vaginal,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Neuralgia,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],confusion,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Back Ache,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],right heart failure,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],erythema multiforme,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],abnormal ECG,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],colitis ischemic,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],increased white blood cell count,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Adenopathy,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],allergic dermatitis,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],disorder Renal,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],rotator cuff syndrome,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],constipated,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Small intestinal obstruction,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],nephrotic syndrome,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],High blood pressure,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],elevated cholesterol,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],constipated,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bradycardia,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],angiitis,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],back injury,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],weight gain,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],herpes zoster,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],myelodysplasia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],fracture nonunion,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],arterial pressure NOS increased,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Back Ache,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Dyspnea exertional,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],increased white blood cell count,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Neutropenia,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],nausea,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gout,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],coronary artery bypass graft,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],hepatitis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Adenopathy,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],aspiration pneumonia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],rotator cuff syndrome,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002891,"cobaltous;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],enlarged spleen,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,myelodysplasia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,rotator cuff syndrome,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,rhinorrhea,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,allergic dermatitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,Back Ache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,rotator cuff syndrome,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,Adenopathy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,eruption,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,deglutition disorder,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,edema,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,Excess potassium,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004893,19216-56-9,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,deglutition disorder,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,erythema,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,deglutition disorder,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Bleeding,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,cholecystitis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,back injury,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,apoplexy,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,apoplexy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,erythema,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,erythema,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Cardiomyopathy,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,allergic dermatitis,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,nausea,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Difficulty breathing,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,cholelithiasis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Osteoarthritis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,drowsiness,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,erythema,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,gastric inflammation,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005358,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,drug withdrawal,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,angiitis,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,brain neoplasm,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,adenomyosis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,connective tissue disease,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Cardiomyopathy,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,deglutition disorder,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,increased white blood cell count,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,eruption,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,icterus,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Hepatic failure,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,enlarged spleen,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,abnormal ECG,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Hepatic failure,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,thrombocytopenia,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,loss of weight,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,chronic obstructive airway disease,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,cellulitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,thrombocytopenia,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,thrombocytopenia,CID000444033,"2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate",CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gout,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,weight gain,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,erythema,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Back Ache,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Neutropenia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,right heart failure,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Caesarean Section,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,angiitis,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,kidney failure,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,bursitis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,abdominal pain upper,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Bacteraemia,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Infection Upper Respiratory,CID000005234,Sodium chloride,[Na+].[Cl-]
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,eruption,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,thrombocytopenia,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,apoplexy,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,thrombocytopenia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,High blood pressure,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,angiitis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,angioedema,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,enlarged liver,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,elevated erythrocyte sedimentation rate,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,loss of weight,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,heart rate increased,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,metabolic acidosis,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,connective tissue disease,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,hepatitis,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,increased white blood cell count,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,thrombocytopenia,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,thrombocytopenia,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,myelodysplasia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,cholecystitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,eruption,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,erythema,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,erythema,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,cholecystitis,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,right heart failure,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,myelodysplasia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,difficulty in walking,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,erythema,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,allergic dermatitis,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Arrhythmia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,apoplexy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,acute pancreatitis,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,cholecystitis,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,elevated erythrocyte sedimentation rate,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000005234,Sodium chloride,[Na+].[Cl-],loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005234,Sodium chloride,[Na+].[Cl-],Bleeding,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000005234,Sodium chloride,[Na+].[Cl-],loss of weight,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005234,Sodium chloride,[Na+].[Cl-],Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005234,Sodium chloride,[Na+].[Cl-],agitated,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005234,Sodium chloride,[Na+].[Cl-],gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005234,Sodium chloride,[Na+].[Cl-],Chest infection,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000005234,Sodium chloride,[Na+].[Cl-],loss of weight,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005234,Sodium chloride,[Na+].[Cl-],drug toxicity NOS,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000005234,Sodium chloride,[Na+].[Cl-],subarachnoid haemorrhage,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000005234,Sodium chloride,[Na+].[Cl-],eruption,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000005234,Sodium chloride,[Na+].[Cl-],cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005234,Sodium chloride,[Na+].[Cl-],dizziness,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005234,Sodium chloride,[Na+].[Cl-],erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005234,Sodium chloride,[Na+].[Cl-],eruption,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000005234,Sodium chloride,[Na+].[Cl-],allergic dermatitis,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005234,Sodium chloride,[Na+].[Cl-],heart rate increased,CID000024011,BLAH,S=[Se]
CID000005234,Sodium chloride,[Na+].[Cl-],loss of weight,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005234,Sodium chloride,[Na+].[Cl-],erythema,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000005234,Sodium chloride,[Na+].[Cl-],edema,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005234,Sodium chloride,[Na+].[Cl-],aspiration pneumonia,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005234,Sodium chloride,[Na+].[Cl-],abnormal ECG,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005234,Sodium chloride,[Na+].[Cl-],weight gain,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005234,Sodium chloride,[Na+].[Cl-],thrombocytopenia,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000005234,Sodium chloride,[Na+].[Cl-],dysarthria,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005234,Sodium chloride,[Na+].[Cl-],atelectasis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005234,Sodium chloride,[Na+].[Cl-],increased white blood cell count,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000005234,Sodium chloride,[Na+].[Cl-],elevated cholesterol,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005234,Sodium chloride,[Na+].[Cl-],peritonitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005234,Sodium chloride,[Na+].[Cl-],cholecystitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005234,Sodium chloride,[Na+].[Cl-],erythema,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005234,Sodium chloride,[Na+].[Cl-],erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005234,Sodium chloride,[Na+].[Cl-],cholecystitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005234,Sodium chloride,[Na+].[Cl-],neumonia,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005234,Sodium chloride,[Na+].[Cl-],muscle disorder,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000005234,Sodium chloride,[Na+].[Cl-],gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000005234,Sodium chloride,[Na+].[Cl-],increased white blood cell count,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005234,Sodium chloride,[Na+].[Cl-],nausea,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005234,Sodium chloride,[Na+].[Cl-],aspiration pneumonia,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005234,Sodium chloride,[Na+].[Cl-],heart rate increased,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,drug toxicity NOS,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,cholelithiasis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,Bacteraemia,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,Abnormal LFTs,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,eruption,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,neumonia,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,deglutition disorder,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,loss of weight,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,drug toxicity NOS,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,gastric inflammation,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,angiitis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,myelodysplasia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,gastroenteritis viral,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,abnormal EEG,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,Bleeding,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,gastric inflammation,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,angiitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,erythema,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,respiratory alkalosis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,erythema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,atelectasis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,aspiration pneumonia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,loss of weight,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,coughing blood,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,respiratory alkalosis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,erythema,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,bulging,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,Bacteraemia,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,eruption,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002578,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,thrombocytopenia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,myelodysplasia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,right heart failure,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gout,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Arrhythmia,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,weight gain,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,insulin dependent diabetes mellitus,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,allergic dermatitis,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,dyspepsia,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Dyspnea exertional,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Dyspnea exertional,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,erythema,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Bleeding,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,erythema,CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Decreased Libido,CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,eruption,CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,abnormal ECG,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,bradycardia,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,nausea,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,increased platelet count,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,allergic dermatitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,thrombocytopenia,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,icterus,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,back injury,CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,dysarthria,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Back Ache,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,eruption,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystectomies,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,abnormal ECG,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,odynophagia,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,weight gain,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,erythema,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,abnormal EEG,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Light sensitivity,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,back injury,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,erythema,CID000003278,58-54-8,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,agitated,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,hyperglycaemia,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Back Ache,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,abnormal ECG,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Ovarian cancer,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,abnormal EEG,CID000002170,Amoxapine,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Arrhythmia,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,increased white blood cell count,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,bradycardia,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Back Ache,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,back injury,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Dyspnea exertional,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,eruption,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,neumonia,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,right heart failure,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,dysarthria,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,angiitis,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Acne,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Arrhythmia,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,allergic dermatitis,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,bundle branch block right,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Extrasystoles Ventricular,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,excessive thirst,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,back injury,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,High blood pressure,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,bursitis,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,malnourished,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Infection Urinary Tract,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,thrombocytopenia,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Hypercapnia,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,drug toxicity NOS,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,erythema,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,back injury,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,methaemoglobinaemia,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,angiitis,CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,myelodysplasia,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Amnesia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Dyspnea exertional,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,disorders of lipid metabolism,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,enlarged liver,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,thrombocytopenia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,erythema,CID000002733,95-25-0,C1=CC2=C(C=C1Cl)NC(=O)O2
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,back injury,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,haemorrhage rectum,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Sinus headache,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,bradycardia,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,cholecystitis,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,drug toxicity NOS,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,constipated,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,sunburn,CID000002995,Desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,eruption,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,confusion,CID000003372,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,thrombocytopenia,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,High blood pressure,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,heart rate increased,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,increased white blood cell count,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,arterial pressure NOS decreased,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,elevated cholesterol,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,eruption,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,erythema multiforme,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,respiratory failure,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,erythema,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,High blood pressure,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,deglutition disorder,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,loss of weight,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,thrombocytopenia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Dyspnea exertional,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,methaemoglobinaemia,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,weight gain,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,bursitis,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002118,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,weight gain,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,loss of weight,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,trigeminal neuralgia,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,constipated,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,allergic dermatitis,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,nausea,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,erythema,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,icterus,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,back injury,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Back Ache,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Adenopathy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gout,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gout,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gout,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,cellulitis,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,asthenia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,trigeminal neuralgia,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,coronary artery bypass graft,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,hiccough,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,emesis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,cholecystitis,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gout,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,elevated cholesterol,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Back Ache,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,arterial pressure NOS increased,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,drug toxicity NOS,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Adenopathy,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Back Ache,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,loss of weight,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,cholecystitis,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,peritonitis,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,bursitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gastric inflammation,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Acute Respiratory Distress Syndrome,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Pain,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,deglutition disorder,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Alcoholic intoxication,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,eruption,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,drug toxicity NOS,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gastric inflammation,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,elevated erythrocyte sedimentation rate,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,cellulitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Diplopia,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,angiitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Pleural Effusion,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Dyspnea exertional,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,abnormal EEG,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,drug toxicity NOS,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003715,indometacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Enuresis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,Lyell,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,loss of weight,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,erythema,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,cellulitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,cellulitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,increased white blood cell count,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,heart rate increased,CID000024011,BLAH,S=[Se]
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,gastric inflammation,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,Acidosis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,cellulitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,apoplexy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,apoplexy,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,increased white blood cell count,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,Scleroderma,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,drug withdrawal,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,apoplexy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004264,"9-{[4-(3,4-dihydroxy-5-{[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl}oxan-2-yl)-3-methylbut-2-enoyl]oxy}nonanoic acid",CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,drug toxicity NOS,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,bleeding Vaginal,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,nasopharyngitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,icterus,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,abdominal pain upper,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,ecchymoses,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,drug toxicity NOS,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Back Ache,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,enlarged liver,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,drug toxicity NOS,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Dyspnea exertional,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,myelodysplasia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,allergic dermatitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Dyspnea exertional,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,eruption,CID000004913,procainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,eruption,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,insulin dependent diabetes mellitus,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,bursitis,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,deglutition disorder,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,eruption,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,myelodysplasia,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,methaemoglobinaemia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,myelodysplasia,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,erythema,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,hemiparesis,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,allergic dermatitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,metabolic encephalopathy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,angiitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,increased white blood cell count,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Dyspnea exertional,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,weight gain,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,thrombocytopenia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Back Ache,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,myelodysplasia,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystectomies,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,High blood pressure,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Dyspnea exertional,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,icterus,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,thrombocytopenia,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,abnormal EEG,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,insulin dependent diabetes mellitus,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,insulin dependent diabetes mellitus,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,insulin dependent diabetes mellitus,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,pulmonary arrest,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,respiratory alkalosis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,color blindness,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,acute pancreatitis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Cardiomyopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,myelodysplasia,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,abnormal ECG,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,breast neoplasm,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cerebral vascular disorder,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,abnormal ECG,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,abnormal EEG,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,insulin dependent diabetes mellitus,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,confusion,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,right heart failure,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,eruption,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,High blood pressure,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Scleroderma,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,insulin dependent diabetes mellitus,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,angiitis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,allergic dermatitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Bleeding,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,respiratory alkalosis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,thrombocytopenia,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,myelodysplasia,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Acute Respiratory Distress Syndrome,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,edema,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,adenomyosis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,nocturia,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,thrombocytopenia,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,metabolic encephalopathy,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,right heart failure,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,myelodysplasia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,back injury,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,brain neoplasm,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Infection Upper Respiratory,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Dyspnea exertional,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,back injury,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,weight gain,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,insulin dependent diabetes mellitus,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,eruption,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,drug toxicity NOS,CID000003381,"4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Diplopia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Dyspnea exertional,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,right heart failure,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,fracture nonunion,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,deglutition disorder,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,erythema,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,atelectasis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,abnormal EEG,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,weight gain,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Back Ache,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003062,"3-{[2,6-Dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,gastric inflammation,CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,dizziness,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,High blood pressure,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,angiitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Arrhythmia,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Bleeding,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,cerebral vascular disorder,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,bursitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,nasopharyngitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Adenopathy,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,insomnia,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,erythema,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,abnormal EEG,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,thrombocytopenia,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,gastric inflammation,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,cholecystitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,allergic dermatitis,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,conjunctivitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,elevated cholesterol,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,cholecystectomies,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Back Ache,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,nasopharyngitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,ear infection,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,weight gain,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,dizziness,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,agitated,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,bursitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,thrombocytopenia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,edema,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,drug toxicity NOS,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Embolism pulmonary,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,neumonia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Anorexia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,bundle branch block right,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,erythema,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Dyspnea exertional,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Neutropenia,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,loss of weight,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,abnormal EEG,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,bladder cancer,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,hepatitis B,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,angiitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,heart rate increased,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Bleeding,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,loss of weight,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Adenopathy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,angiitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,inflammatory bowel disease,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,thrombocytopenia,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,hemiplegia,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000003825,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,increased white blood cell count,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,back injury,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,edema,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,insulin dependent diabetes mellitus,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,apoplexy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Dyspnea exertional,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastroenteritis viral,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,apoplexy,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,nephrotic syndrome,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,cholecystectomies,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Bleeding,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,High blood pressure,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,shoulder pain,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,bone marrow failure,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,back injury,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,eruption,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,herpes zoster,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,weight gain,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Infection Urinary Tract,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,weight gain,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastroenteritis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Back Ache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,back injury,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Acne,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,thrombocytopenia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,neumonia,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,cholecystectomies,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,drug withdrawal,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,erythema,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,abnormal EEG,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Dyspnea exertional,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,cholecystectomies,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,thrombocytopenia,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Diplopia,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,sacroiliitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Back Ache,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,abnormal ECG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Adenopathy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,insulin dependent diabetes mellitus,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Pain,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,back injury,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,angina,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,bradycardia,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,rotator cuff syndrome,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,abnormal ECG,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,deglutition disorder,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Back Ache,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,shoulder pain,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,hyperalimentation,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Excess potassium,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,myelodysplasia,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,insulin dependent diabetes mellitus,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,bulging,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,apoplexy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Adenopathy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,Adenopathy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,abnormal ECG,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,gastric inflammation,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,neumonia,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004052,"3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O,loss of weight,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,syncope vasovagal,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,loss of weight,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,Personality disorder,CID000002733,95-25-0,C1=CC2=C(C=C1Cl)NC(=O)O2
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,colitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,heart rate increased,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,agitated,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,atelectasis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,agitated,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,loss of weight,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,eruption,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,apoplexy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,back injury,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,back injury,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,cardiovascular collapse,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,drug withdrawal,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,Adenopathy,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,chest pain,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,drug withdrawal,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,acute pancreatitis,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,coughing blood,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,abdominal pain upper,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,Adenopathy,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,back injury,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,neumonia,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,weight gain,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,attempted suicide,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,eruption,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,hyperalimentation,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002487,"17-(Cyclobutylmethyl)morphinan-3,14-diol",C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,gastric inflammation,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,subarachnoid haemorrhage,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,dysarthria,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,abdominal pain upper,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,transient ischaemic attack,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Aching joints,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,edema,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,anaemia,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,erythema,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Back Ache,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,methaemoglobinaemia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,angina,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,thrombocytopenia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,edema,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,constipated,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Adenopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,difficulty in walking,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,erythema,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,dysarthria,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,apoplexy,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,back injury,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Diplopia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,hepatic necrosis,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,erythema,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,enlarged liver,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,abnormal ECG,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Back Ache,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,confusion,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,right heart failure,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,insulin dependent diabetes mellitus,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,apoplexy,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,subarachnoid haemorrhage,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,arterial pressure NOS decreased,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,rotator cuff syndrome,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Adenopathy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,weight gain,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,weight gain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Adenopathy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,metabolic encephalopathy,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,aptyalism,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,abnormal EEG,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,rhinorrhea,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,narcolepsy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,hyperglycaemia,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Back Ache,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,nasopharyngitis,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,micturition urgency,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,erythema,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Fainting,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,gastric inflammation,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,gastric inflammation,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,aortic regurgitation,CID000004723,pemoline,C1=CC=C(C=C1)C2C(=O)N=C(O2)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,angina,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,syncope vasovagal,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,apoplexy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,elevated erythrocyte sedimentation rate,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Back Ache,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,back injury,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,gastric inflammation,CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,apoplexy,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,weight gain,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,apoplexy,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,myelodysplasia,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,gastric inflammation,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Adenopathy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,dysarthria,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,apoplexy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,weight gain,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,insulin dependent diabetes mellitus,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,blood sodium decreased,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,neck mass,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,subarachnoid haemorrhage,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,subarachnoid haemorrhage,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Sinus headache,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Adenopathy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,cardiovascular collapse,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,Back Ache,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,loss of weight,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003152,120014-06-4,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,infection,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004723,pemoline,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004723,pemoline,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,Adenopathy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,abnormal ECG,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,atelectasis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,drug toxicity NOS,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,confusion,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,atelectasis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Neutropenia,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastroenteritis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,muscle disorder,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Supraventricular tachycardia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,haemorrhage rectum,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,drowsiness,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,neumonia,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,back injury,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,abnormal ECG,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Paraesthesia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,neumonia,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,deglutition disorder,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,High blood pressure,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Bacteraemia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,aortic aneurysm,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,malnourished,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Hypoventilation,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Anorexia,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,myelodysplasia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Sinus headache,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Adenopathy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,asthenia,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Dyspnea exertional,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,trigeminal neuralgia,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,nausea,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,angina,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,erythema,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,atelectasis,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Sinus headache,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,nocturia,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Dyspnea exertional,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Bacteraemia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,bradycardia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,cholecystitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,back injury,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,subarachnoid haemorrhage,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,back injury,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Adenopathy,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,bulging,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Sinus headache,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,erythema,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,arteriosclerotic heart disease,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,angina,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Pain,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,aseptic necrosis bone,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,back injury,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,eruption,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Infection Upper Respiratory,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,nephrotic syndrome,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,abnormal ECG,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,thrombocytopenia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gout,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,peritonitis,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,hepatitis,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,eruption,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,edema,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Adenopathy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,neumonia,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,weight gain,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,drug toxicity NOS,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,thrombocytopenia,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,increased white blood cell count,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,nasopharyngitis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Aspartate Aminotransferase Increase,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,cholelithiasis,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,cholecystitis,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,right heart failure,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,erythema,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003157,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Arrhythmia,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,erythema,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,phlebothrombosis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,failure to thrive,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,aspiration pneumonia,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,respiratory alkalosis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,arterial pressure NOS decreased,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,abnormal ECG,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,thrombocytopenia,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,increased white blood cell count,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,haemorrhage rectum,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,drug toxicity NOS,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,allergic dermatitis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,drug toxicity NOS,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,cerebral vascular disorder,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Diplopia,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,cellulitis,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,glaucoma,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Difficulty breathing,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Arrhythmia,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,deglutition disorder,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,increased white blood cell count,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,atelectasis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,elevated cholesterol,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,agitated,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,corneal disorder,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,respiratory failure,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Bleeding,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,angiitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,thrombocytopenia,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,weight gain,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Back Ache,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,angiitis,CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,subarachnoid haemorrhage,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,atelectasis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,acute kidney failure,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,Back Ache,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,thrombocytopenia,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,thrombocytopenia,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,respiratory alkalosis,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,respiratory alkalosis,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,elevated cholesterol,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,flashing lights,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,lymphoma,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,Extrasystoles Ventricular,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,angiitis,CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,weight gain,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,aortic aneurysm,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,adenocarcinoma,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,Arrhythmia,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,thrombocytopenia,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,respiratory alkalosis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,bulging,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,pneumothorax,CID000001117,14808-79-8,[O-]S(=O)(=O)[O-]
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,thrombocytopenia,CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,nasopharyngitis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,bulging,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,erythema,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,neumonia,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,alopecia,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,muscle inflammation,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,right heart failure,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,increased white blood cell count,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,apoplexy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,atelectasis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,Extrasystoles Ventricular,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,gastric inflammation,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,weight gain,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,Pain,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,right heart failure,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,elevated cholesterol,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,thrombocytopenia,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,weight gain,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,thrombocytopenia,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,weight gain,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000214,8-iso Prostaglandin E1,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,atelectasis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,dysarthria,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,myelodysplasia,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID006398970,"(6R,7R)-7-{[(2-Amino-1,3-thiazol-4-yl)(hydroxyimino)acetyl]amino}-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,bulging,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,confusion,CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,nephrotic syndrome,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Pain,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,abnormal ECG,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,peritonitis,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,weight gain,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,edema,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,increased white blood cell count,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,confusion,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Acidosis,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,apoplexy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000003008,Racemethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,myelodysplasia,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,peritonitis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Extrasystoles Ventricular,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,apoplexy,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Infection Upper Respiratory,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,neumonia,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,difficulty in walking,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,apoplexy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,abnormal EEG,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000024011,BLAH,S=[Se]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,edema,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,enlarged spleen,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Pain,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,angiitis,CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,angiitis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,eruption,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,lung neoplasm malignant,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,apoplexy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,disorder Renal,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,eruption,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Back Ache,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Bone Fracture Spontaneous,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,ear ache,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Dyspnea exertional,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,bursitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,stridor,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cellulitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,thrombocytopenia,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastroenteritis viral,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Back Ache,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,stridor,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Bone Fracture Spontaneous,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,back injury,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,angiitis,CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,angiitis,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,atelectasis,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,abnormal EEG,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystectomies,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,drug toxicity NOS,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Dyspnea exertional,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,deglutition disorder,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,bulging,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholelithiasis,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,confusion,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,increased white blood cell count,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,deglutition disorder,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Acute Respiratory Distress Syndrome,CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastroenteritis viral,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,neumonia,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Atherosclerosis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,hepatitis,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,High blood pressure,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,thrombocytopenia,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,myelodysplasia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,angiitis,CID000003198,Econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,hepatitis,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,abnormal EEG,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Back Ache,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,drug toxicity NOS,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,haemorrhage rectum,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,myelodysplasia,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Pain,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,allergic dermatitis,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,angiitis,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,drug toxicity NOS,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,weight gain,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Alcoholic intoxication,CID000004645,"2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydro-1,3,12(2H,4H,5H)-tetracenetrione",CC1(C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystectomies,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Dyspnea exertional,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,loss of weight,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Adenopathy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,thrombocytopenia,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,agitated,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,back injury,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Splenic infarction,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,ear ache,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Scleroderma,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,dizziness,CID000003381,"4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cholecystitis,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003003,.beta.-Methasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,erythema,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,allergic dermatitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cellulitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,abnormal ECG,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,bradycardia,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,erythema,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,abnormal EEG,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,contact dermatitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,abnormal ECG,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Difficulty breathing,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,dysarthria,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,erythema,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,sepsis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Sinus headache,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,erythema,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,myelodysplasia,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Pleural Effusion,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,weight gain,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cellulitis,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,weight gain,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,ear ache,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,edema,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Adenopathy,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,abnormal ECG,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,aspiration pneumonia,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,drug toxicity NOS,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,thrombocytopenia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,drug toxicity NOS,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,disseminated lupus erythematosus,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Adenopathy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,drug toxicity NOS,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,gout,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,loss of weight,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,ear infection,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cellulitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Back Ache,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,kidney failure,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,insulin dependent diabetes mellitus,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,weight gain,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,thrombocytopenia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,erythema,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,angiitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,thrombocytopenia,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cellulitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,insulin dependent diabetes mellitus,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,drug toxicity NOS,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,angiitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000024011,BLAH,S=[Se]
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Dyspnea exertional,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,back injury,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,confusion,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,angiitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,angina,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,weight gain,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,edema,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,back injury,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Dyspnea exertional,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,loss of weight,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,erythema,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,loss of weight,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Aspartate Aminotransferase Increase,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,loss of weight,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003333,(±)-Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,myelodysplasia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,eruption,CID003081884,147245-92-9,CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,heart rate increased,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,nasopharyngitis,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,bradycardia,CID000003730,66108-95-0,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Acidosis,CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,food allergy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,myelodysplasia,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,atelectasis,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,eruption,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,eruption,CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,erythema,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,increased white blood cell count,CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,neumonia,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,subarachnoid haemorrhage,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,allergic dermatitis,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,coughing blood,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,adenitis,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,haemorrhage intracranial,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Clotting,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,drug toxicity NOS,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,subarachnoid haemorrhage,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,icterus,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,erythema,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,atelectasis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,atrioventricular block,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,constipated,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,thrombocytopenia,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,nephrotic syndrome,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,angiitis,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cellulitis,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,thrombocytopenia,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,dysarthria,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,erythema,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,movement disorder,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,abnormal EEG,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,OPTIC NEURITIS,CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Bleeding,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,abnormal EEG,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,High blood pressure,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,loss of weight,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,angiitis,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Bacteraemia,CID000002370,Bethanechol,CC(C[N+](C)(C)C)OC(=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000001117,14808-79-8,[O-]S(=O)(=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,nasopharyngitis,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,myocarditis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,empyema,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Near Syncope,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,loss of weight,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,metabolic encephalopathy,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,dysarthria,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,myelodysplasia,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,angiitis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,insulin dependent diabetes mellitus,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,abortion spontaneous,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,myelodysplasia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,loss of weight,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,coughing blood,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,eruption,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Paraesthesia,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,right heart failure,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,icterus,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Bone Fracture Spontaneous,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,hematoma subdural,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,adenitis,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,abortion spontaneous,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,dysarthria,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,agitated,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Porphyria,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,right heart failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cellulitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,myelodysplasia,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,disseminated lupus erythematosus,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Extrasystoles Ventricular,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,constipated,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,right heart failure,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Acute Respiratory Distress Syndrome,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,abnormal EEG,CID000002725,chlorphenamine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,drug toxicity NOS,CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,difficulty in walking,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,bulging,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,allergic dermatitis,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,empyema,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Hepatic failure,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,aspiration pneumonia,CID000003198,Econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Infection Upper Respiratory,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Dyspnea exertional,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,abnormal ECG,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,erythema,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,erythema,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,increased white blood cell count,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,atelectasis,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,angiitis,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,drug toxicity NOS,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,angiitis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,rotator cuff syndrome,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,constipated,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Acute Respiratory Distress Syndrome,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,intraocular inflammation,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Bacteraemia,CID000004913,procainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,atelectasis,CID000024011,BLAH,S=[Se]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,increased white blood cell count,CID000002637,3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystectomies,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,upper gastrointestinal bleeding,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,loss of consciousness,CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Bacteraemia,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,erythema,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,bursitis,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,weight gain,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,allergic dermatitis,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,erythema,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,angiitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,eruption,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Porphyria,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,angiitis,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,eruption,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,subarachnoid haemorrhage,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,dysarthria,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,icterus,CID000002141,Amifostine,C(CN)CNCCSP(=O)(O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Adenopathy,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,acute pancreatitis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,hepatitis B,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,abnormal ECG,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,difficulty in walking,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,allergic dermatitis,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,myelodysplasia,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,apoplexy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,Embolism pulmonary,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000772,alpha-Heparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,methaemoglobinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,drug toxicity NOS,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,rhinorrhea,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,elevated cholesterol,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,abnormal EEG,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,Adenopathy,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,cholecystitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,thrombocytopenia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,Cardiac decompensation,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,apoplexy,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,muscle inflammation,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,abnormal ECG,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,allergic dermatitis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,hyperalimentation,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,myelodysplasia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,hyperglycaemia,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,defaecation urgency,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,erythema,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000060147,(+)-tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,thrombocytopenia,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,Adenopathy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,gastric inflammation,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,bursitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,elevated cholesterol,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,rotator cuff syndrome,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,Back Ache,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,dysarthria,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,nausea,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,ear infection,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,rotator cuff syndrome,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,enlarged liver,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,agitated,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,Adenopathy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,bursitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,erythema,CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,Bleeding,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,dysarthria,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,ear infection,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,eruption,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,drug withdrawal,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,loss of weight,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,allergic dermatitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,rotator cuff syndrome,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,rotator cuff syndrome,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,dysarthria,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,elevated cholesterol,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,constipated,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,Pain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],loss of weight,CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],loss of weight,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],stridor,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],loss of weight,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],nervous tension,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],increased white blood cell count,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],biliary tract disorder,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],herpes zoster,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholelithiasis,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],abnormal ECG,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],eruption,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],increased white blood cell count,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],aspiration pneumonia,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Back Ache,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],myelodysplasia,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],nephrotic syndrome,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],meningeal irritation,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],eruption,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],constipated,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Pain,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],abnormal EEG,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],embolism,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],methaemoglobinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Arrhythmia,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],peritonitis,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],back injury,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],body temperature increased,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Aspartate Aminotransferase Increase,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],abnormal ECG,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],angiitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema multiforme,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],still birth,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],mouth ulcer,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],loss of weight,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Chest infection,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],nasopharyngitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema multiforme,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],methaemoglobinaemia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],nausea,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],haemorrhage intracranial,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Diplopia,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],loss of weight,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],periodontitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Diplopia,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],eruption,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],constipated,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],High blood pressure,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],eruption,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Extrasystoles Ventricular,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],methaemoglobinaemia,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],angiitis,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],colitis pseudomembranous,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],gastric inflammation,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],increased white blood cell count,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],abnormal EEG,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],atelectasis,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],angiitis,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Extrasystoles Ventricular,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],elevated cholesterol,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],stridor,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Back Ache,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],nasopharyngitis,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],nasopharyngitis,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Bleeding,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],right heart failure,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],dysarthria,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],angiitis,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],neumonia,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],drug toxicity NOS,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],angiitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],eruption,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],arterial pressure NOS decreased,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Eosinophil Count Increased,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],ear infection,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],drug toxicity NOS,CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Dyspnea exertional,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],abnormal EEG,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],loss of weight,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],arterial pressure NOS decreased,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],methaemoglobinaemia,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002656,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],abnormal ECG,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Pain,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,edema,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,atelectasis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,eruption,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,colitis ischemic,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cellulitis,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,haemorrhage intracranial,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Blood Calcium Increased,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,angiitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,abdominal pain upper,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,abnormal ECG,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,angiitis,CID000002719,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,elevated cholesterol,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,constipated,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Bleeding,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,ocular hypertension,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,angiitis,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,thrombocytopenia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,abnormal ECG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,allergic dermatitis,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,back injury,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,elevated erythrocyte sedimentation rate,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,neumonia,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,angiitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,nasopharyngitis,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,emesis,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,drug toxicity NOS,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,defaecation urgency,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,facial flushing,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,glaucoma,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,ear ache,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000024011,BLAH,S=[Se]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gout,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,icterus,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Dyspnea exertional,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,nausea,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,acanthosis nigricans,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,insulin dependent diabetes mellitus,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,sick sinus syndrome,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,rotator cuff syndrome,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,heart rate increased,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Pain,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,agitated,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,trigeminal neuralgia,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,bulging,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,weight gain,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,colitis ischemic,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,rhinorrhea,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gout,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Back Ache,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,back injury,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,drug toxicity NOS,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,angiitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,insulin dependent diabetes mellitus,CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cellulitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Sinus headache,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Acne,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastroenteritis viral,CID009571074,"(6R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,metabolic encephalopathy,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,bipolar disorder,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gout,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,allergic dermatitis,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,bulging,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,eruption,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,colitis,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,apoplexy,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,abnormal ECG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,eruption,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,right heart failure,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,myelodysplasia,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Back Ache,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,rotator cuff syndrome,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,drug toxicity NOS,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,anaemia,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,thrombocytopenia,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,back injury,CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000002662,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,edema,CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,haemorrhage rectum,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,neumonia,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,bradycardia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,edema,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,gastroenteritis viral,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,angiitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,decubitus ulcer,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,apoplexy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,edema,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,angina,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,nasopharyngitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,confusion,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,haemorrhage intracranial,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,coughing blood,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,eruption,CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,deglutition disorder,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,atelectasis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Bleeding,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,flashing lights,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,deglutition disorder,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,thrombocytopenia,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,atelectasis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,drowsiness,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,dysarthria,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Hypercapnia,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,neumonia,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,dysarthria,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,drowsiness,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,agitated,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,loss of weight,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,drowsiness,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Adenopathy,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,thrombocytopenia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,emesis,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Cough,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,erythema,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,eruption,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,respiratory alkalosis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,dysarthria,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Paraesthesia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,abnormal EEG,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,bundle branch block right,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,angina,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Adenopathy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,dysarthria,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Acne,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Bleeding,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,subarachnoid haemorrhage,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,erythema,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,dysarthria,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,abnormal ECG,CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,abnormal EEG,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,Acute Respiratory Distress Syndrome,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,cellulitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,bradycardia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,angiitis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,abnormal ECG,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004419,N-Cyclobutylmethyl-14-hydroxydihydronormorphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,abnormal ECG,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,hyperalimentation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,nausea,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005210,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,loss of weight,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,drug toxicity NOS,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,increased white blood cell count,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,drug toxicity NOS,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,myelodysplasia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,back injury,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,apoplexy,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,dysarthria,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,loss of weight,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,abnormal ECG,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,erythema,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,metabolic encephalopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,metabolic encephalopathy,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,cholecystitis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Nephrolithiasis,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,belching,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Sinus headache,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,apoplexy,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,abnormal ECG,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,apoplexy,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,erythema,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Acne,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,drug toxicity NOS,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,bleeding Vaginal,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,loss of weight,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,deglutition disorder,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,dizziness,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Adenopathy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,cellulitis,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,weight gain,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,ear infection,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,eruption,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,meningioma,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,High blood pressure,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,periodontitis,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,loss of weight,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Adenopathy,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,abnormal ECG,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,dysarthria,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,bruxism,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Back Ache,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,methaemoglobinaemia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,insulin dependent diabetes mellitus,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Embolism pulmonary,CID000040976,"(17R)-13-Ethyl-17-ethynyl-17-hydroxy-11-methylene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one",CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,abnormal ECG,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Back Ache,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,apoplexy,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Sinus headache,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Dyspnea exertional,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,apoplexy,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,insulin dependent diabetes mellitus,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,cholecystectomies,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,ADVERSE DRUG EFFECT,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,allergic dermatitis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,dry skin,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,back injury,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,Acute Respiratory Distress Syndrome,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,erythema,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000005203,"SERTRALINE, CIS-(−)-",CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,apoplexy,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,loss of weight,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,heart rate increased,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,Sinus headache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,acute pancreatitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,apoplexy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,Back Ache,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,erythema,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,abdominal pain upper,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,eruption,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,loss of weight,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,Infection Upper Respiratory,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,Dyspnea exertional,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,cholecystectomies,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,Adenopathy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,Sinus headache,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,angiitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,ear infection,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,Dyspnea exertional,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,erythema,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,Back Ache,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,back injury,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,rotator cuff syndrome,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003516,93-14-1,COC1=CC=CC=C1OCC(CO)O,insulin dependent diabetes mellitus,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,tracheostomy,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,abnormal EEG,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,myelodysplasia,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,abnormal EEG,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,Hepatic failure,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,rhinorrhea,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,apoplexy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,insulin dependent diabetes mellitus,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,erythema,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,erythema,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,loss of weight,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,respiratory alkalosis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,Porphyria,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,cholecystectomies,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,dysarthria,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,weight gain,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,abnormal EEG,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,weight gain,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,myelodysplasia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,erythema,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003510,1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,Scleroderma,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,cholecystitis,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,icterus,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,aseptic necrosis bone,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,heart rate increased,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,eruption,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,abnormal EEG,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,loss of weight,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,cholelithiasis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,drug toxicity NOS,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,abnormal EEG,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,acute kidney failure,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005040,Rapamycin-d3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,apoplexy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,allergic dermatitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,abnormal EEG,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,abnormal EEG,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,excessive thirst,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,angiitis,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,insulin dependent diabetes mellitus,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,erythema,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,insulin dependent diabetes mellitus,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003404,5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,insulin dependent diabetes mellitus,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,neumonia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,myelodysplasia,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,drug toxicity NOS,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,eruption,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,weight gain,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystectomies,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,confusion,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,carotid bruit,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,subarachnoid haemorrhage,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,insulin dependent diabetes mellitus,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,facial flushing,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,confusion,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,eruption,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,failure to thrive,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,back injury,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gout,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,rhinorrhea,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,weight gain,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,eruption,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000003730,66108-95-0,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Alcoholic intoxication,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,constipated,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,infection,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Cardiac decompensation,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,weight gain,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,deglutition disorder,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Diplopia,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Extrasystoles Ventricular,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,thrombocytopenia,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,heart rate increased,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,constipated,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,arteriosclerotic heart disease,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,abnormal ECG,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,constipated,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,right heart failure,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,weight gain,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,constipated,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Bilirubinaemia,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Amnesia,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,hemiplegia,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,abnormal ECG,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,thrombocytopenia,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,thrombocytopenia,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,peritonitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Back Ache,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,edema,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,pulmonary hypertension,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,thrombocytopenia,CID000444033,"2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate",CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,abnormal EEG,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,edema,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,bulging,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,weight gain,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,thrombocytopenia,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,ADVERSE DRUG EFFECT,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,elevated cholesterol,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,drug withdrawal,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,allergic dermatitis,CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,insulin dependent diabetes mellitus,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,metabolic encephalopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholelithiasis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,weight gain,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,insulin dependent diabetes mellitus,CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,thrombocytopenia,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Anorexia,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,increased white blood cell count,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,neumonia,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Bilirubinaemia,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003325,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,loss of weight,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Pain,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Back Ache,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Infection Urinary Tract,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,angiitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Adenopathy,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,loss of weight,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,erythema,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,eruption,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,hepatitis,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Adenopathy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Atrioventricular block complete,CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,back injury,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,herpes zoster,CID000024011,BLAH,S=[Se]
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,myelodysplasia,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,bundle branch block left,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Adenopathy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,loss of weight,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,allergic dermatitis,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,asthenia,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,dysarthria,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,coughing blood,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,myelodysplasia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,back injury,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,erythema,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,anogenital warts,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,methaemoglobinaemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cellulitis,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,weight gain,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Pain,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,respiratory alkalosis,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Neutropenia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,loss of weight,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,atelectasis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,bleeding Vaginal,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Adenopathy,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Adenopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,deglutition disorder,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Adenopathy,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Scleroderma,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,loss of weight,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,myelodysplasia,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,loss of weight,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,erythema,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,intraocular inflammation,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Cystitis Interstitial,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,thyroid cancer,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Adenopathy,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,angiitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004900,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,erythema,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,insulin dependent diabetes mellitus,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,hypoxia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,deglutition disorder,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,glaucoma,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,thrombocytopenia,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,hepatitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,pneumothorax,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,eruption,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,insulin dependent diabetes mellitus,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,abnormal ECG,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,nervous tension,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,asthenia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,Bacteraemia,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,insulin dependent diabetes mellitus,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004856,"3-[Hydroxy(2-pyridinylamino)methylene]-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,apoplexy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,cholecystitis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Back Ache,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,insulin dependent diabetes mellitus,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Chest infection,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,loss of weight,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Dyspnea exertional,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,neonatal respiratory distress syndrome,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,thrombocytopenia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,abnormal ECG,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,thrombocytopenia,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Sinus headache,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Dyspnea exertional,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,erythema,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,thrombocytopenia,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,erythema,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,eruption,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,phlebothrombosis,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,thrombocytopenia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,neuropathy peripheral,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,right heart failure,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gout,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,erythema,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,eruption,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,dysarthria,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,insulin dependent diabetes mellitus,CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,methaemoglobinaemia,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,erythema,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,arterial pressure NOS decreased,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,adenocarcinoma,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,abdominal pain upper,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,erythema,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,thrombocytopenia,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,convulsion,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,weight gain,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,ear infection,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,loss of weight,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,cholelithiasis,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,methaemoglobinaemia,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,weight gain,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,loss of weight,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,thrombocytopenia,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,neumonia,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,stridor,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,abnormal EEG,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,hyperalimentation,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,loss of weight,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,cholelithiasis,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,eruption,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000004645,"2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydro-1,3,12(2H,4H,5H)-tetracenetrione",CC1(C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,apoplexy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Adenopathy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,neumonia,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,loss of weight,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Adenopathy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,loss of weight,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,angiitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003255,Kesso-Mycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Dyspnea exertional,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,deglutition disorder,CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,nocturia,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,apoplexy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,apoplexy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,hyperglycaemia,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,edema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,nocturia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,confusion,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005077,rac-Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,metabolic acidosis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,bulging,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,High blood pressure,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,Back Ache,CID000024011,BLAH,S=[Se]
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,insomnia,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,Arrhythmia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,aortic regurgitation,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,bulging,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,aspiration pneumonia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,gout,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,nausea,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,loss of weight,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,thrombocytopenia,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,Pain,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,drowsiness,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,anaphylactic reaction,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,onychomycosis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,hyperalimentation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,weight gain,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,aspiration pneumonia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,apoplexy,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,diarrhea,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,galactorrhea,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,weight gain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,weight gain,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,agitated,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,thrombocytopenia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,heart rate increased,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,abnormal ECG,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,weight gain,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,rotator cuff syndrome,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,loss of weight,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,angiitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,abnormal EEG,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005095,91374-21-9,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,thrombocytopenia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,abnormal EEG,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,proctalgia,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,weight gain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Porphyria,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,abnormal EEG,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,erythema,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,allergic dermatitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Adenopathy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Adenopathy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,apoplexy,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Decreased Libido,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,insulin dependent diabetes mellitus,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,agitated,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Adenopathy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,confusion,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,erythema,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,drug toxicity NOS,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,insulin dependent diabetes mellitus,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,apoplexy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,abnormal EEG,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,back injury,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,haemorrhage rectum,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,peritonitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,agitated,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Back Ache,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,angiitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,apoplexy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,still birth,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Adenopathy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,dysarthria,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,cholelithiasis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,ear ache,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,thrombocytopenia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,abnormal EEG,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,dry skin,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,deglutition disorder,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,dysarthria,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,elevated cholesterol,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,drug withdrawal,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Adenopathy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,dyspepsia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,thrombocytopenia,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,abnormal ECG,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Back Ache,CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Dyspnea exertional,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,edema,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,eruption,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,convulsion,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Bacteraemia,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Paraesthesia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Cystitis Interstitial,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,cellulitis,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,loss of weight,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,thrombocytopenia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,loss of weight,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,weight gain,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,weight gain,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Adenopathy,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Acute Respiratory Distress Syndrome,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,difficulty in walking,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Back Ache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,elevated cholesterol,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,angiitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,loss of weight,CID000051634,miglustat,CCCCN1CC(C(C(C1CO)O)O)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,bulging,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,insulin dependent diabetes mellitus,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,eruption,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,abortion spontaneous,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,bradycardia,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,loss of weight,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,dysarthria,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,paranoia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,loss of weight,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003878,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Adenopathy,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,methaemoglobinaemia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,apoplexy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,dysarthria,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,weight gain,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,soft tissue infection,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,abnormal ECG,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Adenopathy,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,cerebral vascular disorder,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,apoplexy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,weight gain,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,thrombocytopenia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,disorder Renal,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,thrombocytopenia,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Adenopathy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,erythema,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,thrombocytopenia,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,bulging,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,erythema,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,apoplexy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,drug withdrawal,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,erythema,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,angiitis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,methaemoglobinaemia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,eruption,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Infection Upper Respiratory,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,angioedema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004058,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Adenopathy,CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,angioedema,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,ear ache,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Pain,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,dysarthria,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,loss of weight,CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,right heart failure,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,angioedema,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,edema,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,erythema multiforme,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,haemorrhage rectum,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,angiitis,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,angiitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,insulin dependent diabetes mellitus,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,bursitis,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal EEG,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Osteogenesis Imperfecta,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cerebral vascular disorder,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,loss of weight,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,angiitis,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,right heart failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,angiitis,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,atelectasis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,back injury,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Back Ache,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,subarachnoid haemorrhage,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,erythema,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,periodontitis,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,loss of weight,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,erythema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gout,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Diplopia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cellulitis,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Scleroderma,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,dysarthria,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000024011,BLAH,S=[Se]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,back injury,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Osteogenesis Imperfecta,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,synovial cyst,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Infection Upper Respiratory,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,angiitis,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,loss of weight,CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,respiratory failure,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,insulin dependent diabetes mellitus,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,back injury,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,erythema,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Adenopathy,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,myelodysplasia,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abdominal pain upper,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,erythema,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,weight gain,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,back injury,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,periodontitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,drug toxicity NOS,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,eruption,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Sinus headache,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,loss of weight,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal EEG,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal EEG,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,haematoma,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cellulitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Adenopathy,CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,haematoma,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,hepatic neoplasia,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,loss of weight,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Back Ache,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Back Ache,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,hyperalimentation,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,erythema,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,loss of weight,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,erythema,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Extrasystoles Ventricular,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,angiitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,loss of weight,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,drug toxicity NOS,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,bleeding Vaginal,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,back injury,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,abnormal ECG,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,back injury,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,adenomyosis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,metabolic encephalopathy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,emesis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,back injury,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Back Ache,CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,adenomyosis,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,malnourished,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,High blood pressure,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,back injury,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,gastric inflammation,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Dyspnea exertional,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Bone Fracture Spontaneous,CID000003372,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,atelectasis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,insulin dependent diabetes mellitus,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002244,50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,cholecystitis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,dysarthria,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,dysarthria,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,dermatitis exfoliative,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,herpes zoster,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000054374,"10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-
carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,nausea,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O,eruption,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O,Adenopathy,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000060843,"(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O,gingivitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000160051,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,back injury,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,allergic dermatitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Back Ache,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,dysarthria,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,thrombocytopenia,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,myelodysplasia,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,elevated cholesterol,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,drug toxicity NOS,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,connective tissue disease,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Sinus headache,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,failure to thrive,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Decreased Libido,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,fractured pelvis NOS,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,pain in throat,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000003372,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,agitated,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,myelodysplasia,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000024011,BLAH,S=[Se]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,drug withdrawal,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,drug toxicity NOS,CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,galactorrhea,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Dyspnea exertional,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,ear ache,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,ear ache,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,thrombocytopenia,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Acute Respiratory Distress Syndrome,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,angiitis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,weight gain,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,drug toxicity NOS,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,weight gain,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,muscle disorder,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,hepatitis,CID000003381,"4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,hyperglycaemia,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,agitated,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastroenteritis viral,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,allergic dermatitis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,thrombocytopenia,CID000040976,"(17R)-13-Ethyl-17-ethynyl-17-hydroxy-11-methylene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one",CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,haematoma,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Infection Upper Respiratory,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,methaemoglobinaemia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,metabolic encephalopathy,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,angiitis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,constipated,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,haemorrhage rectum,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Pain,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,contracture,CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,thrombocytopenia,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,abnormal EEG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,palpitation,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,still birth,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,deglutition disorder,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,malnourished,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,myelodysplasia,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,herpes zoster,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystectomies,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,drug toxicity NOS,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,metabolic encephalopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,back injury,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,allergic dermatitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Bleeding,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,myelodysplasia,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,abnormal ECG,CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,adenomyosis,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,allergic dermatitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,agitated,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,confusion,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,bursitis,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,atelectasis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,angiitis,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Extrasystoles Ventricular,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,rotator cuff syndrome,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,angiitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Atherosclerosis,CID009571074,"(6R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,narcolepsy,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID005311039,"N-{(2R,6S,9S,11R,12S,14aS,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11-dihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,
22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2′,1′-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)NCCN)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cataract,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,respiratory alkalosis,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,dysarthria,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,odynophagia,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,obesity,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,myelodysplasia,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Enuresis,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Acne,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,weight gain,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,panic attack,CID000444033,"2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate",CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,allergic dermatitis,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002771,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,Fainting,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,Infection Urinary Tract,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,increased white blood cell count,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,aspiration pneumonia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,hepatitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,bone marrow failure,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,weight gain,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,Ekbom Syndrome,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,constipated,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,arterial pressure NOS increased,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,dysarthria,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,weight gain,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,aspiration pneumonia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,nervous tension,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,weight gain,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,nervous tension,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,duodenitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,anaemia,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,weight gain,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,weight gain,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,bradycardia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,back injury,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005735,43200-80-2,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,neumonia,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,erythema,CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,drug toxicity NOS,CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Adenopathy,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Back Ache,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cellulitis,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,dysarthria,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Back Ache,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,coronary artery bypass graft,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Adenopathy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,constipated,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,angiitis,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Dyspnea exertional,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Bilirubinaemia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Back Ache,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Pain,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,arteriosclerotic heart disease,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Adenopathy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,drug toxicity NOS,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,increased white blood cell count,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,agitated,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Dyspnea exertional,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,apoplexy,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,still birth,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Candida Infection,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,subarachnoid haemorrhage,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,neumonia,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,nausea,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,abnormal ECG,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,myelodysplasia,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,confusion,CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,methaemoglobinaemia,CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,apoplexy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,allergic dermatitis,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Arrhythmia,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,thrombocytopenia,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,elevated cholesterol,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,dysarthria,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cellulitis,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,gastric inflammation,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,angiitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,atelectasis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,weight gain,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Back Ache,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,eruption,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Bacteraemia,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cellulitis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,angiitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,drug toxicity NOS,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,abnormal ECG,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,lung infiltration,CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,edema,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,edema,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,erythema,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,abnormal ECG,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Sinus headache,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,erythema,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,methaemoglobinaemia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Hepatic failure,CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,eruption,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,fracture nonunion,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,erythema,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Extrasystoles Ventricular,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,insulin dependent diabetes mellitus,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,arteriosclerotic heart disease,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,increased white blood cell count,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Adenopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,gastric inflammation,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,Adenopathy,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,methaemoglobinaemia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,thrombocytopenia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,loss of weight,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,dysarthria,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,malnourished,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cholecystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,eruption,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,angiitis,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000004253,"Morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-",CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,neumonia,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,neuropathy peripheral,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004497,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,muscle disorder,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID004659568,"2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,contracture,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,cellulitis,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Hepatitis C,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,cholecystitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,weight gain,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,panic attack,CID000024011,BLAH,S=[Se]
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,abnormal EEG,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,erythema,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,gastric inflammation,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,abnormal ECG,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,insulin dependent diabetes mellitus,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,dry skin,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Acute Respiratory Distress Syndrome,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,apoplexy,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,erythema,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,methaemoglobinaemia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,eruption,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,loss of weight,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,cholecystitis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,increased white blood cell count,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,dysarthria,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,prostatitis,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Arrhythmia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,angiitis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,insulin dependent diabetes mellitus,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Back Ache,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,atelectasis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,allergic dermatitis,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,constipated,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Pain,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,scotoma,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,deglutition disorder,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,bulging,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,eruption,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,gastric inflammation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,nasopharyngitis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Pain,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,abnormal ECG,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,gastric inflammation,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,erythema,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Enuresis,CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
CID000005732,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Feeling unwell,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,erythema multiforme,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,erythema multiforme,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,bradycardia,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,arterial pressure NOS decreased,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,thrombocytopenia,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,deglutition disorder,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,thrombocytopenia,CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
CID000004499,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,abnormal ECG,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,allergic dermatitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,still birth,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,insulin dependent diabetes mellitus,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,Neutropenia,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,elevated erythrocyte sedimentation rate,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,aortic regurgitation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,atelectasis,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,aspiration pneumonia,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000000564,Aminocaproic acid,C(CCC(=O)O)CCN
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,insulin dependent diabetes mellitus,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,allergic dermatitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,muscle paresis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,insulin dependent diabetes mellitus,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,bleeding Vaginal,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,respiratory alkalosis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,decubitus ulcer,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,drug toxicity NOS,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,myelodysplasia,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,loss of weight,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,neumonia,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,haemorrhage rectum,CID000001117,14808-79-8,[O-]S(=O)(=O)[O-]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,neumonia,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,Adenopathy,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000002141,Amifostine,C(CN)CNCCSP(=O)(O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,erythema,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,drug toxicity NOS,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,Apnea,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,edema,CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,allergic dermatitis,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,atelectasis,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,increased white blood cell count,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,erythema multiforme,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,myelodysplasia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,respiratory alkalosis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,High blood pressure,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,myelodysplasia,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,edema,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,insulin dependent diabetes mellitus,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,hypermagnesemia,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,Convulsions Grand Mal,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,Bleeding,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,dermatitis medicamentosa,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,right heart failure,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,Dyspnea exertional,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,loss of weight,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,loss of weight,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,Bacteraemia,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,right heart failure,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,right heart failure,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,coughing blood,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,aortic stenosis,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,angiitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,thrombocytopenia,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,thrombocytopenia,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,arterial pressure NOS decreased,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,Adenopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,hypokalaemia,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,eruption,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,Bacteraemia,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,loss of weight,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,failure to thrive,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,right heart failure,CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,bradycardia,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,Fainting,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,thrombocytopenia,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,right heart failure,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,right heart failure,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,aortic stenosis,CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,diarrhea,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,weight gain,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,eruption,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,right heart failure,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,coughing blood,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000000159,61849-14-7,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,Back Ache,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,Back Ache,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,angiitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,erythema,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,erythema,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,ingrowing nail,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,erythema,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,apoplexy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,Back Ache,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,apoplexy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,Adenopathy,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,gastric inflammation,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,weight gain,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,gastric inflammation,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,erythema,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,erythema,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,apoplexy,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,back injury,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003419,4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3,erythema,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,deglutition disorder,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000443871,"N-{[(1S,3S)-3-Isopropylcyclohexyl]carbonyl}-D-phenylalanine",CC(C)C1CCCC(C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,arteriosclerotic heart disease,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002800,911-45-5,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,Paraesthesia,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002800,911-45-5,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,weight gain,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002800,911-45-5,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,Hypoventilation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002800,911-45-5,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,cleft palate,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002800,911-45-5,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,Hypoventilation,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002800,911-45-5,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,agitated,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002800,911-45-5,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,neuropathy,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,aspiration pneumonia,CID000003198,Econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,back injury,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,myelodysplasia,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,drug toxicity NOS,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,edema,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,back injury,CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Dyspnea exertional,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abnormal EEG,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,eruption,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,back injury,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,icterus,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Decreased Libido,CID000002973,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,back injury,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,aspiration pneumonia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abnormal ECG,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,inflammatory bowel disease,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,myelodysplasia,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Acne,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,angiitis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Back Ache,CID000024011,BLAH,S=[Se]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Dyspnea exertional,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,back injury,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Dyspnea exertional,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,right heart failure,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,myelodysplasia,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,atelectasis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,eruption,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Pain,CID000003730,66108-95-0,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,angina,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,eruption,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abnormal ECG,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,belching,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gout,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,adenomyosis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,agitated,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,haematoma,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,angiitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,angiitis,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Bleeding,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,bursitis,CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,right heart failure,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,myelodysplasia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,ear infection,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,allergic dermatitis,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,methaemoglobinaemia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,alopecia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,bursitis,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,dysarthria,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,back injury,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,elevated cholesterol,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholelithiasis,CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,allergic dermatitis,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,muscle disorder,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Acne,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,nausea,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,acute pancreatitis,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,dacrocystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,dysarthria,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,dyspepsia,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abnormal EEG,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Adenopathy,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,drug toxicity NOS,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Adenopathy,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,myelodysplasia,CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,malnourished,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Acne,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,right heart failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,heart attack,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Back Ache,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Pain,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,nasopharyngitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,aphasia,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,dysarthria,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,drug toxicity NOS,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abdominal pain upper,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gout,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,insulin dependent diabetes mellitus,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abnormal ECG,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,methaemoglobinaemia,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002806,(±)-Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,apoplexy,CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,Dyspnea exertional,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,apoplexy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,nausea,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,rotator cuff syndrome,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,abnormal ECG,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,insulin dependent diabetes mellitus,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,proctalgia,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,gastric inflammation,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,bradycardia,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,back injury,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,allergic dermatitis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,Arrhythmia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005379,(±)-Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,acute psychosis,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,Back Ache,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,Paraesthesia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,thrombocytopenia,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,elevated cholesterol,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,loss of weight,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,abnormal ECG,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000054688,CHEMBL143,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,loss of weight,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,diarrhea infectious,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000012536,"(4bS,6bS,9aR,10aS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,Adenopathy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000123606,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,bulging,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,deglutition disorder,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Bone Fracture Spontaneous,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,drug toxicity NOS,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,thrombocytopenia,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,abnormal ECG,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,elevated cholesterol,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,herpes simplex,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,emesis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,thrombocytopenia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,eruption,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,confusion,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,apoplexy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,anogenital warts,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,agranulocytoses,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,myelodysplasia,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Sinus headache,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,Hepatic failure,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000036811,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,lung infiltration,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,erythema,CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Dyspnea exertional,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Dyspnea exertional,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,bladder retention,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,erythema,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Dyspnea exertional,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,narcolepsy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,ear infection,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Sinus headache,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,allergic dermatitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,polymyalgia rheumatica,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Dyspnea exertional,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,dysarthria,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,ear infection,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,gastric inflammation,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,loss of weight,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Dyspnea exertional,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,apoplexy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,abnormal ECG,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,gastric inflammation,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,angiitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003463,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,insulin dependent diabetes mellitus,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,renal tubular acidosis,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,metabolic encephalopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,enlarged spleen,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,thrombocytopenia,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,right heart failure,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,hypermagnesemia,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,thrombocytopenia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,myelodysplasia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,loss of weight,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,apoplexy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Adenopathy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,rotator cuff syndrome,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,atelectasis,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,elevated cholesterol,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystectomies,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,loss of weight,CID000024011,BLAH,S=[Se]
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,abnormal EEG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,erythema,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,apoplexy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,apoplexy,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,apoplexy,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Back Ache,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,haemorrhoids,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Infection Upper Respiratory,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,eruption,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,elevated cholesterol,CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,abnormal ECG,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Back Ache,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,bursitis,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,apoplexy,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,arterial pressure NOS decreased,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,thrombocytopenia,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,dizziness,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,contact dermatitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,thrombocytopenia,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,difficulty in walking,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,increased white blood cell count,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,hypermagnesemia,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,weight gain,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,loss of weight,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,drug toxicity NOS,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,encephalopathy,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,erythema,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Infection Upper Respiratory,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,drug toxicity NOS,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,loss of weight,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Adenopathy,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,abnormal EEG,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,loss of weight,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,thrombocytopenia,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,angiitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Sinus headache,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000004583,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,difficulty in walking,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,enlarged liver,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,erythema,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,dermatitis exfoliative,CID003085017,52757-95-6,C=CCN.C1C(O1)CCl
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,contracture,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,angiitis,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,dermatitis exfoliative,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,hypermagnesemia,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,erythema,CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,enlarged liver,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,cholecystitis,CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,angiitis,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,edema,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,neumonia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,loss of weight,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,cellulitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,myelodysplasia,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,thrombocytopenia,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,Adenopathy,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,High blood pressure,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,thrombocytopenia,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,loss of weight,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,gastric inflammation,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,myelodysplasia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,drug toxicity NOS,CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,contracture,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,drug toxicity NOS,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,loss of weight,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,pleural pain,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,drug toxicity NOS,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,confusion,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,gastric inflammation,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,angiitis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,angiitis,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,abnormal EEG,CID000002019,50-76-0,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,Pain,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,erythema,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,gastric inflammation,CID000001117,14808-79-8,[O-]S(=O)(=O)[O-]
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,Arrhythmia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,acute kidney failure,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000000598,2-Mercaptoethanesulfonic acid,C(CS(=O)(=O)O)S,Adenopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,cellulitis,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,dysarthria,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,abscess,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,angiitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,bladder retention,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,metabolic encephalopathy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Back Ache,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,apoplexy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,loss of weight,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Dyspnea exertional,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Adenopathy,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,angiitis,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Supraventricular tachycardia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,apoplexy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,cholecystectomies,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,agitated,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,apoplexy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Adenopathy,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Dyspnea exertional,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,dysarthria,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,abnormal EEG,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,bursitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,gastric inflammation,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Bone Fracture Spontaneous,CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,trigeminal neuralgia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,adenomyosis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Adenopathy,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,gastric inflammation,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,allergic dermatitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,back injury,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002284,1134-47-0,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,weight gain,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID003085017,52757-95-6,C=CCN.C1C(O1)CCl,Blood calcium decreased,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID003085017,52757-95-6,C=CCN.C1C(O1)CCl,hydronephrosis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,anaphylactic reaction,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholelithiasis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,apoplexy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,elevated cholesterol,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,nasopharyngitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,arteriosclerotic heart disease,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,thrombocytopenia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,back injury,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,alopecia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000024011,BLAH,S=[Se]
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,eruption,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,disseminated lupus erythematosus,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,insulin dependent diabetes mellitus,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,disease of liver,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,apoplexy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,apoplexy,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,belching,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,asthma,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,enlarged liver,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,defaecation urgency,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,erythema,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,High blood pressure,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,abdominal pain upper,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,abnormal ECG,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,icterus,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Acne,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,weight gain,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,insulin dependent diabetes mellitus,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,aortic regurgitation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,belching,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,confusion,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,apoplexy,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,apoplexy,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,elevated cholesterol,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,weight gain,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,bulging,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,asthenia,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004829,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,nocturia,CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,tracheostomy,CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,malnourished,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,abnormal EEG,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,loss of weight,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,loss of weight,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,deglutition disorder,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,cellulitis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,loss of weight,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,loss of weight,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,Bleeding,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,atelectasis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,respiratory alkalosis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,atelectasis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,drug toxicity NOS,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,dysarthria,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,periodontitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,myelodysplasia,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,loss of weight,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,respiratory alkalosis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003385,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,weight gain,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000060198,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C,hyperalimentation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C,allergic dermatitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C,deglutition disorder,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C,Pleural Effusion,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005195,(±)-selegiline,CC(CC1=CC=CC=C1)N(C)CC#C,nervous tension,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,gastric inflammation,CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,atelectasis,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,hepatitis toxic,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,abnormal ECG,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,elevated cholesterol,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,apoplexy,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,insulin dependent diabetes mellitus,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,cholecystitis,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,loss of weight,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,thrombocytopenia,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Acidosis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Adenopathy,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,loss of weight,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,gastric inflammation,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,palsies,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,apoplexy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,insulin dependent diabetes mellitus,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,drug toxicity NOS,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Abnormal LFTs,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,constipated,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Adenopathy,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,herpes simplex,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,thrombocytopenia,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,allergic dermatitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,allergic dermatitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,drug toxicity NOS,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,apoplexy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,abnormal ECG,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,cholecystitis,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,hepatitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,hepatic necrosis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,allergic dermatitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,ear ache,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,loss of weight,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,weight gain,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Bleeding,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,gastric inflammation,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,elevated cholesterol,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Back Ache,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,loss of weight,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,ectopic pregnancies,CID000040976,"(17R)-13-Ethyl-17-ethynyl-17-hydroxy-11-methylene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one",CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003203,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,eruption,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Difficulty breathing,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,gastric inflammation,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,asthenia,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,upper gastrointestinal bleeding,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Acute Respiratory Distress Syndrome,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,hyperuricaemia,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,deglutition disorder,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,abnormal ECG,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,neumonia,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,parotid gland enlargement,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,thrombocytopenia,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,loss of weight,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,nausea,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,angiitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,erythema,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,icterus,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,apoplexy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,abnormal ECG,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,allergic dermatitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,acute kidney failure,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,cholecystitis,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,drug toxicity NOS,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,enlarged liver,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,hepatic neoplasia,CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Hepatic failure,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,dysarthria,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,dysarthria,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,peritonitis,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,bursitis,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,weight gain,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,abnormal ECG,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,tracheostomy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Infection Upper Respiratory,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Sinus headache,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,weight gain,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,erythema,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,cholecystitis,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,angiitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,deglutition disorder,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,trigeminal neuralgia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003877,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,enlarged liver,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,hypochloraemia,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cataract,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,respiratory alkalosis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gout,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,loss of weight,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,dysarthria,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,respiratory alkalosis,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,allergic dermatitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,abnormal EEG,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,allergic dermatitis,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,eruption,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,angiitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,abnormal ECG,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,abnormal ECG,CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,Neuromuscular Disorder,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002153,Theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,abortion spontaneous,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000077993,143322-58-1,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,Acne,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,abnormal ECG,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,subarachnoid haemorrhage,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,loss of weight,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,cellulitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,loss of weight,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,hyperglycaemia,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,Ekbom Syndrome,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,subarachnoid haemorrhage,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,High blood pressure,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,loss of weight,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,elevated cholesterol,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,thrombocytopenia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002732,chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,bleeding Vaginal,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,thrombocytopenia,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,icterus,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,cholecystitis,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,Acidosis,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,Spinal fracture,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,gastric inflammation,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,drug toxicity NOS,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,eruption,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,Difficulty breathing,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,weight gain,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000005155,Stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,loss of weight,CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,abnormal ECG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,tremor,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,edema,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,cellulitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,abnormal ECG,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,eruption,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,atelectasis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,aptyalism,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,abnormal ECG,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,loss of weight,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,rhinorrhea,CID000444033,"2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate",CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,gastric inflammation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Back Ache,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,thrombocytopenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,adenitis,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,glaucoma,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Chronic Kidney Disease,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,erythema,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Colon Spastic,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,abnormal ECG,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,loss of weight,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O,apoplexy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,confusion,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,muscle disorder,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000074989,95233-18-4,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,acute pancreatitis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,deglutition disorder,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,trigeminal neuralgia,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,heart attack,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,angina,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,enlarged liver,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,confusion,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Adenopathy,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,drug toxicity NOS,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,ear infection,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,angiitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,apoplexy,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,dizziness,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,edema,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Back Ache,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,High blood pressure,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Pain,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Dyspnea exertional,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,thrombocytopenia,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,hiccough,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,drug toxicity NOS,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,increased white blood cell count,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,gastric inflammation,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,odynophagia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,edema,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,constipated,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,nausea,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,drug toxicity NOS,CID000004913,procainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,atelectasis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Excess potassium,CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,abnormal EEG,CID000003730,66108-95-0,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,angina,CID000003734,"N,N′-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide",CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,methaemoglobinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,dysarthria,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,angiitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,drug toxicity NOS,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Gastric Cancer,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Acute Respiratory Distress Syndrome,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,methaemoglobinaemia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,apoplexy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,ecchymoses,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,right heart failure,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,fractured pelvis NOS,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,angiitis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,hepatitis B,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,High blood pressure,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Adenopathy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003676,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,heart rate increased,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Bacteraemia,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,angiitis,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,still birth,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Bleeding,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,insulin dependent diabetes mellitus,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,loss of weight,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Clotting,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Bacteraemia,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,abnormal ECG,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,neumonia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Alcoholic intoxication,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Adenopathy,CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Neutropenia,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,weight gain,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,mast cell disease,CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,loss of weight,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Dyspnea exertional,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,drug toxicity NOS,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Bleeding,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,insulin dependent diabetes mellitus,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,loss of weight,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Infection Upper Respiratory,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,loss of weight,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Neutropenia,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,bulging,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,abnormal EEG,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,myelodysplasia,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,weight gain,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Adenopathy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,myelodysplasia,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003367,2-Fluoro-9-pentofuranosyl-9H-purin-6-amine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,Clotting,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,proctalgia,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,dacrocystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Pain,CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,erythema,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Infection Upper Respiratory,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,diarrhea,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Back Ache,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Back Ache,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,loss of weight,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,bleeding Vaginal,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,loss of weight,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,allergic dermatitis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,High blood pressure,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,acanthosis nigricans,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,erythema,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,agitated,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,loss of weight,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,methaemoglobinaemia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,dry skin,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,nasopharyngitis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,methaemoglobinaemia,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,eruption,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,angiitis,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,renal abscess,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Cerebral thrombosis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,erythema,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,dacrocystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,loss of weight,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,brain neoplasm,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystectomies,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,dysarthria,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,drug toxicity NOS,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,eruption,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,hepatitis,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Bacteraemia,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,rotator cuff syndrome,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,periodontitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,bursitis,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,angiitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,abnormal EEG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,belching,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,abnormal EEG,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,dysarthria,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Adenopathy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Adenopathy,CID005329102,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,back injury,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Ekbom Syndrome,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Back Ache,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Back Ache,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Acne,CID000024011,BLAH,S=[Se]
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,dyspepsia,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,thrombocytopenia,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,apoplexy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,agitated,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,dacrocystitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,colitis ischemic,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gout,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,allergic dermatitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,respiratory alkalosis,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,failure to thrive,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Dyspnea exertional,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Adenopathy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,loss of weight,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gout,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,loss of weight,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Bleeding,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Bacteraemia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Bacteraemia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Back Ache,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,methaemoglobinaemia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,apoplexy,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,loss of weight,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,weight gain,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,narcolepsy,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,apoplexy,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,nasopharyngitis,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003672,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,apoplexy,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000003730,66108-95-0,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,bradycardia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003730,66108-95-0,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,body temperature increased,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,cholecystectomies,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,metabolic encephalopathy,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,loss of weight,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,Enuresis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,loss of weight,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,Adenopathy,CID000003372,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,loss of weight,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,drug toxicity NOS,CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,ADH inappropriate,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,cholelithiasis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,bulging,CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,drug toxicity NOS,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,Bilirubinaemia,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,amentia,CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,trigeminal neuralgia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,drug toxicity NOS,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,loss of weight,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,drug toxicity NOS,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,cholelithiasis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,metabolic encephalopathy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,Porphyria,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,Adenopathy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,elevated cholesterol,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002726,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,metabolic encephalopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,eruption,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,rotator cuff syndrome,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,rotator cuff syndrome,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,rotator cuff syndrome,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004999,36735-22-5,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,rotator cuff syndrome,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,edema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,bulging,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,nasal sinus congestion,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,Near Syncope,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,apoplexy,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,constipated,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,apoplexy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,weight gain,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,drug toxicity NOS,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,gastroenteritis viral,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,confusion,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,Aspartate Aminotransferase Increase,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004547,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,motor retardation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,nasopharyngitis,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,right heart failure,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,drowsiness,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,bursitis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,loss of weight,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,right heart failure,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,drug toxicity NOS,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,flashbacks,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,erythema,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,cholecystitis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,insulin dependent diabetes mellitus,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Pain,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Pain,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,weight gain,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,apoplexy,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Bleeding,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,insulin dependent diabetes mellitus,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,back injury,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,weight gain,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,failure to thrive,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Excess potassium,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,right heart failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,rhinorrhea,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,elevated cholesterol,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,back injury,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,thrombocytopenia,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,disseminated lupus erythematosus,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,deglutition disorder,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,enlarged liver,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,cholecystitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Sinus headache,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,lung edema,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,thrombocytopenia,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,drug toxicity NOS,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,abnormal EEG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Adenopathy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,constipated,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,weight gain,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Acne,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,drug toxicity NOS,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Back Ache,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Sinus headache,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,ear infection,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,periodontitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,bursitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,loss of weight,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,hypermagnesemia,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,aphasia,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,difficulty in walking,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,allergic dermatitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,weight gain,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,right heart failure,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Neutropenia,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,subarachnoid haemorrhage,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,eruption,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,edema extremities,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,drug toxicity NOS,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,neumonia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Ovarian cancer,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,loss of weight,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,drug toxicity NOS,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,right heart failure,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Adenopathy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,elevated cholesterol,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,hepatic neoplasia,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,atelectasis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Adenopathy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,High blood pressure,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,edema,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,gout,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,thrombocytopenia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,cellulitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,abdominal pain upper,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,gout,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,myelodysplasia,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,asthenia,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,malnourished,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,erythema,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,right heart failure,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,hepatic neoplasia,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Back Ache,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,gastric inflammation,CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Diplopia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,arteriosclerotic heart disease,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,weight gain,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,subarachnoid haemorrhage,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Bone Fracture Spontaneous,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,weight gain,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Sinus headache,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,colitis ischemic,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,loss of weight,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Bleeding,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,apoplexy,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,angiitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,thrombocytopenia,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,drug toxicity NOS,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002471,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,High blood pressure,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,hepatitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,still birth,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,neumonia,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,drug toxicity NOS,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,thrombocytopenia,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,anaemia,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,bursitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,proctitis,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,Arrhythmia,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,chondrocalcinosis pyrophosphate,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003305,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,thrombocytopenia,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,loss of consciousness,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,High blood pressure,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,Adenopathy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,loss of weight,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003410,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,Adenopathy,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,angiitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,myelodysplasia,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,abnormal EEG,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003449,MLS000766281,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,drug toxicity NOS,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Pain,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,wheeze,CID000444033,"2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate",CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,allergies,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,loss of weight,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,thrombocytopenia,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,confusion,CID000002266,Azelaic acid,C(CCCC(=O)O)CCCC(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,neumonia,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Acne,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,loss of weight,CID000002733,95-25-0,C1=CC2=C(C=C1Cl)NC(=O)O2
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,increased white blood cell count,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,High blood pressure,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,eruption,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,loss of weight,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,ear infection,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,anaemia,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Bacteraemia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,eruption,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000024011,BLAH,S=[Se]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,heart rate increased,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,eruption,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,drug withdrawal,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,neumonia,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gout,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,insulin dependent diabetes mellitus,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,respiratory failure,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,abnormal EEG,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,aching muscles,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,neuropathy,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,bulging,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,abnormal EEG,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,adenomyosis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,aspiration pneumonia,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,bleeding Vaginal,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,drug withdrawal,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,loss of weight,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,ADVERSE DRUG EFFECT,CID000003008,Racemethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,weight gain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,atelectasis,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,excessive thirst,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,loss of weight,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,head injury,CID000002973,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,weight gain,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,High blood pressure,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,deglutition disorder,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,myelodysplasia,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,deglutition disorder,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,drug withdrawal,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,abnormal ECG,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Back Ache,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000003372,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,adenomyosis,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,abnormal ECG,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,muscle inflammation,CID000004645,"2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydro-1,3,12(2H,4H,5H)-tetracenetrione",CC1(C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,atelectasis,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,angiitis,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,back injury,CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,neumonia,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,heart rate increased,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Dyspnea exertional,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Back Ache,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,High blood pressure,CID000002141,Amifostine,C(CN)CNCCSP(=O)(O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,myelodysplasia,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,erythema,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,ear infection,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,weight gain,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,drug toxicity NOS,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,weight gain,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,thrombocytopenia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,nasopharyngitis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,High blood pressure,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,right heart failure,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Dyspnea exertional,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,dysarthria,CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Adenopathy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,neumonia,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,back injury,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,abnormal ECG,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,colitis,CID009571074,"(6R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,abnormal EEG,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,apoplexy,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,gastric inflammation,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002083,(±)-Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,drug toxicity NOS,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,atelectasis,CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,bursitis,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,weight gain,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,atelectasis,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000002725,chlorphenamine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Cardiomyopathy,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,eruption,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,xerosis,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,angiitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,angiitis,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Hepatitis A,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Back Ache,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Ovarian cancer,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,deep vein thromboses,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cholecystitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,atelectasis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,High blood pressure,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Back Ache,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Dyspnea exertional,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,atelectasis,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,abnormal ECG,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Bladder inflammation,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,methaemoglobinaemia,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Neuralgia,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,dysarthria,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,angiitis,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,abnormal ECG,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,abnormal ECG,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,elevated cholesterol,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cellulitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Neutropenia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Back Ache,CID000004873,Potassium chloride,[Cl-].[K+]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,alopecia,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,hepatic neoplasia,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000004211,53-19-0,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Back Ache,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cholecystectomies,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,colitis ischemic,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,drug toxicity NOS,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,haematoma,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Back Ache,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,edema,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Pain,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,increased white blood cell count,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,metabolic encephalopathy,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Ovarian cancer,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,eruption,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Bone Fracture Spontaneous,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,eruption,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Dyspnea exertional,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,right heart failure,CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,increased white blood cell count,CID000002708,Chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,weight gain,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cholecystitis,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,angiitis,CID000002019,50-76-0,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,confusion,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Cystitis Interstitial,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000005731,"ZOLMITRIPTAN, (R)-",CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,Paraesthesia,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,abnormal ECG,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,erythema,CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,empyema,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,thrombocytopenia,CID000002019,50-76-0,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,edema,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,abnormal EEG,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,rhinorrhea,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,peritonitis,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,haemorrhage rectum,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,dysarthria,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,apoplexy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,angiitis,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,drug toxicity NOS,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,abnormal EEG,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,sick sinus syndrome,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,myelodysplasia,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Abnormal LFTs,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,atelectasis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,allergic dermatitis,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,neuropathy,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Arrhythmia,CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,neumonia,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Adenopathy,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,allergic dermatitis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,abscess,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Back Ache,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Adenopathy,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,abnormal EEG,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,High blood pressure,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,abnormal EEG,CID000002725,chlorphenamine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,gastric inflammation,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,nausea,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,angiitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,angiitis,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Aspartate Aminotransferase Increase,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,angiitis,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,High blood pressure,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,thrombocytopenia,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,loss of weight,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,erythema,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,myelodysplasia,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,gastric inflammation,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,erythema,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Back Ache,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,allergic dermatitis,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,gastric inflammation,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,erythema,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,aortic regurgitation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,icterus,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,erythema,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,High blood pressure,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Hepatic failure,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,pulmonary arrest,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000001972,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,arterial pressure NOS decreased,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,increased white blood cell count,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Adenopathy,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Dyspnea exertional,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,back injury,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,rhinorrhea,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Acne,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,abnormal ECG,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,loss of weight,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,loss of weight,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,nasopharyngitis,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,erythema,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Adenopathy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,loss of weight,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Dyspnea exertional,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,apoplexy,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Adenopathy,CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,angiitis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,weight gain,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,agitated,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Back Ache,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,abnormal ECG,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,erythema,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,cholecystitis,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,right heart failure,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,haemorrhage rectum,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Adenopathy,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,erythema,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,insulin dependent diabetes mellitus,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Adenopathy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,erythema,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,ear infection,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002171,D-(−)-α-Amino-p-hydroxybenzyl penicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,gastric inflammation,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,apoplexy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,gastric inflammation,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,apoplexy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,gastric inflammation,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,Acne,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,gastric inflammation,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003403,"7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid",CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,thrombocytopenia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,nephrotic syndrome,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,myelodysplasia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,nephrotic syndrome,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000005746,mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,drug toxicity NOS,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,aortic regurgitation,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,bradycardia,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,drug toxicity NOS,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,angiitis,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Cardiomyopathy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,drug toxicity NOS,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,confusion,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,hepatic neoplasia,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Bleeding,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,elevated cholesterol,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Neutropenia,CID000153941,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one",C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,thrombocytopenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,gastric inflammation,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,apoplexy,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,apoplexy,CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,Aching joints,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,acute kidney failure,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,angiitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,muscle inflammation,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,hepatitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,angiitis,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,eruption,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,Decreased Libido,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,increased white blood cell count,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,High blood pressure,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,angiitis,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,angiitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,myelodysplasia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,dizziness,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,thrombocytopenia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,thrombocytopenia,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,angiitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Enuresis,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Decreased hearing,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,dysarthria,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,loss of weight,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,loss of weight,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,insulin dependent diabetes mellitus,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,erythema,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,loss of weight,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,allergic dermatitis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,thrombocytopenia,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,back injury,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Scleroderma,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,agitated,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Acute Respiratory Distress Syndrome,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,loss of weight,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,failure to thrive,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,bulging,CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Adenopathy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Decreased Libido,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,methaemoglobinaemia,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Adenopathy,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,cellulitis,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,insulin dependent diabetes mellitus,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,abnormal ECG,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,deglutition disorder,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Embolism pulmonary,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Adenopathy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,elevated cholesterol,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,agitated,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,cholecystitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Back Ache,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,insulin dependent diabetes mellitus,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,nephrotic syndrome,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Adenopathy,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,erythema,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004585,"2-Methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[2,3-b][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,abnormal EEG,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,Paraesthesia,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005078,144034-80-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,gastric inflammation,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,Arrhythmia,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,cardiovascular collapse,CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F
CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,phlebothrombosis,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,loss of weight,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000041693,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,right heart failure,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,elevated cholesterol,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,abnormal ECG,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,heart rate increased,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,abnormal ECG,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,bulging,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,nephrotic syndrome,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,cellulitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,weight gain,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,Back Ache,CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,apoplexy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,apoplexy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,back injury,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,gout,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,Back Ache,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,neumonia,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,Back Ache,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,abnormal EEG,CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,skin lesion,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,abnormal EEG,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,erythema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003869,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,eruption,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,renal abscess,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,abnormal EEG,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,thrombocytopenia,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,eruption,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,sepsis,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,proteinuria,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,elevated cholesterol,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,eruption,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,loss of weight,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,acute pancreatitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,Collagen disease,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,Back Ache,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,eruption,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,cholecystitis,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,hypermagnesemia,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,thrombocytopenia,CID000024011,BLAH,S=[Se]
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,thrombocytopenia,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,elevated cholesterol,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,apoplexy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,heart rate increased,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,apoplexy,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,High blood pressure,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,status epilepticus,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,acute pancreatitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,abnormal EEG,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,increased white blood cell count,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,diarrhea,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,myelodysplasia,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000005372,"17-Allyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)-1-propen-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,eruption,CID000213039,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Adenopathy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,angina,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gout,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,erythema,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,thrombocytopenia,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,apoplexy,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,drug withdrawal,CID000004091,657-24-9,CN(C)C(=N)N=C(N)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,deglutition disorder,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,respiratory alkalosis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,loss of weight,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,weight gain,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Adenopathy,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gout,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,bleeding Vaginal,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,apoplexy,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,apoplexy,CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,paranoia,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,apoplexy,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,weight gain,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,elevated erythrocyte sedimentation rate,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,weight gain,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,nasopharyngitis,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,hyperparathyroidism,CID000024011,BLAH,S=[Se]
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Osteoarthritis,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystectomies,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,allergic dermatitis,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,elevated cholesterol,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,eruption,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,loss of weight,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,aphasia,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,loss of weight,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,weight gain,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,bulging,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,dacrocystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Dyspnea exertional,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,elevated cholesterol,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,right heart failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,allergic dermatitis,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,erythema,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,loss of weight,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystectomies,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Adenopathy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,abnormal EEG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,adenomyosis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,angina,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,myelodysplasia,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,confusion,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,insulin dependent diabetes mellitus,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003961,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,deglutition disorder,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,deglutition disorder,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004991,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,dysarthria,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Back Ache,CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Back Ache,CID000024011,BLAH,S=[Se]
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,weight gain,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,bleeding Vaginal,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,hepatitis,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,apoplexy,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,myelodysplasia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,nasopharyngitis,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,hepatitis,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,dysarthria,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,erythema,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,eruption,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,muscle inflammation,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,atelectasis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Pain,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,myelodysplasia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,dysarthria,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Bladder inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,aseptic necrosis bone,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,myelodysplasia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,abnormal ECG,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,High blood pressure,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,constipated,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,atelectasis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,heart attack,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,bulging,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,kidney pain,CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,erythema,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Adenopathy,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Amnesia,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,hepatitis,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,abnormal ECG,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,abnormal ECG,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,enlarged liver,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,drug withdrawal,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,eruption,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,nausea,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,cholecystitis,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,erythema,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,insulin dependent diabetes mellitus,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,abnormal EEG,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,insulin dependent diabetes mellitus,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,enlarged liver,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,dysarthria,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,cholecystitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,gout,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,myelodysplasia,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Adenopathy,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,drug withdrawal,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,decubitus ulcer,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,deglutition disorder,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,cardiac murmur,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,apoplexy,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,Adenopathy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,gout,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,difficulty in walking,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,belching,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004091,657-24-9,CN(C)C(=N)N=C(N)N,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,Bleeding,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,subarachnoid haemorrhage,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,Chronic Kidney Disease,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005496,"4,6-Diamino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,6-trideoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,herpes zoster,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],apoplexy,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],bursitis,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],confusion,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],loss of weight,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],loss of weight,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],neumonia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],abnormal EEG,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],muscle disorder,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],weight gain,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],weight gain,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Adenopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cellulitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],neumonia,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],loss of weight,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],elevated cholesterol,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],thrombocytopenia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Adenopathy,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],apoplexy,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],neonatal respiratory distress syndrome,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Adenopathy,CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],apoplexy,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Adenopathy,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],acute pancreatitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],apoplexy,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],right heart failure,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Adenopathy,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],alopecia,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],High blood pressure,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],myelodysplasia,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],erythema,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],failure to thrive,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],AFIB,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Infection Upper Respiratory,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],arterial pressure NOS decreased,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],High blood pressure,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],thrombocytopenia,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],loss of weight,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],erythema,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],abnormal EEG,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cellulitis,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],myelodysplasia,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],trigeminal neuralgia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],arterial pressure NOS decreased,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],gastric inflammation,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],ventricular septal defect,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Excoriation,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],dizziness,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Adenopathy,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],constipated,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],allergic dermatitis,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],hypermagnesemia,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Adenopathy,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],gastric inflammation,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],abnormal EEG,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],allergic dermatitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],allergic dermatitis,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],loss of weight,CID000002141,Amifostine,C(CN)CNCCSP(=O)(O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],sleep disorder,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],loss of weight,CID000024011,BLAH,S=[Se]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],loss of weight,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],abnormal EEG,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],arterial pressure NOS decreased,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],gastric inflammation,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],apoplexy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],subarachnoid haemorrhage,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],edema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],metabolic encephalopathy,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],loss of consciousness,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],gastric inflammation,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],loss of weight,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000001117,14808-79-8,[O-]S(=O)(=O)[O-],Back Ache,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cerebellar ataxia,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,confusion,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Bleeding,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,arterial pressure NOS decreased,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Sinus headache,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Sinus headache,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,pyelonephritis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,haemorrhage intracranial,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,nasopharyngitis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,acute pancreatitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal ECG,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,dizziness,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Enuresis,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,subarachnoid haemorrhage,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cellulitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,edema,CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gout,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystectomies,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,atelectasis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Bleeding,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Infection Upper Respiratory,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal ECG,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002719,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,loss of weight,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,Back Ache,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,Dyspnea exertional,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,loss of weight,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,angiitis,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,gastric inflammation,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,cellulitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,thrombocytopenia,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,loss of weight,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,loss of weight,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,weight gain,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,periodontitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,weight gain,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,angiitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,apoplexy,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,neumonia,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,drug toxicity NOS,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,bronchiectasis,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,thrombocytopenia,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,weight gain,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,myocarditis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,angiitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,thrombocytopenia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,angiitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000091270,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,apoplexy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F,Arrhythmia,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000042113,Desflurane,C(C(F)(F)F)(OC(F)F)F,Bleeding,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,apoplexy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,thrombocytopenia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,hepatitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,High blood pressure,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,thrombocytopenia,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,leucocytosis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,Paraesthesia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,weight gain,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,angiitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,gout,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,apoplexy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,abdominal pain upper,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,Anorexia,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,nasopharyngitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,erythema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,apoplexy,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,bulging,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,weight gain,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,icterus,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,Hepatic failure,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,atrioventricular block,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,apoplexy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,abnormal ECG,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,bulging,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003108,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,abnormal ECG,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],apoplexy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],abortion spontaneous,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],apoplexy,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Adenopathy,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],cholecystitis,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],insulin dependent diabetes mellitus,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Adenopathy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],weight gain,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Adenopathy,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],cholecystitis,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],erythema,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],paranoia,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Back Ache,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],right heart failure,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],kidney failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],erythema,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],dysarthria,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002265,azothioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,drug toxicity NOS,CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,lung infiltration,CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,drug toxicity NOS,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,acanthosis nigricans,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,enlarged liver,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,Phlebitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,phlebothrombosis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,loss of weight,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,dry skin,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,weight gain,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,confusion,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,Drug hypersensitivity,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,abnormal EEG,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,Adenopathy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,abnormal ECG,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,apoplexy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,enlarged liver,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,loss of weight,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,Alcoholic intoxication,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,agitated,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002801,303-49-1,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,allergic dermatitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,dyspepsia,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,nervous tension,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Pain,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,abnormal EEG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,dysarthria,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000034312,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,bursitis,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000072054,"2-{1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide",C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,neumonia,CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,Acne,CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,Eustachian tube disorder,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,Arrhythmia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,Hypoventilation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,asthenia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,Adenopathy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,muscle inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,thrombocytopenia,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,nasopharyngitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,insulin dependent diabetes mellitus,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002749,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,High blood pressure,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Paraesthesia,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,anaemia,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,atelectasis,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,loss of weight,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Scleroderma,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Infection Upper Respiratory,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,edema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,right heart failure,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,insomnia,CID000060871,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,weight gain,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,apoplexy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,bursitis,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Chronic Kidney Disease,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,insulin dependent diabetes mellitus,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,cholecystitis,CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Adenopathy,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Back Ache,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,increased white blood cell count,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,thrombocytopenia,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Adenopathy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,asystole,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Acne,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,hypermagnesemia,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,weight gain,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,High blood pressure,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,thrombocytopenia,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,hydronephrosis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,thrombocytopenia,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,respiratory alkalosis,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,cellulitis,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,bradycardia,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,loss of weight,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,icterus,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,malnourished,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,erythema,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,weight gain,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,eruption,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,abnormal EEG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,apoplexy,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,weight gain,CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,haematoma,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004168,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,thrombocytopenia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000154059,solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,weight gain,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,atelectasis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,cellulitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,asthenia,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,body temperature increased,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,Acidosis,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,angiitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,aspiration pneumonia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005394,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,Bleeding,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,elevated cholesterol,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,loss of weight,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,rhinorrhea,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,panic attack,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,cholecystitis,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,abnormal ECG,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,edema,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,myelodysplasia,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,loss of weight,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,trigeminal neuralgia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,abnormal ECG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Abnormal Gait,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,hiccough,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,metabolic encephalopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,confusion,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,apoplexy,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,heart attack,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Dyspnea exertional,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,apoplexy,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,apoplexy,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,bursitis,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000004634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,deglutition disorder,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,High blood pressure,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,erythema,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,loss of weight,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,loss of weight,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,agitated,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,angiitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,apoplexy,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Back Ache,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Adenopathy,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,icterus,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,flu,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,back injury,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,ear infection,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,edema,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,apoplexy,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,neumonia,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,High blood pressure,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,allergic dermatitis,CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,abnormal ECG,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,loss of weight,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,erythema,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,apoplexy,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,elevated erythrocyte sedimentation rate,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,erythema,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Cardiomyopathy,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,drug toxicity NOS,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gout,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,loss of weight,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,weight gain,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,enlarged spleen,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,hepatitis,CID000004645,"2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydro-1,3,12(2H,4H,5H)-tetracenetrione",CC1(C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,body temperature increased,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Infection Upper Respiratory,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,chill,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Aspartate Aminotransferase Increase,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,ecchymoses,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,abnormal ECG,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,atelectasis,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,abnormal ECG,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,apoplexy,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,hiccough,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,angiitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,weight gain,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,eruption,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,High blood pressure,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Adenopathy,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,eruption,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,tetany,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,erythema,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Back Ache,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,apoplexy,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,bradycardia,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,herpes zoster,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,peritonitis,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,failure to thrive,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,insulin dependent diabetes mellitus,CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Bone Fracture Spontaneous,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,bursitis,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,apoplexy,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,apoplexy,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,Bacteraemia,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,infection,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,erythema,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,erythema,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002764,85721-33-1,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,gastric inflammation,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,erythema,CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,deglutition disorder,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,Infection Upper Respiratory,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,myelodysplasia,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,Small intestinal obstruction,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,loss of weight,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,erythema,CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,constipated,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,hemiparesis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,loss of weight,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,Adenopathy,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,enlarged liver,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,nervous tension,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,tremor,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,erythema,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,apoplexy,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,erythema,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,elevated cholesterol,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,loss of weight,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,apoplexy,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,Back Ache,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,drug toxicity NOS,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,apoplexy,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,diarrhea,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,gastric inflammation,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,agitated,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,neuropathy,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,confusion,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,erythema,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,weight gain,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,nervous tension,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,drug toxicity NOS,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,apoplexy,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,dysarthria,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,apoplexy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,dysarthria,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,Back Ache,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,deglutition disorder,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,proctalgia,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,hypoxia,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,Back Ache,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000942,22083-74-5,CN1CCCC1C2=CN=CC=C2,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,erythema,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastroenteritis viral,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,back injury,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,cholecystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gout,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,Adenopathy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,back injury,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,back injury,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,Dyspnea exertional,CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,abnormal EEG,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,loss of weight,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,back injury,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,back injury,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,cholecystitis,CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,abdominal pain upper,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,erythema,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002160,50-48-6,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,cholecystectomies,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004211,53-19-0,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,thrombocytopenia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,increased white blood cell count,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,insulin dependent diabetes mellitus,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,haematoma,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,drug toxicity NOS,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,gout,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,cholecystitis,CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Excoriation,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,loss of weight,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,gout,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,insulin dependent diabetes mellitus,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Acne,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,apoplexy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,abnormal ECG,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,cellulitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,dysphemia,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,haemorrhage intracranial,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,thrombocytopenia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,High blood pressure,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,loss of weight,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,allergic dermatitis,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,High blood pressure,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004170,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,nervous tension,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,abnormal ECG,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,loss of weight,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,abdominal pain upper,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,back injury,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,insulin dependent diabetes mellitus,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Back Ache,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,adenomyosis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,edema,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,abnormal ECG,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,right heart failure,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,sinus tachycardia,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,back injury,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,loss of weight,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,abdominal pain upper,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Adenopathy,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,erythema,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,neumonia,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,thrombocytopenia,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,apoplexy,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,weight gain,CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,loss of weight,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,agitated,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Adenopathy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,back injury,CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,apoplexy,CID000054547,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,abnormal ECG,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,apoplexy,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,abnormal ECG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,erythema,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,gastric inflammation,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Adenopathy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,loss of weight,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,back injury,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,belching,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,gastric inflammation,CID000024011,BLAH,S=[Se]
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,erythema,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,abnormal ECG,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Adenopathy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,weight gain,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,diarrhea,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,disseminated lupus erythematosus,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,rectal polyp,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,failure to thrive,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Dyspnea exertional,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,increased white blood cell count,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,erythema,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,loss of weight,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,gastric inflammation,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,nausea,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,erythema,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,erythema,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,gastric inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,insulin dependent diabetes mellitus,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,muscle disorder,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,gastric inflammation,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,weight gain,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,atelectasis,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Adenopathy,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,loss of weight,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,apoplexy,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,loss of weight,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Infection Upper Respiratory,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,aspiration pneumonia,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cellulitis,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,loss of weight,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004171,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,erythema,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,erythema,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,edema,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,apoplexy,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,bulging,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,thrombocytopenia,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,Hypotension Orthostatic,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,dizziness,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,nausea,CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,contracture,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,Arrhythmia,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,neumonia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,back injury,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,angioedema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,apoplexy,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,nausea,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,erythema,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,weight gain,CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,atelectasis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,Pain,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,haematoma,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,Bacteraemia,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,weight gain,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,Arrhythmia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,gastric inflammation,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,constipated,CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,drug toxicity NOS,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,dysarthria,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,angiitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,angiitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,gastric inflammation,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,loss of weight,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,glaucoma,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,palsies,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,kidney failure,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,right heart failure,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,dysarthria,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,sleep apnea,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,cardiovascular collapse,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,dysarthria,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,ear ache,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,edema,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,Pain,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,insulin dependent diabetes mellitus,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002550,EPICAPTOPRIL,CC(CS)C(=O)N1CCCC1C(=O)O,weight gain,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,hepatitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,weight gain,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000024011,BLAH,S=[Se]
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,subarachnoid haemorrhage,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,Osteogenesis Imperfecta,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,weight gain,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,apoplexy,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,weight gain,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,Bacteraemia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,deglutition disorder,CID000005070,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,ecchymoses,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,Acne,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,hyperglycaemia,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,weight gain,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,heart rate increased,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004885,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,erythema,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,Infection Urinary Tract,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,gastric inflammation,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,apoplexy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,sinus tachycardia,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000004614,Oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,cellulitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,bulging,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,abnormal ECG,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,apoplexy,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,abnormal ECG,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,hyperlipaemia,CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,Abnormal Gait,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,insulin dependent diabetes mellitus,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,apoplexy,CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,insulin dependent diabetes mellitus,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,apoplexy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,abnormal ECG,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,apoplexy,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,drug toxicity NOS,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003042,Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,insulin dependent diabetes mellitus,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,loss of weight,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,nasopharyngitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,facial flushing,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Bacteraemia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,dysarthria,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,gastric inflammation,CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,loss of weight,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Decreased Libido,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,drug toxicity NOS,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,gastric inflammation,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Dyspnea exertional,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,erythema,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,loss of weight,CID000024011,BLAH,S=[Se]
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,bradycardia,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,elevated cholesterol,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,bulging,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,cellulitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,back injury,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,apoplexy,CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,back injury,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005212,Sildenafil,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,loss of weight,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],thrombocytopenia,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],aortic regurgitation,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],hepatitis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],thrombocytopenia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],aspiration pneumonia,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],thrombocytopenia,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],cholecystitis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],apoplexy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],loss of weight,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],hepatic neoplasia,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],cholecystitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],increased white blood cell count,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],Dyspnea exertional,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],allergic dermatitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],alkalosis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000004609,(2-azanidylcyclohexyl)azanide;oxalic acid;platinum(2+),C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],Adenopathy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000001206,(±)-Metamfetamine,CC(CC1=CC=CC=C1)NC,allergic dermatitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000001206,(±)-Metamfetamine,CC(CC1=CC=CC=C1)NC,Colon Spastic,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001206,(±)-Metamfetamine,CC(CC1=CC=CC=C1)NC,insomnia,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000001206,(±)-Metamfetamine,CC(CC1=CC=CC=C1)NC,elevated cholesterol,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000001206,(±)-Metamfetamine,CC(CC1=CC=CC=C1)NC,drug toxicity NOS,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,apoplexy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,cholelithiasis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,sepsis,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,myocarditis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,muscle weakness,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,apoplexy,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,elevated cholesterol,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,abnormal EEG,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,body temperature increased,CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C
CID000004603,Ethyl 4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,abnormal EEG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000047725,"5-Oxoprolylhistidyl-N-[18,18-diamino-13-({2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-isobutyl-7-{[(2-methyl-2-propanyl)oxy]methyl}-2,5,8,11-te
traoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide",CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,malnourished,CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,drug toxicity NOS,CID006436173,80621-81-4,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C
CID000125017,desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,High blood pressure,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,amentia,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,loss of consciousness,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,nasopharyngitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,weight gain,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,septic shock,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,apoplexy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,bleeding Vaginal,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,Adenopathy,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,erythema,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005719,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,elevated cholesterol,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,ear ache,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,cholecystitis,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,CMV infection,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,Paraesthesia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,abnormal ECG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,drug toxicity NOS,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,angiitis,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,apoplexy,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,allergic dermatitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,deglutition disorder,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,abdominal pain upper,CID000057537,(±)-Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,loss of weight,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,abnormal EEG,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,contracture,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,contracture,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,drug toxicity NOS,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000005514,"(2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,petit mal,CID000051634,miglustat,CCCCN1CC(C(C(C1CO)O)O)O
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,insomnia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,rotator cuff syndrome,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,loss of weight,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Back Ache,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Dyspnea exertional,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,cholecystectomies,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,apoplexy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,cholecystectomies,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,cholecystectomies,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,insulin dependent diabetes mellitus,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,apoplexy,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002311,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,thrombocytopenia,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,insulin dependent diabetes mellitus,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,Bacteraemia,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,High blood pressure,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,Adenopathy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,atelectasis,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,erythema,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,thrombocytopenia,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,cholecystitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,confusion,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,insulin dependent diabetes mellitus,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,heart rate increased,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,gastroenteritis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003148,"3-oxooctahydro-2H-2,6-methanoquinolizin-8-yl 1H-indole-3-carboxylate",C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,increased white blood cell count,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,deglutition disorder,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,bleeding Vaginal,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,heart rate increased,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,abnormal EEG,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,insulin dependent diabetes mellitus,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,enlarged liver,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,apoplexy,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,septic shock,CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,abnormal EEG,CID004659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Adenopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Adenopathy,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Abnormal Gait,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,drug toxicity NOS,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,deglutition disorder,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,heart rate increased,CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,drug toxicity NOS,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,drug toxicity NOS,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Drug hypersensitivity,CID000056339,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,angiitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,erythema,CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,haemorrhage intracranial,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,angiitis,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,coughing blood,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,bleeding Vaginal,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,subarachnoid haemorrhage,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,erythema,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,drug toxicity NOS,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,acute pancreatitis,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,heart rate increased,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,apoplexy,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,abnormal ECG,CID000004873,Potassium chloride,[Cl-].[K+]
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Back Ache,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,abnormal EEG,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,back injury,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,meningioma,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,insulin dependent diabetes mellitus,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,haemorrhage intracranial,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,apoplexy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,deglutition disorder,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Fainting,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,hepatitis,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,dysarthria,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,cholecystitis,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,drug toxicity NOS,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,apoplexy,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,drug toxicity NOS,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,allergic dermatitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,angiitis,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,increased white blood cell count,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,loss of weight,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,acute pancreatitis,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000001775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,apoplexy,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,angiitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,Infection Upper Respiratory,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,confusion,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,right heart failure,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,edema extremities,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,enlarged liver,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,cellulitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,Bleeding,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,weight gain,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,deglutition disorder,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,heart rate increased,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,eruption,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003767,Isoniazid,C1=CN=CC=C1C(=O)NN,hepatitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],weight gain,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],erythema,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Acute Respiratory Distress Syndrome,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],elevated cholesterol,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],angiitis,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],neumonia,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],body temperature increased,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],palsies,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Acute Respiratory Distress Syndrome,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],back injury,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],thrombocytopenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],angiitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],heart rate increased,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],rotator cuff syndrome,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],paraplegia,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],loss of weight,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],allergic dermatitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],thrombocytopenia,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Dyspnea exertional,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],atelectasis,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholelithiasis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],flashing lights,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],loss of weight,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],apoplexy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],angiitis,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Amnesia,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],bulging,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],weight gain,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],lung edema,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],angiitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Adenopathy,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],rotator cuff syndrome,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],dysarthria,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],ADH inappropriate,CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Bleeding,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002658,3-[(Carbamoyloxy)methyl]-7-{[2-furyl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],hepatitis,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,insomnia,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,loss of weight,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,apoplexy,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,insulin dependent diabetes mellitus,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,periodontitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,dizziness,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,insulin dependent diabetes mellitus,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,apoplexy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,dry skin,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,OPTIC NEURITIS,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,obesity,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,obesity,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,periodontitis,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,allergic dermatitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,insulin dependent diabetes mellitus,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,periodontitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,Neutropenia,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,enlarged liver,CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,loss of weight,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,loss of weight,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,loss of weight,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,dry skin,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,arthritis,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,agitated,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000000861,rathyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,loss of weight,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Drug hypersensitivity,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,drug toxicity NOS,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [1-methyl-2-[3-[2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,increased white blood cell count,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,eruption,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,thrombocytopenia,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,edema,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,rhinorrhea,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,back injury,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,right heart failure,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,drug toxicity NOS,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Bacteraemia,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,apoplexy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,herpes zoster,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Infection Upper Respiratory,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,nervous tension,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,mycosis fungoides,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,weight gain,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,neumonia,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Bleeding,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,icterus,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,thrombocytopenia,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,back injury,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,constipated,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,insulin dependent diabetes mellitus,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Decreased Libido,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,erythema,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gout,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,elevated erythrocyte sedimentation rate,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,drug toxicity NOS,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,angiitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,confusion,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,myelodysplasia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,apoplexy,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,erythema,CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,myelodysplasia,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,apoplexy,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,weight gain,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,apoplexy,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,apoplexy,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Back Ache,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN,icterus,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN,neumonia,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN,loss of weight,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN,dysarthria,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN,thrombocytopenia,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN,nervous tension,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN,thrombocytopenia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN,neuropathy,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000125889,R-Pregabalin,CC(C)CC(CC(=O)O)CN,weight gain,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000104741,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,right heart failure,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,dysarthria,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,Bleeding,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,eruption,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,haemorrhage rectum,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,erythema,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,atelectasis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,constipated,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,abnormal ECG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,herpes zoster,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,muscle disorder,CID000024011,BLAH,S=[Se]
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,agitated,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,Adenopathy,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,pleural pain,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,bleeding Vaginal,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,enlarged liver,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,dysarthria,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,glaucoma,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,abnormal ECG,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,Adenopathy,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,adenomyosis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,nasopharyngitis,CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,cellulitis,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,ecchymoses,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,High blood pressure,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,angiitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,Adenopathy,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,eruption,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,Pain,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,nasopharyngitis,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,nasopharyngitis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,dysarthria,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,dysarthria,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,deglutition disorder,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,Ovarian cancer,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,hepatitis,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,weight gain,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,macula lutea degeneration,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,aseptic necrosis bone,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,Adenopathy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,Dyspnea exertional,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003032,"{2-[(2,6-Dichlorophenyl)amino]phenyl}acetate",C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,Adenopathy,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,gastric inflammation,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,Adenopathy,CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,decubitus ulcer,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,Infection Upper Respiratory,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,Adenopathy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,tracheostomy,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002187,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,apoplexy,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,Acne,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,apoplexy,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,gout,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,cholecystitis,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,gastric inflammation,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,angiitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002267,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,gastric inflammation,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000001546,2-Chloro-9-(2-deoxypentofuranosyl)-9H-purin-6-amine,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,Bacteraemia,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001546,2-Chloro-9-(2-deoxypentofuranosyl)-9H-purin-6-amine,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,enlarged liver,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000001546,2-Chloro-9-(2-deoxypentofuranosyl)-9H-purin-6-amine,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,enlarged liver,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,allergic dermatitis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,Dyspnea exertional,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,myelodysplasia,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,myelodysplasia,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,respiratory alkalosis,CID003002190,Telithromycin,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,Bone marrow fibrosis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,Adenopathy,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,Extrasystoles Ventricular,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,hematoma subdural,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,abnormal EEG,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,abnormal ECG,CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,right heart failure,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,cholecystitis,CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,edema,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,atelectasis,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,abnormal ECG,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,abnormal ECG,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,failure to thrive,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,loss of weight,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,drug toxicity NOS,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,Dyspnea exertional,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,bursitis,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,cerebral vascular disorder,CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,cholecystitis,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,abnormal ECG,CID000004911,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,agitated,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,cholecystitis,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,insulin dependent diabetes mellitus,CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,cholecystitis,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,respiratory failure,CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,icterus,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,dysarthria,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,cholecystitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,Infection Upper Respiratory,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,angiitis,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,gastric inflammation,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000002249,DL-Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,apoplexy,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],heart attack,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],loss of weight,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],thrombocytopenia,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],neumonia,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],abnormal ECG,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],elevated cholesterol,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002951,"1-({[5-(4-Nitrophenyl)-2-furyl]methylene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate",C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],right heart failure,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,acute kidney failure,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,urosepsis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,weight gain,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,Adenopathy,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,loss of weight,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,Pain,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,polymyalgia rheumatica,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004740,6493-05-6,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,Near Syncope,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,elevated cholesterol,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,acute kidney failure,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,eruption,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,loss of weight,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,abnormal EEG,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,thrombocytopenia,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Bone Fracture Spontaneous,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Adenopathy,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,heart rate increased,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Adenopathy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,deglutition disorder,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,methaemoglobinaemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,haemorrhage intracranial,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Enuresis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,methaemoglobinaemia,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,methaemoglobinaemia,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,loss of weight,CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,apoplexy,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,abnormal EEG,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,neumonia,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,insulin dependent diabetes mellitus,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,dry skin,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002955,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,cholecystitis,CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,thrombocytopenia,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,insulin dependent diabetes mellitus,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,failure to thrive,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,Enuresis,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,apoplexy,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,aching muscles,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,dysarthria,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,thrombocytopenia,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,Back Ache,CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,agitated,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,loss of consciousness,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,Multiple Myeloma,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,drug toxicity NOS,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,insulin dependent diabetes mellitus,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,Dyspnea exertional,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,dysarthria,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,weight gain,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,chronic active hepatitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,agitated,CID000003372,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,insulin dependent diabetes mellitus,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,deglutition disorder,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,hyperglycaemia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,elevated cholesterol,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002818,"8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,anaphylactic reaction,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,gout,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,gout,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,High blood pressure,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,abnormal ECG,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003379,"12-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,nausea,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,abnormal ECG,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,colitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,hypermagnesemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,Sinus headache,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,apoplexy,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,drug toxicity NOS,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,back injury,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005408,17-Hydroxyandrost-4-en-3-one,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,loss of weight,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,cholecystitis,CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,abnormal ECG,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,Multiple Myeloma,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,cholecystitis,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,constipated,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,constipated,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,apoplexy,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,methaemoglobinaemia,CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,erythema,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,agitated,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,dysarthria,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,weight gain,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,cholecystitis,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,apoplexy,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000024011,BLAH,S=[Se]
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,loss of weight,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,Dyspnea exertional,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,apoplexy,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,arterial pressure NOS increased,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,enlarged liver,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,arteriosclerotic heart disease,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,Enuresis,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,cholecystitis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,loss of weight,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,Arrhythmia,CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,Bleeding,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,disseminated lupus erythematosus,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,apoplexy,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,abnormal EEG,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,eruption,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,back injury,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,atelectasis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,bulging,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,erythema,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,thrombocytopenia,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,Back Ache,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,atelectasis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,bleeding Vaginal,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,weight gain,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,gastric inflammation,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000002895,303-53-7,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,Acne,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,gastric inflammation,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,periodontitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,myelodysplasia,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000068740,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,thrombocytopenia,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],heart attack,CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],chalazion,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],still birth,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],allergic dermatitis,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],gastric inflammation,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],apoplexy,CID005493381,"4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid",C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],gastric inflammation,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],thrombocytopenia,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000051263,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,drug toxicity NOS,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,dysarthria,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Fainting,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,thrombocytopenia,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Back Ache,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,High blood pressure,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,rotator cuff syndrome,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,loss of weight,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,insulin dependent diabetes mellitus,CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,ecchymoses,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,elevated cholesterol,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,agitated,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,thrombocytopenia,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Pleural Effusion,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,weight gain,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,erythema,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,loss of weight,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,loss of weight,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,loss of weight,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,dry skin,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000002435,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Infection Upper Respiratory,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,abnormal EEG,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,nasopharyngitis,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003706,1-[2-Hydroxy-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,hepatitis,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,hypochloraemia,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,cholecystitis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,thrombocytopenia,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,abnormal EEG,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,abnormal EEG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,dysarthria,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,muscle disorder,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,dizziness,CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,heart rate increased,CID000024011,BLAH,S=[Se]
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,Adenopathy,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,abnormal ECG,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,angiitis,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,Adenopathy,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004943,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,erythema,CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,gastric inflammation,CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Dyspnea exertional,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,gastric inflammation,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,loss of weight,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,loss of weight,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,abnormal EEG,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,loss of weight,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,angiitis,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,abdominal pain upper,CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Dyspnea exertional,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,apoplexy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003478,29094-61-9,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,respiratory alkalosis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,elevated cholesterol,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005578,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000060815,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,angiitis,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,weight gain,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,atelectasis,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,abdominal distension,CID000024011,BLAH,S=[Se]
CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,drowsiness,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,hyperalimentation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005401,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,cellulitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,cholecystitis,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,angiitis,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,cholecystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,cholecystitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,disseminated lupus erythematosus,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,Adenopathy,CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,cholecystitis,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,muscle inflammation,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,tooth disease,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,muscle disorder,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,edema,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,erythema,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,leucocytosis,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,abnormal ECG,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,apoplexy,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,abdominal pain upper,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,gastric inflammation,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,gastric inflammation,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,angiitis,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,weight gain,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003652,hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,loss of weight,CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,loss of weight,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,loss of weight,CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,cellulitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,asthenia,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,sepsis,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,back injury,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,diarrhea,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,chronic obstructive airway disease,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,acute pancreatitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,Back Ache,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,High blood pressure,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,thrombocytopenia,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,dizziness,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,thrombocytopenia,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,thrombocytopenia,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,gastric inflammation,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,thrombocytopenia,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,neumonia,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,erythema multiforme,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,thrombocytopenia,CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,anaphylactic reaction,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,angiitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,acute pancreatitis,CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,eruption,CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-]
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,constipated,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,confusion,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,Adenopathy,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000000581,DL-N-Acetylcysteine,CC(=O)NC(CS)C(=O)O,apoplexy,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000068844,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC,insulin dependent diabetes mellitus,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,loss of weight,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,elevated cholesterol,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,nervous tension,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,loss of weight,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,adenomyosis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,elevated cholesterol,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,periodontitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004409,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,adenomyosis,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,erythema,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,deglutition disorder,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,rhinorrhea,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,chest pain,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,respiratory failure,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,allergic dermatitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,stridor,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000004812,cis-Vitamin K1 (Z-Phytonadione),CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,rhinorrhea,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,Adenopathy,CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,gastric inflammation,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,myelodysplasia,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,dysarthria,CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,Back Ache,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,apoplexy,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,cellulitis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,Back Ache,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,colitis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,metabolic encephalopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,gastric inflammation,CID005473385,SCHEMBL12257420,C1=NC2C(=N1)NC(=NC2=S)N
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,Bacteraemia,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,muscle paresis,CID000005515,"8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,apoplexy,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,encephalitis viral,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,cholecystitis,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,erythema,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,gastric inflammation,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,apoplexy,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,cholecystitis,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,agitated,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,angiitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,bradycardia,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,increased white blood cell count,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,loss of weight,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,gastric inflammation,CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CID000003310,"9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-ethylidenehexopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,cellulitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000005184,(-)-Scopolamine,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,loss of weight,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000093860,((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,abnormal ECG,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,albuminuria,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,dysarthria,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005291,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,myelodysplasia,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,malnourished,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,weight gain,CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,erythema,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,drug toxicity NOS,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,heart rate increased,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000003008,Racemethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,periodontal disease,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,metabolic alkalosis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,Infection Upper Respiratory,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,abnormal ECG,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,apoplexy,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,allergic dermatitis,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,sunburn,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,loss of weight,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,insulin dependent diabetes mellitus,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,elevated cholesterol,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,gastric inflammation,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,allergic dermatitis,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,metabolic encephalopathy,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,apoplexy,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,cholecystitis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,cellulitis,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,apoplexy,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,periodontitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,loss of weight,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,disorder Renal,CID000003741,87771-40-2,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Gastrointestinal Obstruction,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,allergic dermatitis,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Arrhythmia,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,cholelithiasis,CID000016231,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,loss of weight,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Decreased Libido,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,gastric inflammation,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,bradycardia,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,eruption,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,apoplexy,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,loss of weight,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,erythema,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Bleeding,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,nasopharyngitis,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Adenopathy,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Decreased Libido,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,drug withdrawal,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,apoplexy,CID000082146,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,bradycardia,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,abnormal EEG,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,drug toxicity NOS,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,loss of weight,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,deep vein thromboses,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,constipated,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,insulin dependent diabetes mellitus,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,erythema,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003339,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,apoplexy,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,drug toxicity NOS,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,insulin dependent diabetes mellitus,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,drug toxicity NOS,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002476,"17-(Cyclopropylmethyl)-18-(2-hydroxy-3,3-dimethyl-2-butanyl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol",CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,erythema,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C,abnormal ECG,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C,adenomyosis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002308,"9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C,erythema,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,thrombocytopenia,CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-]
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,thrombocytopenia,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,elevated cholesterol,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,eruption,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,drug toxicity NOS,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Neutropenia,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,nasopharyngitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,dysarthria,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholelithiasis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,myelodysplasia,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Bleeding,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,thrombocytopenia,CID000002019,50-76-0,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Back Ache,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,erythema,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,apoplexy,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,abnormal ECG,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,hepatitis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,angiitis,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,gastric inflammation,CID000151165,Alternative Stereochemistry Form of Aprepitant CSID133235,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
CID000000143,folinic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cholecystitis,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],hepatitis,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],elevated cholesterol,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],enlarged liver,CID000002266,Azelaic acid,C(CCCC(=O)O)CCCC(=O)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Acne,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],abnormal ECG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Adenopathy,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],aspiration pneumonia,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],cholecystitis,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],apoplexy,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],loss of weight,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],elevated cholesterol,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Back Ache,CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],loss of weight,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Dyspnea exertional,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Sinus headache,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],apoplexy,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Bleeding,CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Chronic Kidney Disease,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],angina,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],cholecystectomies,CID000004873,Potassium chloride,[Cl-].[K+]
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Extrasystoles Ventricular,CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],angiitis,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],erythema,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Back Ache,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],asthenia,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],back injury,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],heart rate increased,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],panic attack,CID000024011,BLAH,S=[Se]
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],belching,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Dyspnea exertional,CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],pancreatitis,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],metabolic acidosis,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],cholecystitis,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],pulmonary hypertension,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],loss of weight,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],cholecystitis,CID000002676,"7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000000937,Nicotinate,C1=CC(=CN=C1)C(=O)[O-],Dyspnea exertional,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,gastric inflammation,CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,gastric inflammation,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,Back Ache,CID000004873,Potassium chloride,[Cl-].[K+]
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,apoplexy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,haemorrhage intracranial,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,dysarthria,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,Adenopathy,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,angiitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,elevated cholesterol,CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,polymyalgia rheumatica,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,failure to thrive,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,apoplexy,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,cellulitis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,gastric inflammation,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,angiitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,apoplexy,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,dysarthria,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002786,Methyl 5-{2-chloro-1-[(1-methyl-4-propylprolyl)amino]propyl}-1-thiopentopyranoside,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,eruption,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,heart rate increased,CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,elevated cholesterol,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005402,"N,6,6-Trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine",CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,Erythema nodosum,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,cellulitis,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,cellulitis,CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,loss of weight,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,eyelid diseases,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,dysarthria,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,insulin dependent diabetes mellitus,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,Adenopathy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,gastric inflammation,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,Adenopathy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,thrombocytopenia,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,adenomyosis,CID000004873,Potassium chloride,[Cl-].[K+]
CID000004513,P41PML4GHR,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,High blood pressure,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000054808,"Chloromethyl (8ξ,9ξ,11β,14ξ,17α)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate",CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,blindness,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,apoplexy,CID000003121,Valproic acid,CCCC(CCC)C(=O)O
CID000003066,"5′-Benzyl-12′-hydroxy-2′-methyl-3′,6′,18-trioxo-9,10-dihydroergotaman",CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,chest pain,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000003008,Racemethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,loss of weight,CID000004873,Potassium chloride,[Cl-].[K+]
CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,abnormal ECG,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000054841,83015-26-3,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,eruption,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,loss of weight,CID000004873,Potassium chloride,[Cl-].[K+]
CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,abnormal ECG,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,dysarthria,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,eruption,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000003168,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,edema extremities,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004873,Potassium chloride,[Cl-].[K+],weight gain,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004873,Potassium chloride,[Cl-].[K+],erythema,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000004873,Potassium chloride,[Cl-].[K+],bursitis,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004873,Potassium chloride,[Cl-].[K+],Hypoventilation,CID000024011,BLAH,S=[Se]
CID000004873,Potassium chloride,[Cl-].[K+],cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004873,Potassium chloride,[Cl-].[K+],apoplexy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004873,Potassium chloride,[Cl-].[K+],gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004873,Potassium chloride,[Cl-].[K+],dysarthria,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000004873,Potassium chloride,[Cl-].[K+],loss of weight,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004873,Potassium chloride,[Cl-].[K+],gastric inflammation,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004873,Potassium chloride,[Cl-].[K+],hypermagnesemia,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004873,Potassium chloride,[Cl-].[K+],rhabdomyolysis,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004873,Potassium chloride,[Cl-].[K+],confusion,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004873,Potassium chloride,[Cl-].[K+],Diplopia,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004873,Potassium chloride,[Cl-].[K+],thrombocytopenia,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000004873,Potassium chloride,[Cl-].[K+],diarrhea,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000004873,Potassium chloride,[Cl-].[K+],cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004873,Potassium chloride,[Cl-].[K+],polymyalgia rheumatica,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004873,Potassium chloride,[Cl-].[K+],folate deficiency,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000004873,Potassium chloride,[Cl-].[K+],atelectasis,CID005282044,"N-[(5aR,6aS,7S,9Z,10aS)-9-[Amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-N~2~-tert-butylglycinamide",CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C
CID000004873,Potassium chloride,[Cl-].[K+],cardiac murmur,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000004873,Potassium chloride,[Cl-].[K+],thrombocytopenia,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000004873,Potassium chloride,[Cl-].[K+],abdominal pain upper,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000004873,Potassium chloride,[Cl-].[K+],cholecystitis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004873,Potassium chloride,[Cl-].[K+],loss of weight,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000004873,Potassium chloride,[Cl-].[K+],Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004873,Potassium chloride,[Cl-].[K+],loss of weight,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000004873,Potassium chloride,[Cl-].[K+],subarachnoid haemorrhage,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,thrombocytopenia,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,Pain,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,apoplexy,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,weight gain,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,gastric inflammation,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,cholecystitis,CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,constipated,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,insulin dependent diabetes mellitus,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,insulin dependent diabetes mellitus,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,Arrhythmia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,loss of weight,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,cholecystitis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,confusion,CID000004730,"3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,gastric inflammation,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,glaucoma,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,ADH inappropriate,CID000004645,"2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydro-1,3,12(2H,4H,5H)-tetracenetrione",CC1(C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,loss of weight,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,muscle paresis,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,failure to thrive,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,abnormal ECG,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,loss of weight,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,Back Ache,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004205,85650-52-8,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,cellulitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,Abnormal LFTs,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,abnormal ECG,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,dysarthria,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,myelodysplasia,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,Decreased Libido,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,herpes zoster,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,Back Ache,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,elevated cholesterol,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,dysarthria,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,Adenopathy,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,abnormal ECG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,abnormal ECG,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000005002,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,icterus,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,decubitus ulcer,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,muscle weakness,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,cholelithiasis,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,agitated,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,acute psychosis,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Dyspnea exertional,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002474,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,drug toxicity NOS,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,edema,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,weight gain,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,apoplexy,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,constipated,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,abnormal ECG,CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,thrombocytopenia,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,abnormal EEG,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,dysarthria,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,loss of weight,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,Infection Upper Respiratory,CID000051634,miglustat,CCCCN1CC(C(C(C1CO)O)O)O
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,drug toxicity NOS,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,body temperature increased,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,Bleeding,CID000003381,"4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,birth defect,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,gastric inflammation,CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,constipated,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,CMV infection,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,apoplexy,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,apoplexy,CID000004845,Pirbuterol,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,gastric inflammation,CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,eruption,CID000071158,Acamprosate,CC(=O)NCCCS(=O)(=O)O
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,insulin dependent diabetes mellitus,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,gastric inflammation,CID000005454,5591-45-7,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,gastric inflammation,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,drug toxicity NOS,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,bruxism,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,insulin dependent diabetes mellitus,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,Enuresis,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,Burns Second Degree,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,acute pancreatitis,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,cellulitis,CID000003372,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,drug toxicity NOS,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,insulin dependent diabetes mellitus,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,aphasia,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,contracture,CID000444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,deglutition disorder,CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,apoplexy,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003121,Valproic acid,CCCC(CCC)C(=O)O,eruption,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003467,"4,6-Diamino-3-({3-amino-6-[1-(methylamino)ethyl]tetrahydro-2H-pyran-2-yl}oxy)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,increased white blood cell count,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000000815,"4,6-diamino-3-[(6-amino-6-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxyhexopyranoside",C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N,Bleeding,CID000001046,pyrazinamide,C1=CN=C(C=N1)C(=O)N
CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,Difficulty breathing,CID005362070,Balsalazide,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O
CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,apoplexy,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,bulging,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,nocturia,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,abnormal ECG,CID000110635,171596-29-5,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,thrombocytopenia,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,abnormal EEG,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000004236,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,High blood pressure,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,eruption,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,gastric inflammation,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,erythema,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000003902,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,bursitis,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],rotator cuff syndrome,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],metabolic acidosis,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],apoplexy,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],odynophagia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],dysarthria,CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],Infection Upper Respiratory,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],drug toxicity NOS,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],gastric inflammation,CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
CID000003780,"1,4:3,6-Dianhydro-2,5-di-O-nitrohexitol",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000056959,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,deglutition disorder,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,icterus,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,Adenopathy,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,cellulitis,CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,Back Ache,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,Dyspnea exertional,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,gastric inflammation,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000002269,"2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methylhexopyranoside",CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,myelodysplasia,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000005472,Ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,aortic regurgitation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,thrombocytopenia,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,insulin dependent diabetes mellitus,CID000003454,Ganciclovir,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,flashing lights,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,elevated cholesterol,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,loss of weight,CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,respiratory alkalosis,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,colitis,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,folate deficiency,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,gastric inflammation,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005426,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,thrombocytopenia,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO,heart rate increased,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000001046,pyrazinamide,C1=CN=C(C=N1)C(=O)N,subarachnoid haemorrhage,CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O
CID000001046,pyrazinamide,C1=CN=C(C=N1)C(=O)N,deglutition disorder,CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000001046,pyrazinamide,C1=CN=C(C=N1)C(=O)N,adenitis,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000001046,pyrazinamide,C1=CN=C(C=N1)C(=O)N,Infection Upper Respiratory,CID000005297,"2,2′-[4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-C-formylpentofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID000013342,(+)-Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,thrombocytopenia,CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,rhabdomyolysis,CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,nephrotic syndrome,CID000004727,DL-Penicillamine,CC(C)(C(C(=O)O)N)S
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Aspartate Aminotransferase Increase,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,allergic dermatitis,CID000004819,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,angiitis,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Infection Urinary Tract,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,gastric inflammation,CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,back injury,CID000024486,Calcium chloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2]
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,dysarthria,CID000002283,SR-05000001570,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CCCCNC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,folate deficiency,CID000002637,3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,deglutition disorder,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,allergic dermatitis,CID000072938,"7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,eruption,CID000047320,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,thrombocytopenia,CID000004748,Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,eruption,CID000115237,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,dermatitides,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,High blood pressure,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,abnormal EEG,CID000002725,chlorphenamine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,loss of weight,CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,eruption,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,dacrocystitis,CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Pain,CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,erythema,CID000003724,Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,loss of weight,CID000002099,122852-42-0,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,loss of weight,CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,contracture,CID000002019,50-76-0,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID005311027,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,loss of weight,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,apoplexy,CID000003637,hydralazine,C1=CC=C2C(=C1)C=NN=C2NN
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Bacteraemia,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,haemorrhage rectum,CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,erythema,CID000002141,Amifostine,C(CN)CNCCSP(=O)(O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,apoplexy,CID000508230,2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)acetic acid,CC1=C2COC(=O)C2=C(C(=C1OC)CC(=O)O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,haematoma,CID000004195,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,abnormal EEG,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,right heart failure,CID000002512,6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,allergic dermatitis,CID000003914,LEVOBUNOLOL,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,thrombocytopenia,CID000005486,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,cholecystitis,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,kidney failure,CID000197712,(±)-AMBRISENTAN,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,abnormal ECG,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Porphyria,CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,nasopharyngitis,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,loss of weight,CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,apoplexy,CID000024011,BLAH,S=[Se]
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,neonatal respiratory distress syndrome,CID000002673,CHEMBL1161461,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,haemorrhage rectum,CID000002675,79350-37-1,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,gastric inflammation,CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,atelectasis,CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Back Ache,CID000003964,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,gastric inflammation,CID000004178,31828-71-4,CC1=C(C(=CC=C1)C)OCC(C)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,constipated,CID000004828,13523-86-9,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,rhinorrhea,CID000003384,"9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione",CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,respiratory alkalosis,CID000003382,"2-(4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,apoplexy,CID000003381,"4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-2-one",CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,acute pancreatitis,CID000003414,Dioxidophosphinecarboxylate oxide,C(=O)([O-])P(=O)([O-])[O-]
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,apoplexy,CID000005352,{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,periodontitis,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,erythema,CID000003114,Disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,drug toxicity NOS,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,aspiration pneumonia,CID000003198,Econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,atelectasis,CID003062316,302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,thrombocytopenia,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,erythema,CID000004932,54063-53-5,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,abnormal ECG,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,increased white blood cell count,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,Neuromuscular Disorder,CID000071273,"ROPIVACAINE, (R)-",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,erythema,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,dysarthria,CID000003040,"6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,subarachnoid haemorrhage,CID000002973,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
CID000001983,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,gastric inflammation,CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004542,CHEBI:7630,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,Ovarian Cyst,CID000004771,122-09-8,CC(C)(CC1=CC=CC=C1)N
CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,erythema,CID000002274,"2-[({1-(2-Amino-1,3-thiazol-4-yl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene}amino)oxy]-2-methylpropanoic acid",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N
CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,angiitis,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002142,4-Amino-N-{5-amino-2-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,Adenopathy,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,erythema,CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3
CID000004674,Pamidronic acid,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Adenopathy,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000000158,"11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,cerebral palsy,CID000005771,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003461,3'-Epi Gemcitabine (Gemcitabine Impurity),C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,cholecystitis,CID000148211,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5
CID000004993,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,eruption,CID000005215,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
CID000000564,Aminocaproic acid,C(CCC(=O)O)CCN,weight gain,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000000564,Aminocaproic acid,C(CCC(=O)O)CCN,weight gain,CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000004440,121679-13-8,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,insomnia,CID000077992,158747-02-5,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000060184,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,thrombocytopenia,CID000150310,"Methyl (4aS,4bR,6aS,7R,9aS,10R)-4a,6a-dimethyl-2,5′-dioxo-2,4,4′,4a,5′,5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3′H-spiro[cyclopenta[7,8]phenanthro[4b,5-b]oxirene-7,2′-furan]-10-carboxylate",CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC
CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,angina,CID000004834,"6-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,bulging,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000003702,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,erythema,CID000005525,1-{2-[(1-Ethoxy-1-oxo-4-phenyl-2-butanyl)amino]propanoyl}octahydro-1H-indole-2-carboxylic acid,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
CID000002375,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,elevated cholesterol,CID000003397,Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,elevated cholesterol,CID000060164,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000005381,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,nasopharyngitis,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000060787,CHEMBL296480,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,apoplexy,CID000060877,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,deglutition disorder,CID006435110,"(18E,19E,21E,23′S,24S,27R,33R,36R,37S,38′R,39R,45R,46S)-36,46-dihydroxy-37-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-38′-isopropyl-23′,24,40,41-tetramethyl-spiro[51,54,55-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(40),19,21(42),22(41)-tetraene-45,2′-tetrahydropyran]-43-one;(18E,19E,21E,24′S,25S,28R,34R,37R,38S,39′R,40R,46R,47S)-37,47-dihydroxy-38-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-24′,25,41,42-tetramethyl-39′-sec-butyl-spiro[52,55,56-trioxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]pentacosa-18(41),19,21(43),22(42)-tetraene-46,2′-tetrahydropyran]-44-one",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
CID000003827,34580-13-7,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,Bleeding,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000003821,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,thrombocytopenia,CID000060612,119717-21-4,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000041317,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,mycosis fungoides,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000003278,58-54-8,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl,edema,CID000003784,75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],eruption,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],drug toxicity NOS,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000004607,"3,3-dimethyl-6-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-]
CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],sepsis,CID000002637,3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3
CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Acute Respiratory Distress Syndrome,CID000004053,melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
CID000002622,"7-{[(2-Amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],methaemoglobinaemia,CID000027991,"1-{[7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolylarginylglycinamide",C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,proctalgia,CID000119182,123318-82-1,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000003494,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,erythema,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
CID000002637,3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3,Adenopathy,CID000060696,SCHEMBL13875772,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
